Tissue-Specific Roles for Hedgehog Co-Receptors During Vertebrate Embryogenesis by Echevarria Andino, Martha




Martha L. Echevarria Andino 
 
A dissertation submitted in partial fulfillment 
 of the requirements for the degree of  
Doctor of Philosophy  
(Cell and Developmental Biology) 





Associate Professor Jason Spence, Co-Chair  
Professor Deneen Wellik, Co-Chair   
Associate Professor Benjamin Allen 
Professor Vesa Kaartinen  



























To my family. 




I would like to acknowledge many individuals who made this work possible helping me 
professionally and personally. 
First, I would like to thank my undergraduate mentors Edu Suárez-Martinez and Abigail 
Ruiz, who gave me my first opportunity to do research. Thank you both for believing in my 
potential, sparking my interest in science and for showing me all the opportunities that were 
available for me. 
Also, I want to acknowledge my mentor Ben Allen, I cannot thank you enough for all the 
things that you have taught me over all these years. You are an amazing scientist. Your 
excitement for science, creativity to design experiments, collaborative skills, skepticism, strong 
ethics and morals have taught me how to do high quality science. Thank you for teaching me 
how to do great science and for making me a scientist. Being your trainee has been a privilege. 
Thanks for your endless patience and for always making time to talk, even when you did not 
have time. I really appreciate all the time that you spent teaching me concepts, discussing 
experiments, analyzing data, reviewing my written work and improving my presentation skills. 
You have also provided me with numerous opportunities to present my research, learn new 
techniques, and endless resources to do every experiment that I wanted. Thanks for providing me 
encouragement and unconditional support professionally and personally. Your integrity, 
kindness, wisdom, and characteristic humor has positively impacted my personality and has 
made me a better person. Thanks for being so nice, sometimes way too nice! You are an 
 iv 
outstanding mentor and scientist and I will be eternally grateful for the having had the 
opportunity of being your trainee. Gracias Ben!      
Thank you to all the former and current members of the Allen lab: Jane, Irene, Justine, 
Brandon, Alex, Arielle, Nicole, Mike, Bridget, Anna, Tyler, Nina, Haeyoung and Hannah. 
Thanks for creating an amazing, collaborative and productive lab environment. We spend so 
much time together that I consider you my family, I will never forget all of our adventures in and 
outside the lab. Also, I would like to thank the Allen lab undergraduates, Katarina, Sam, Allie, 
Melissa, Rajko, Philip, Christa, Ahmad, Nayanna, Justine, Anna, Olivia, and Savannah for their 
continuous support to keep the lab running. I also want to acknowledge the technical assistance 
of Nicole and Savannah, which helped me move my research project forward. 
I would also like to thank my thesis committee, Deneen Wellik, Marina Pasca Di 
Magliano, Jason Spence, and Vesa Kaartinen. Thanks for all the helpful discussions to improve 
my research project and the professional advice to move my career forward. Especially, I would 
like to thank Deneen. Thanks for your professional and personal support. Thanks for challenging 
me to be a better scientist, to do great science, and for setting the example of a fearless woman in 
science. 
Thanks to the staff of the Cell and Developmental Biology department for their help in all 
the administrative aspects of graduate school. Specifically, Karen Lang, Brittney Longeway, 
Rebecca Rennells, Lori Mirabitur, Kristen Hug, Deontae Hooks, Annette Klomparens and Mohi 
Shakibafar and Brooke Lorigan. Thanks for all the things that you do to make CDB a great place 
for students! I also want to thank the Giger, Wellik, Engel, Spence, O’Shea and Schipani 
laboratories for providing equipment, reagents and mouse models to make my research possible. 
I want to extend my gratitude to Ben Allen, Deb Gumucio, Deneen Wellik and Scott Barolo and 
 v 
the CDB department staff for supporting the initiation and development of the outreach program 
Developing Future Biologists. Furthermore, thanks to all the students, postdocs and professors 
that kept this program running. To the CDB students and my peers, Seth, Emily, Rafi for 
interesting science discussions and always be willing to make fun of all the ups and downs of 
graduate school. I would also give special thanks to the BSRB building employee, David Jones, 
who always checked in on my well-being and made sure to make me laugh to keep the stress 
away.  
Additionally, I want to express my gratitude to the Microscopy and Image Analysis 
Laboratory and the MicroCT Core at the University of Michigan. Especially, to Sasha Meshinchi 
and Michelle Lynch for their assistance. Also, I want to acknowledge Yang Chai and Thach Vu 
Ho at the University of Southern California and Christopher Panaretos at the University of 
Michigan for teaching me how to do three dimensional reconstructions in different software. I 
am also grateful for our collaborator Robert Krauss at Icahn School of Medicine at Mount Sinai 
for providing mouse models for my research. This work would not have been possible with the 
funding from, the NSF Graduate Research Fellowship Program, Rackham Merit Fellowship 
(DGE1256260), Bradley Merill Patten Fellowship, Rackham Pre-Candidate Graduate Student 
Research Grant, Rackham Travel Grants and the Travel Award from the American Association 
of Anatomists (AAA). Also, I want to acknowledge the funding support from the Organogenesis 
Training Grant (T32 HD00705) from the Center of Organogenesis, and to its former director 
Linda Samuelson and current administrator Tamika Mohr.  
I want to thank my Ann Arbor family, Barbara, Leilani, Jorge, titi Nilda, Luna, Yanaira, 
Andrea, Elliot, Robinson; thanks for always make me feel like I was at home. To my friends, 
 vi 
Jane and Molly for all the fun adventures during this journey and for always being there. All of 
you helped to me to get through this and made it more bearable.  
Thanks to my family for their continuous support even in the distance and unconditional 
love. To my parents William and Marta, for believing in me and always saying yes to support 
me, and for saying no if I wanted to give up. To my siblings Analyd and William, for showing 
me how hard work and perseverance achieves dreams. To my nephews, William Alexander, 
Angel Gabriel and Dylan for your contagious joy and all the nerf gun battles that relieved my 
stress from graduate school. Also, I want to acknowledge my godparents César and Liper who 
have always supported me in all my academic and personal aspirations. Finally, to my significant 
other, Andy. Thanks for your support, love and for making me laugh during every stressful 













List of Tables x 
List of Figures xi 
Abstract xiv 
Chapter 1 Cell Surface Regulation of the Hedgehog Signaling Pathway During Vertebrate 
Embryogenesis 1 
1.1 Abstract .................................................................................................................................. 1 
1.2 Hedgehog signaling from its discovery to its role in development and disease .................... 2 
1.2.1 Discovery of the Hedgehog gene and core pathway components in Drosophila ........... 2 
1.2.2 Hedgehog pathway functions during vertebrate embryogenesis .................................... 4 
1.2.3 SHH signaling in birth defects and disease ................................................................... 12 
1.3 Cell surface regulation of HH signaling .............................................................................. 13 
1.3.1 HH ligand synthesis ...................................................................................................... 13 
1.3.2 HH ligand release and trafficking mediated by cell surface proteins ........................... 14 
1.3.3 HH ligand reception and trafficking ............................................................................. 18 
 viii 
1.3.3 HH ligand trafficking independent of cell surface proteins .......................................... 23 
1.3.4 HH ligand reception ...................................................................................................... 25 
1.3.6 HH ligand-independent cell surface regulators ............................................................. 42 
1.4 Tissue specific roles for GAS1, CDON and BOC ............................................................... 53 
1.5 Conclusion ........................................................................................................................... 55 
1.6 Figures ................................................................................................................................. 57 
Chapter 2 The Hedgehog Co-Receptor BOC Differentially Regulates SHH Signaling During 
Craniofacial Development 85 
2.1 Abstract ................................................................................................................................ 85 
2.2 Introduction ......................................................................................................................... 86 
2.3 Results ................................................................................................................................. 89 
2.4 Discussion ............................................................................................................................ 99 
2.4.1 Genetic background-dependent phenotypic differences in HH co-receptor mutants . 100 
2.4.2 Tissue-specific functions of Boc in HH signal transduction ...................................... 103 
2.4.3 Boc as a multi-functional regulator of HH signaling .................................................. 103 
2.5 Materials and methods ....................................................................................................... 105 
2.6 Acknowledgements ........................................................................................................... 115 
2.7 Author contributions .......................................................................................................... 116 
2.8 Tables ................................................................................................................................. 117 
2.10 References ....................................................................................................................... 139 
 ix 
Chapter 3 Cdon is Required for Proper HH-Dependent Patterning of the Developing Limb 144 
3.1 Abstract .............................................................................................................................. 144 
3.2 Introduction ....................................................................................................................... 145 
3.3 Results ............................................................................................................................... 148 
3.4 Discussion .......................................................................................................................... 152 
3.4.1 Novel role for CDON during digit specification and limb development .................... 153 
3.4.2 Forelimb and hindlimb phenotypic differences .......................................................... 154 
3.4.3 Role of Gas1, Cdon and Boc in SHH-dependent digit specification .......................... 155 
3.5 Materials and methods ....................................................................................................... 156 
3.6 Acknowledgments ............................................................................................................. 160 
3.7 Author contributions .......................................................................................................... 160 
3.8 Tables ................................................................................................................................. 161 
3.9 Figures ............................................................................................................................... 163 
3.10 References ....................................................................................................................... 170 
Chapter 4 Discussion and Future Directions 174 
4.1 Summary of findings ......................................................................................................... 174 
4.2 Future directions ................................................................................................................ 176 
4.3 Figures ............................................................................................................................... 188 
4.4 References ......................................................................................................................... 189 
 x 
List of Tables 
Table 2.1 General reagents .......................................................................................................... 117 
Table 2.2 Primary and secondary antibodies used for immunofluorescence .............................. 119 
Table 2.3 Western blot antibodies ............................................................................................... 120 
Table 2.4 qRT-PCR primers ........................................................................................................ 121 
Table 3.1 General reagents II ...................................................................................................... 161 
Table 3.2 Primary antibodies used for immunofluorescence II .................................................. 162 
 
 xi 
List of Figures 
 
Figure 1.1 Summary of vertebrate HH signal transduction .......................................................... 57 
Figure 1.2 Shh expression and function in E10.5 mouse tissues. ................................................. 57 
Figure 1.3 Cell surface regulation of HH signaling. ..................................................................... 58 
Figure 2.1 The HH co-receptors Gas1, Cdon and Boc are expressed throughout early craniofacial 
development. ............................................................................................................................... 122 
Figure 2.2 Gas1, Cdon and Boc are differentially expressed across multiple HH-responsive 
tissues. ......................................................................................................................................... 123 
Figure 2.3 Loss of Boc results in midface widening and increased Gli1 expression on a congenic 
C57BL/6J background. ................................................................................................................ 124 
Figure 2.4 Telencephalic vesicle division and MNP separation in Gas1, Cdon and Boc mutants.
 ..................................................................................................................................................... 125 
Figure 2.5 Gas1, but not Cdon or Boc, mutant embryos exhibit decreased embryo size at E10.5.
 ..................................................................................................................................................... 126 
Figure 2.6 The Spectrum of HPE phenotypes correlates with changes in Gli1 expression. ....... 127 
Figure 2.7 Tissue-specific rescue of HH signaling in E10.5 Gas1;Boc double mutant embryos.
 ..................................................................................................................................................... 128 
Figure 2.8 Reduced Crown-Rump Length in E10.5 Gas1;Boc double mutant embryos. ........... 129 
Figure 2.9 Reduced Gli1 mRNA and protein levels in E10.5 Gas1 mutant forelimb buds ........ 130 
 xii 
Figure 2.10 Selective contribution of Boc to patterning of the neural tube, but not the forebrain 
neuroepithelium. .......................................................................................................................... 131 
Figure 2.11 Boc promotes HH-dependent neural patterning in the developing chicken ............ 132 
Figure 2.12 Partial rescue of HPE phenotypes persists through E18.5 in Gas1;Boc mutant 
embryos. ...................................................................................................................................... 133 
Figure 2.13 HPE phenotypes and digit specification defects in E18.5 Gas1;Boc mutant embryos.
 ..................................................................................................................................................... 134 
Figure 2.14 E18.5 Gas1;Boc mutants display partially ameliorated midfacial defects. ............. 135 
Figure 2.15 Boc selectively inhibits mesenchymal proliferation during craniofacial development.
 ..................................................................................................................................................... 136 
Figure 2.16 Boc does not contribute to neural tube or forelimb mesenchyme proliferation. ..... 137 
Figure 2.17 BOC is a multi-functional regulator of HH signaling. ............................................. 138 
Figure 3.1 Analysis of HH-coreceptor expression and function in the developing forelimb bud.
 ..................................................................................................................................................... 163 
Figure 3.2 Gas1;Boc and Gas1;Cdon but not Cdon;Boc mutant embryos exhibit significant 
reduction of Gli1 in the developing forelimb bud. ...................................................................... 164 
Figure 3.3 Analysis of limb development in single and double HH co-receptors mutants. ........ 165 
Figure 3.4 Conditional Cdon knockout allele. ............................................................................ 166 
Figure 3.5 Prx1-Cre recombination activity in E10.5 embryos. ................................................. 167 
Figure 3.6 Tissue-specific expression of Cre recombinase in the developing forelimb bud and 
spinal cord of Prx1-Cre;tdTomato E10.5 embryos. .................................................................... 168 
Figure 3.7 Digit specification and long bone defects in E18.5 Prx1-Cre;Gas1-/-;Cdonfl/fl;Boc-/-.
 ..................................................................................................................................................... 169 
 xiii 





The Hedgehog (HH) signaling pathway is essential for the proper patterning of multiple 
tissues during vertebrate embryogenesis, including the spinal cord, craniofacial structures, and 
limbs. At the cell surface, secreted HH ligands signal through the canonical receptor Patched 1 
(PTCH1) and three co-receptors– GAS1, CDON and BOC. Interestingly, these proteins share 
similar expression patterns throughout development, bind to HH ligands, and interact with 
PTCH1. Together, these HH co-receptors are essential to transduce HH signaling in multiple 
tissues during embryogenesis. 
Recent studies suggest that, in addition to their combined, essential role in HH signal 
transduction, these co-receptors also play individual, tissue-specific roles in the regulation of HH 
signaling. However, the tissue-specific contributions of these co-receptors remain largely 
unexplored during vertebrate embryogenesis. The goals of this dissertation are to:  1) investigate 
novel tissue-specific roles for the HH co-receptors and 2) elucidate the mechanism of HH co-
receptor function during vertebrate embryogenesis.  
During craniofacial development, the individual deletion of HH co-receptors results in 
variable craniofacial defects, in which the severity of the phenotype is dependent on the genetic 
background. To investigate the individual and combined contributions of the HH co-receptors to 
craniofacial development, I analyzed Gas1, Cdon and Boc mutant embryos on a congenic 
C57BL/6J background. The deletion of Gas1 and Cdon result in variable degrees of 
holoprosencephaly; a birth defect characterized by the complete or partial failure of the forebrain 
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and the midface structures. In contrast, Boc deletion results in midface widening. Increasing 
severity of the craniofacial defects in Gas1 and Cdon mutants correlated with decreased levels of 
HH pathway activity, while Boc mutants display increased levels of HH pathway function. These 
data suggest that the HH co-receptors differentially contribute to craniofacial development. 
Further, Boc deletion in a Gas1 null background partially ameliorates the phenotypes observed in 
Gas1 single mutants.  However, the rescue of the craniofacial defects observed in Gas1;Boc 
mutants is restricted to the craniofacial structures, while other tissues patterned by HH are more 
severely affected. Mechanistically, BOC can also selectively restrict proliferation in the cranial 
neural crest-derived mesenchyme. These data suggest that Boc functions as a tissue-specific HH 
pathway antagonist during craniofacial development.  
In this thesis, I also investigated the contribution of HH co-receptors to digit specification 
and limb patterning. Notably, previous studies have demonstrated roles for both Gas1 and Boc in 
HH-dependent digit specification, but not for Cdon. However, the known redundant functions of 
these HH co-receptors, combined with the early (embryonic day 9.5) lethality of Gas1;Cdon;Boc 
triple mutants has hindered efforts to definitively examine a potential contribution of Cdon to 
limb development. To dissect the function of CDON during HH-dependent digit specification, I 
performed limb-specific deletion of Cdon in a Gas1;Boc null background. Embryos lacking 
Gas1, Cdon and Boc display both severe digit specification defects in the radius, ulna, tibia and 
fibula. These experiments demonstrate that CDON does indeed contribute to digit specification 
and limb patterning. Overall, the data presented in this dissertation demonstrate that HH co-
receptors contribute in both a redundant and tissue-specific fashion to HH signal transduction, 
and that these co-receptors are multi-functional regulators of HH signaling during vertebrate 
embryogenesis. 
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The Hedgehog (HH) signaling pathway is evolutionarily conserved across many organisms. 
HH signaling is essential for proper tissue and organ formation during embryonic and postnatal 
development and tissue homeostasis during adulthood. Secreted HH ligands act as classic 
morphogens, eliciting different cellular responses in a time-and concentration-dependent manner. 
Interestingly, HH ligands are employed iteratively across different organisms to establish 
different body plans and also within an organism to specify different tissues and organs with 
disparate functions. An outstanding question is: How does a single pathway elicit a multitude of 
distinct cellular responses necessary to achieve such diversity within and across organisms? One 
potential explanation is found in the plethora of cell surface-associated proteins and extracellular 
matrix components that regulate the release, trafficking and signal reception of HH ligands. 
Recently, three proteins– GAS1, CDON and BOC have been identified as essential HH co-
receptors. Together these proteins are required for HH signal transduction in multiple tissues at 
different developmental stages. However, the mechanisms by which these co-receptors regulate 
HH signaling remain poorly understood. Further, genetic evidence suggests that these co-
receptors are differentially employed in a tissue-specific manner to mediate distinct HH signaling 
outcomes. Thus, elucidating how different cell surface proteins regulate HH signaling in a tissue-
specific manner will be critical to understand how HH patterns different tissues during 
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development. Additionally, understanding the cell surface regulation of HH signaling can 
provide significant insight into how mutations in the genes that encode these factors contribute to 
HH-driven diseases, including a variety of birth defects, developmental disorders and various 
pediatric and adult cancers. In this chapter, I review the HH pathway components that control the 
release, trafficking, and reception of HH ligands with an emphasis on the HH co-receptors 
GAS1, CDON and BOC. 
 
1.2 Hedgehog signaling from its discovery to its role in development and disease  
1.2.1 Discovery of the Hedgehog gene and core pathway components in Drosophila  
The Hedgehog (Hh) gene was originally identified in Drosophila genetic screens to 
identify mutations that affected the segmental pattern of the larvae (Nusslein-Volhard and 
Wieschaus, 1980). Drosophila larvae with mutations in Hh displayed patterning defects in 
segmental units containing denticles that were reminiscent of hedgehog spines, leading to the 
assignment of the Hh gene name (Nusslein-Volhard and Wieschaus, 1980). However, its cloning 
and molecular characterization occurred over a decade later, were HH was described as a 
secreted protein that provided patterning information to neighboring cells (Lee et al., 1992; 
Mohler and Vani, 1992; Tabata et al., 1992; Taylor et al., 1993).  
The HH gene is evolutionarily conserved across the animal kingdom including sea 
urchin, planaria, zebrafish, chicken, mouse and human (Ingham et al., 2011). In mammals, the 
HH gene has three homologs, Sonic Hedgehog (Shh), Indian Hedgehog (Ihh) and Desert 
Hedgehog (Dhh) (Echelard et al., 1993; Krauss et al., 1993; Riddle et al., 1993). Their distinct 
expression patterns suggested that these vertebrate homologs had both overlapping and unique 
functions during development (Bitgood and McMahon, 1995). Shh, is the most studied of the 
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three HH genes in vertebrates. Its expressed in major organizing signaling centers including the 
zone of polarizing activity in the limb bud (Riddle et al., 1993), the notochord and floor plate of 
the neural tube (Echelard et al., 1993; Roelink et al., 1994; Roelink et al., 1995) and the pre-
chordal plate in the craniofacial structures (Aoto et al., 2009; Rubenstein and Beachy, 1998). In 
these tissues Shh is required for patterning, differentiation, proliferation and cell survival 
(described in more detail below) (Briscoe and Therond, 2013; McMahon et al., 2003). Ihh plays 
a more limited role, regulating chondrogenesis and osteogenesis during endochondral 
ossification (Chung et al., 2001) (Vortkamp et al., 1996), while Dhh is required for the 
development of germ cells in the testis (Bitgood et al., 1996; Clark et al., 2000) and 
ensheathment of peripheral nerves (Parmantier et al., 1999).  
HH genes encode secreted proteins that are regulated at the cell surface by core HH 
pathway components that are also conserved across organisms. The primary receptor in 
Drosophila is Patched (Ptc), or Patched1 (Ptch1) in mammals, which encodes a twelve pass 
transmembrane protein (Hooper and Scott, 1989; Marigo et al., 1996; Nakano et al., 1989). 
Different biochemical studies demonstrated that Ptc/Ptch1 directly bind HH ligands and that in 
absence of HH ligands Patched constitutively inhibits the activity of a second receptor, 
Smoothened (SMO) a G protein-coupled receptor (Figure 1.1, left panel) (Chen and Struhl, 1996; 
Marigo and Tabin, 1996; Stone et al., 1996). Although, SMO exhibits structural divergence from 
invertebrate to vertebrates and does not bind to HH ligands, it is an essential transducer of the 
HH signaling pathway (van den Heuvel and Ingham, 1996; Zhang et al., 2001).  Upon HH ligand 
binding to Patched, the inhibition of SMO is released, resulting in the modulation of the zinc 
finger transcription factors, Cubitus interruptus (Ci) or the  glioma-associated oncogene (GLI) 
transcription family– in mammals (Figure1.1, right panel) (Alexandre et al., 1996; Chen and 
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Struhl, 1996; Taipale et al., 2002). Ci contains three paralogues in mammals, GLI1, GLI2 and 
GLI3 (Huangfu and Anderson, 2006; Hui and Angers, 2011). The HH transcription factors can 
function to activate or inhibit HH transcriptional targets (Aberger and Ruiz, 2014; Falkenstein 
and Vokes, 2014; Hui and Angers, 2011). Even though most of the core HH pathway 
components are conserved across organisms there are several differences between vertebrates 
and invertebrates. For example, in vertebrates the HH signaling pathway utilizes the primary 
cilium, a microtubule structure in which the GLI transcriptional effectors are processed (Goetz 
and Anderson, 2010; Huangfu et al., 2003). Additionally, several core HH pathway components 
have undergone duplication events, and recently novel receptors with different contributions to 
HH signaling have been identified in vertebrates (Allen et al., 2011; Allen et al., 2007; Cole and 
Krauss, 2003; Izzi et al., 2011; Lum et al., 2003; Tenzen et al., 2006; Zhang et al., 2011).  Below 
I will focus on the cell surface regulation of SHH ligand and the contributions of different cell 
surface proteins to the control of HH pathway activity during mammalian embryogenesis and 
disease. 
 
1.2.2 Hedgehog pathway functions during vertebrate embryogenesis 
The HH signaling pathway is essential during vertebrate embryogenesis, regulating 
diverse processes that pattern nearly all the tissues and organs in an embryo (McMahon et al., 
2003). Primarily, SHH pathway function has been explored during the development and 
patterning of the neural tube, the limb and the craniofacial structures (Chiang et al., 1996). At 
mid-gestation (approximately embryonic day (E) 10.5) in mice, SHH ligands are expressed and 
secreted to pattern these different structures (Figure 1.2, top panel; (Echelard et al., 1993; Riddle 
et al., 1993; Xavier et al., 2016) Notably in these structures SHH is not only required for 
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patterning, it also regulates cell survival and proliferation (Figure 1.2, bottom panel; (Ahlgren 
and Bronner-Fraser, 1999; Bastida et al., 2004; Cayuso et al., 2006; Jeong et al., 2004; Towers et 
al., 2008)). The investigation of the contribution of SHH to the formation of these structures has 
provided great insight into our understanding of HH pathway function. In this section I will 
discuss the roles of SHH in the context of the development of the neural tube, the limb and the 
craniofacial structures. 
 
SHH signaling in patterning of the ventral neural tube 
The neural tube is a structure derived from the ectoderm and is formed by a process 
called neurulation that ultimately give rise to the central nervous system (Gilbert, 2013). During 
this process, the ectoderm originates as a flat plate of epithelial cells that fold and elevate, 
subsequently converging and fusing to form a neural tube (Gilbert, 2013). The neural tube 
contains three different types of neurons including, motor neurons, interneurons and sensory 
neurons (Gilbert, 2013) that are specified during development. As evidenced by different 
embryological studies, the rostrocaudal and dorsoventral patterning of the neural tube is 
regulated by different extrinsic signals derived from the somites and the notochord, mesodermal-
derived structures (Wilson and Maden, 2005). Prior to neurulation and before neural tube closure 
these signals induce all neuronal subtypes in the neural tube (Wilson and Maden, 2005). 
Specifically, SHH is initially expressed in the notochord, which induces a secondary site of SHH 
expression in the ventral midline of the neural tube, the floor plate (Echelard et al., 1993; 
Roelink et al., 1994; Roelink et al., 1995). In these structures SHH functions as a morphogen, 
specifying the identity of five distinct ventral neuronal progenitors including ventral interneuron 
progenitors (V0-V3) and motor neurons (Ericson et al., 1997a; Ericson et al., 1997b; Marti et al., 
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1995b; Roelink et al., 1995; Wijgerde et al., 2002). These distinct neuronal progenitors are 
specified by the induction and repression of transcription factors by distinct levels of HH 
pathway activity (Dessaud et al., 2008). The transcription factors that are repressed by SHH are 
classified as Class I genes (e.g., Pax3, Pax6, Pax7), which are expressed in the dorsal to 
intermediate domains of the neural tube (Briscoe et al., 2000). In contrast, transcription factors 
that are activated by SHH are classified as Class II genes (e.g., Foxa2, Nkx2.2, Olig2, Nkx6.1), 
which are expressed in the ventral neural tube (Briscoe et al., 2000). These transcription factors 
interpret the gradient of HH pathway activity to establish boundaries between their respective 
domains, maintaining their integrity and subsequently regulating their neuronal differentiation 
(Briscoe and Ericson, 1999).  
The levels of HH pathway activity that each neuronal progenitor receive are determined 
by their localization in the neural tube. Neuronal progenitors that are closer to the SHH source 
will receive the highest levels of HH pathway activity, inducing the expression of Class II genes 
and repressing Class I genes (Briscoe et al., 2000). While neuronal progenitors located further 
from the SHH source will receive reduced levels of HH pathway activity, resulting in the 
expression of Class I genes and the repression of Class II genes (Briscoe et al., 2000). The 
specification of these different neuronal progenitors is highly regulated not only by SHH 
concentration, but also by the duration of the exposure to SHH (Dessaud et al., 2007; Ericson et 
al., 1997b). Several studies have demonstrated this by utilizing naive neural plate explants from 
chicken embryos and exposing them to different concentrations of SHH over different periods of 
time (Dessaud et al., 2007; Ericson et al., 1997b; Marti et al., 1995a). These neuronal progenitors 
respond to ongoing SHH exposure through an adaptation mechanism in which cells become 
desensitized to SHH, mediated by the upregulation of PTCH1 (Dessaud et al., 2007; Goodrich et 
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al., 1999; Marigo and Tabin, 1996). Further, the specification of these neuronal progenitor 
populations also relies on cross-repressive interactions between the Class I and Class II 
transcription factors to define the final boundaries of these domains (Briscoe and Ericson, 1999; 
Briscoe et al., 2000; Ericson et al., 1997b; Novitch et al., 2001). Finally, the SHH morphogen 
gradient in the neural tube can be also influenced by the induction of different cell surface 
proteins that bind to HH ligands and antagonize signaling, creating a negative feedback loop that 
maintains the proper levels of HH signaling to specify neuronal progenitor identity (Goodrich et 
al., 1999; Jeong and McMahon, 2005) (Holtz et al., 2013; Marigo et al., 1996) SHH/GLI 
signaling also regulates the proliferation and survival of neural progenitors in the neural tube. 
Overexpression experiments via chicken in ovo electroporations demonstrated that blockage of 
SHH or inhibition of GLI activity decreases the proliferation and survival of the neuronal 
progenitor cells (Cayuso et al., 2006). Further, GLI transcriptional activation promotes 
proliferation and rescues the effects mediated by the inhibition (Cayuso et al., 2006).  These 
cellular responses are also influenced by other signals like Wingless-type MMTV related 
integration site (Wnt), and Bone morphogenetic proteins (Bmp) which also regulate the cell 
cycle progression and cell cycle exit in the dorsal neural tube (Le Dreau and Marti, 2013; 
Megason and McMahon, 2002). 
 
SHH Signaling During Craniofacial Development 
Formation of the face is a complex process that is highly coordinated by the activity of 
multiple developmental signaling pathways. Craniofacial structures are formed by the 
interactions of multiple tissues including, cranial neural crest cells, ectoderm, endoderm and 
mesenchyme (Chai and Maxson, 2006). The patterning and growth of craniofacial structures 
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depends on facial prominences, which grow symmetrically and asymmetrically to properly 
pattern the face (Feng et al., 2009; Rossant and Tam, 2002). Primarily, the facial prominences 
are comprised of mesenchymal swellings that are covered by an overlying epithelium (Feng et 
al., 2009). There are three main paired prominences in mouse and humans, the frontonasal 
prominence (which will give rise to the medial and lateral nasal processes), the maxillary 
prominence and the mandibular prominence. The interactions between all these different tissues 
allow for the proper development of the facial skeleton, connective tissue and muscle.   
In these structures, SHH ligands are expressed sequentially, establishing multiple critical 
points in which HH pathway activity is required. In early craniofacial structures the expression 
of Shh is first detected in the prechordal plate (Aoto et al., 2009; Cordero et al., 2004; Rubenstein 
and Beachy, 1998; Zhang et al., 2006), a mesendoderm-derived structure (Kaufman, 1992). Even 
though the prechordal plate and the notochord are morphologically similar structures that express 
Shh, these structures differentially express genes (e.g., goosecoid-1) during early development 
(Belo et al., 1998). SHH is required to differentiate prechordal cells into ventral cranial 
mesoderm, which is necessary for midline development of the forebrain (Aoto et al., 2009). After 
its expression at the prechordal plate, SHH is expressed in different ectodermal domains in early 
craniofacial structures [reviewed by (Xavier et al., 2016)].  First, SHH is expressed in the ventral 
forebrain neuroepithelium, specifically, in the diencephalon and telencephalon [reviewed by 
(Xavier et al., 2016)]. Subsequently, this expression in the neuroepithelium, establishes the 
bilateral expression of SHH in the surface ectoderm of the medial nasal processes, establishing 
polarity and growth of the facial processes [reviewed by (Xavier et al., 2016)]. Finally, SHH is 
expressed in the pharyngeal endoderm of the first branchial arch, which is critical for survival of 
cranial neural crest cells and formation of Meckel’s cartilage [reviewed by (Xavier et al., 2016)]. 
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This highly coordinated developmental sequence of SHH expression regulates growth and 
patterning of the craniofacial structures. 
Genetic analysis in mice have demonstrated that targeted deletion of Shh results in severe 
craniofacial defects, in which the eyes, nose and oral structures are not recognizable (Chiang et 
al., 1996). Instead, Shh mutants display cyclopia, a proboscis (a nose-like structure) and 
holoprosencephaly (HPE) (Chiang et al., 1996). HPE is a birth defect that is characterized by the 
complete or partial failure of the division of the forebrain and a wide spectrum of midline defects 
(Schachter and Krauss, 2008). The function of SHH was also explored in the developing 
craniofacial structures of chicken embryos. Loss of function studies utilizing function-blocking 
anti-SHH antibody and gain-of function studies by ectopic expression of SHH in the craniofacial 
structures of developing chicken embryos demonstrated that SHH signaling is essential for 
proliferation and survival of neural crest cells (Ahlgren and Bronner-Fraser, 1999; Hu and 
Helms, 1999). These studies were supported by the removal of HH-responsiveness in 
craniofacial structures by the conditional deletion of Smo in neural crest cells using Wnt1Cre 
(Jeong et al., 2004). This conditional deletion leads to increased apoptosis, decreased cell 
proliferation and truncation of the facial skeleton and connective tissue (Jeong et al., 2004). 
Thus, in craniofacial structures HH signaling is required to establish the patterning and growth of 
the face primordia (Chiang et al., 1996; Jeong et al., 2004).  
 
SHH signaling in the developing limb 
The mammalian limbs arise from a combination of mesenchymal cells from the lateral 
plate mesoderm and the somites (Gilbert, 2013). After migration from the lateral plate mesoderm 
and the somites to the limb field, these mesenchymal cells accumulate under an ectodermal 
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tissue pocket to create a condensation of tissue called the limb bud (Gilbert, 2013; Tabin and 
Wolpert, 2007). In each vertebrate embryo there are up to four limb buds that are paired opposite 
to each other along the right and left axis (Gilbert, 2013). Positioning of the limb buds is 
established by a combinatorial code of Hox gene expression, which patterns the limb skeleton 
along the proximodistal axis [reviewed by (Capdevila and Izpisua Belmonte, 2001; Pineault and 
Wellik, 2014)]. The patterning of the limb bud is mediated by several specialized structures that 
function as signaling centers including the apical ectodermal ridge (AER), the zone of polarizing 
activity (ZPA) and the non-ridge ectoderm [reviewed by (Capdevila and Izpisua Belmonte, 2001; 
Gilbert, 2013)]. These structures coordinate patterning along the different axes of the limb: 
dorsal-ventral, anterior-posterior and proximo-distal [reviewed by (Capdevila and Izpisua 
Belmonte, 2001)]. Each one of these signaling centers establish different molecular domains that 
will give rise to the skeletal elements, muscles and connective tissues of the mature limb. During 
this process SHH is secreted from the ZPA, which determines the anterior-posterior axis and 
specifies digit identity (Echelard et al., 1993; Riddle et al., 1993; Saunders, 1968).  
Experiments in chicken embryos provided the first evidence that Shh transcripts were 
expressed in the ZPA of the chicken wing bud and were capable of polarizing limbs in grafting 
experiments (Riddle et al., 1993). Moreover, the activity mediated by SHH in the ZPA also has 
effects in the apical ectodermal ridge, linking anterior-posterior and proximo distal pattern 
formation. This was demonstrated by grafting experiments in which the grafted ZPA was placed 
in the most anterior part of the chicken wing bud resulting in a wider chicken bud (Smith and 
Wolpert, 1981; Tickle et al., 1975). The role of the ZPA initially identified in chicken embryos, 
was also explored and confirmed in mice. Mouse embryos lacking the Shh gene display severe 
defects in limb patterning. Even though, Shh mutants develop limbs, these are severely truncated, 
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and they only exhibit one digit in the hindlimbs (Chiang et al., 1996). In mice, the limb is 
comprised of five digits (1-5 through the anterior-posterior axis). The remaining digit observed 
in Shh mutant embryos is considered to be digit 1, and its patterning is independent of HH 
signaling.  Although these studies demonstrate an essential role for SHH in digit specification in 
the limb, there are discrepancies regarding how HH specifies digit identity in the limbs. 
Different studies have proposed several mechanisms of HH function in digit 
specification.  The first model was reported by (Harfe et al., 2004), and proposed that digit 
identity was determined by the concentration and time of exposure to SHH in both mouse and 
chicken embryos. This model establishes that digits 5, 4 and the posterior part of digit 3 receive 
the highest levels of HH activity by autocrine signaling. While digit 2 receives very low levels of 
HH activity by paracrine signaling. Furthermore, this model was supported by (Scherz et al., 
2007), which performed a series of experiments utilizing genetic and pharmacological 
approaches to limit the time of exposure or the concentration of SHH in the bud mesenchyme of 
chicken and mouse embryos. (Scherz et al., 2007) demonstrated that both exposure and dose of 
SHH contribute to specification of digit identity and that the time of exposure for the most 
posterior digits is critical. This classical model was further extended by (Towers et al., 2008), 
which integrated a growth component. Suggesting that SHH regulates proliferation through the 
control of cell cycle regulators and (Towers et al., 2008). A second model for digit specification 
was proposed by (Zhu et al., 2008), which conditionally deleted Shh at different time points 
using Hoxb6CreER, revealing that Shh is required in two phases. According to this model SHH 
is first required during a transient early phase that regulates digit identity, and then in a second 
expansion growth phase where it maintains sufficient cell numbers for digit condensation (Zhu et 
al., 2008). The cell survival component has not been as integrated as the growth component in 
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these models. Experiments in which SHH was increased or inhibited by grafting or SHH protein 
beads, demonstrated that SHH can selectively regulate cell death and survival in a position-
dependent manner (Sanz-Ezquerro and Tickle, 2000). Additionally, (Bastida et al., 2004) 
suggested that GLI-dependent transcription can mediate cell survival and apoptosis. However, is 
still unclear how SHH regulates cell survival in the developing limb.  
 
1.2.3 SHH signaling in birth defects and disease 
Given the essential roles of SHH signaling during vertebrate embryogenesis, it is not 
surprising that aberrant SHH pathway activity results in a wide variety of birth defects and 
diseases. Mutations in different HH pathway components result in gain-of-function phenotypes 
or loss-of-function phenotypes that contribute to disease. For example, loss-of-function 
mutations in SHH have been identified in human holoprosencephaly (HPE) patients, a birth 
defect in which the forebrain and midfacial structures are not properly developed (Belloni et al., 
1996; Roessler et al., 1996). HPE mutations in other HH pathway components will be described 
in greater detail below.  In the context of cancer, mutations have been identified in basal cell 
carcinoma, the most common skin cancer. Specifically, loss-of-function mutations in PCTH1 
and/or gain-of function mutations in SMO (Hahn et al., 1996; Johnson et al., 1996; Xie et al., 
1998). Moreover, overactive HH signaling has been implicated in other cancers including, 
medulloblastoma, pancreatic cancer and ovarian cancer (Barakat et al., 2010; Teglund and 
Toftgard, 2010; Thayer et al., 2003; Theunissen and de Sauvage, 2009). However, these different 
types of cancers caused by defective HH signaling do not emerge in the same manner. There are 
several mechanisms by which defects in HH activity can lead to cancer. Specifically, these 
mechanisms are classified according the type of mutation, HH ligand requirement, and the type 
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of cell communication between cancer cells and the neighboring cells in the tumor 
microenvironment [reviewed by (Scales and de Sauvage, 2009)]. Understanding the mechanisms 
by which HH signaling is regulated during embryogenesis and disease will be essential to 
develop novel therapeutic approaches. 
 
1.3 Cell surface regulation of HH signaling 
The HH signaling pathway regulates the patterning, morphogenesis, and homeostasis of 
multiple tissues during development and adulthood. However, is unclear how the same pathway 
can be utilized iteratively within the same organism to form such different structures. The HH 
signaling pathway is regulated by an array of different proteins at the cell surface. These proteins 
regulate the release, trafficking, reception, and signal transduction of the HH ligands. Also, this 
multitude of proteins allow the complex regulation of the HH gradient by creating multiple 
feedback loops to maintain the proper levels of HH and further extend the role of the HH 
pathway by performing non-canonical functions. The following section will be focused on 
describing the function of cell surface proteins that regulate HH ligand release, trafficking, 
reception and signal transduction (Figure 1.3). 
 
1.3.1 HH ligand synthesis 
HH ligands are secreted proteins that are synthesized as an approximately 45kDa 
immature precursor (Bumcrot et al., 1995; Lee et al., 1994). During biosynthesis this precursor 
undergoes signal sequence cleavage and enters the secretory pathway, followed by autocatalytic 
cleavage performed by its carboxyl-terminal (C-terminal) (Bumcrot et al., 1995; Lee et al., 1994; 
Porter et al., 1995). Simultaneously, a cholesterol moiety is attached to the amino terminal (N-
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terminal) of the peptide (Porter et al., 1996). This results in a 19 kDa peptide that performs all 
signaling activities; however, this peptide is subjected to additional post-translational 
modifications. Specifically, HH ligands are palmitoylated at an N-terminal cysteine residue by 
the acyltransferase skinny hedgehog (SKI) (Chamoun et al., 2001; Lee and Treisman, 2001; 
Micchelli et al., 2002; Taylor et al., 2001). Both lipid modifications are critical for the 
stabilization and distribution of HH ligands. The cholesterol moiety limits the spread of HH 
ligands by anchoring them to the plasma membrane and limiting their diffusion (Lewis et al., 
2001; Li et al., 2006; Peters et al., 2004). In contrast, palmitoylation enhances the potency of HH 
ligand, presumably by mediating oligomerization (Chen et al., 2004; Kohtz et al., 2001; Lee et 
al., 2001b). Defects in the lipidation or processing of HH precursors result in loss of SHH 
function and subsequently in developmental defects (Belloni et al., 1996; Maity et al., 2005; 
Roessler et al., 1996). After HH ligands are dually lipidated they are tethered to the lipid bilayer 
of the plasma membrane where they can be released by several different mechanisms to employ 
their morphogen functions.  
 
1.3.2 HH ligand release and trafficking mediated by cell surface proteins 
Dispatched (DISP) 
DISP is a twelve-pass transmembrane protein, from the resistance-nodulation division 
(RND) transporter family originally identified in Drosophila genetic screens; which mediates the 
secretion of cholesterol-modified HH ligands (Burke et al., 1999; Caspary et al., 2002; Ma et al., 
2002; Tian et al., 2005). The DISP proteins display structurally similar multi-spanning 
transmembrane domains and sterol sensing domains to the HH ligand receptor, PTCH1 (Burke et 
al., 1999; Caspary et al., 2002; Kawakami et al., 2002). As observed in Drosophila HH mutants, 
 15 
Disp null larvae also display strong defects in segment polarity (Burke et al., 1999). Early studies 
in Drosophila demonstrated that Disp mutant ligand producing cells retain cholesterol modified 
HH ligands, but not HH ligands without cholesterol (Burke et al., 1999). Despite the structural 
similarity between DISP and PTCH1 these experiments demonstrated that these proteins play 
essential distinct functions in HH signal transduction.  DISP is conserved across organisms and 
its role in HH signaling has also been reported in vertebrates which possess two homologs, 
DISP1 and DISP2 (Caspary et al., 2002; Kawakami et al., 2002; Ma et al., 2002). Interestingly, 
DISP1 is ubiquitously expressed during early mouse embryogenesis and overlaps with SHH and 
IHH expression, while DISP2 is undetectable (Kawakami et al., 2002; Ma et al., 2002). 
Furthermore, overexpression of DISP2 in HH ligand export assays demonstrated that it has no 
effect in the release of soluble HH processed ligands, indicating that DISP1 is the main regulator 
of ligand release (Ma et al., 2002). Disp mutant mouse embryos display a severe loss of HH 
function, phenocopying Smo mutant embryos (Caspary et al., 2002; Kawakami et al., 2002; Ma 
et al., 2002). These embryos display severe defects in the forebrain, neural tube patterning 
defects and disrupted left/ right asymmetry, resulting in abnormal embryonic turning and heart 
looping defects (Caspary et al., 2002; Kawakami et al., 2002; Ma et al., 2002). The mechanism 
by which DISP releases HH ligands is still unknown. Based on biochemical data it is thought 
that DISP mediates HH ligand release by binding to cholesterol through its sterol sensing domain 
(Creanga et al., 2012; Tukachinsky et al., 2012). More recently, mechanistic analyses have 
revealed that DISP is cleaved in its predicted first extracellular loop by the proprotein convertase 
Furin; which influences its ability to release HH ligands from producing cells (Stewart et al., 
2018). However, DISP alone is not sufficient to mediate the release of HH ligands. DISP 
functions synergistically with the vertebrate-specific secreted glycoprotein, SCUBE2, which 
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differentially binds the cholesterol moiety and releases HH ligands from the cell surface 
(Creanga et al., 2012; Hollway et al., 2006; Kawakami et al., 2005; Tukachinsky et al., 2012; 
Woods and Talbot, 2005). These data have led to a model in which DISP transfers the 
cholesterol modified HH ligand to SCUBE2 which subsequently increase its solubility in the 
extracellular space.  
 
Signal sequence-CUB domain epidermal growth factor like-related 2 (SCUBE2) 
SCUBE2 is a secreted glycoprotein from the EGF-CUB family (Grimmond et al., 2001; 
Wu et al., 2004; Yang et al., 2002). This protein was originally identified as the you gene in 
zebrafish genetic screens as part of the you-class mutations (Hollway et al., 2006; Kawakami et 
al., 2005; van Eeden et al., 1996; Woods and Talbot, 2005). The molecular cloning of the you 
gene was reported simultaneously by several groups, which also demonstrated that this gene 
encodes the SCUBE2 protein, and that it was conserved from zebrafish to mouse and humans 
(Grimmond et al., 2000; Grimmond et al., 2001; Hollway et al., 2006; Kawakami et al., 2005; 
Woods and Talbot, 2005). Interestingly, the you gene has no homologue in Drosophila. SCUBE2 
is part of a protein family that is comprised by three members, SCBUBE1, SCUBE2 and 
SCUBE3 (Grimmond et al., 2000; Grimmond et al., 2001; Wu et al., 2004; Yang et al., 2002). 
The SCUBE2 protein structure is characterized by a single peptide, followed by nine EGF 
repeats, a spacer region, three cysteine-rich motifs and a CUB domain at the C-terminus 
(Hollway et al., 2006; Kawakami et al., 2005; Tsai et al., 2009). Structure-function analyses of 
SCUBE2 indicate that the spacer region and/or the cysteine rich repeats are critical for 
membrane attachment (Tsai et al., 2009). The expression profile of Scube2 has previously been 
examined in zebrafish, and in mouse embryos where is widely expressed (Grimmond et al., 
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2001; Kawakami et al., 2005; Woods and Talbot, 2005). Primarily, Scube2 is expressed during 
mouse embryogenesis in the neuroectoderm, craniofacial structures, heart, multiple regions of 
the endochondral skeleton (Grimmond et al., 2001; Xavier and Cobourne, 2011). Zebrafish you 
mutants display weak cyclopia, curled tails, and defects in slow muscle and ventral neural 
patterning; defects associated with aberrant HH signaling (Hollway et al., 2006; Kawakami et al., 
2005; Woods and Talbot, 2005). The combined loss of the SCUBE family of proteins results in 
complete loss of HH signaling in zebrafish (Johnson et al., 2012). Several studies in zebrafish 
have demonstrated that the primary function of SCUBE2 is to mediate long range HH signaling, 
by releasing HH ligands into the extracellular environment (Hollway et al., 2006; Kawakami et 
al., 2005; Woods and Talbot, 2005). Specifically, SCUBE2 binds to the cholesterol moiety in 
HH ligands, increasing its solubility and enhancing its potency (Creanga et al., 2012; 
Tukachinsky et al., 2012). There is some conflicting evidence from (Creanga et al., 2012) 
suggesting that SCUBE2 can also mediate the release of pamiltoylated HH ligands, however this 
is unclear. Additional biochemical analyses and functional reporter assays showed that human 
SCUBE2 interacts with SHH and PTCH1 and promote HH signaling within the cholesterol-rich 
raft microdomains in the plasma membrane (Tsai et al., 2009). Recent studies have also 
examined the function of SCUBE2 on mammalian embryos. Mouse mutants lacking Scube2 
have been examined in the context of bone development, where its deletion impairs IHH 
function resulting in defective endochondral bone formation (Lin et al., 2015). However, despite 
SCUBE2 function in HH signaling, other HH-responsive tissues seem to remain unaffected in 
Scube mutants (Lin et al., 2015). 
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1.3.3 HH ligand reception and trafficking 
Low-density lipoprotein receptor- related protein 2 (LRP2) 
LRP2 is a multi-ligand glycoprotein receptor from the low density lipoprotein (LDL) 
receptor gene family, originally identified as the major autoantigen in induced glomerular 
nephritis model in rats (Kerjaschki and Farquhar, 1983; Kerjaschki et al., 1992; Saito et al., 
1994). LRP2 is a single-spanning protein comprised of an N-terminal signal peptide sequence, an 
extracellular region, a transmembrane domain and a C-terminal cytoplasmic domain 
(Christensen and Birn, 2002; Saito et al., 1994). The extracellular portion contains four cysteine-
rich clusters of LDL receptor type A repeats (putative ligand binding regions), which are 
separated by seventeen epidermal growth factor (EGF)-like repeats and eight cysteine spacer 
regions that contain YWTD repeats (Christensen and Birn, 2002; Saito et al., 1994). The 
cytoplasmic domain has an NPXY sequence, which mediate clathrin coated endocytosis 
(Christensen and Birn, 2002; Saito et al., 1994). In mice, throughout gastrulation the expression 
of LRP2 is distributed in the apical side of the neural plate; this expression persists during 
development and becomes restricted to the midline of the ventral forebrain neuroepithelium 
(Christ et al., 2012). LRP2 is also expressed in the kidney anlage in the mesonephric tubules; 
while in the adult kidney it is expressed in glomerular and proximal tubule cells (Kerjaschki et 
al., 1984; Sahali et al., 1993) . Consistent with its expression in the kidney, the main function of 
LRP2 was initially described in kidney proximal-tubule epithelium, where it functions as a 
clearance (or endocytic) receptor, mediating the nonspecific uptake of proteins (Kerjaschki et al., 
1984). The function of LRP2 was further explored Lrp2-/- mice, which primarily display defects 
in the forebrain, lungs and kidneys; notably these mutants die from respiratory insufficiency 
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(Spoelgen et al., 2005; Willnow et al., 1996). The forebrain defects in Lrp2 mutants, are in fact 
HPE defects (Willnow et al., 1996). Specifically, Lrp2 mutants display forebrain fusion, a 
protusion in the midline of the head, shortened nose, occasional microphthalmia and absence of 
olfactory bulbs (Willnow et al., 1996). Notably, human mutations in Lrp2 result in Donnai-
Barrow syndrome, which is characterized by HPE-like phenotypes (Kantarci et al., 2007). The 
requirement of LRP2 in forebrain development was further explored by (Spoelgen et al., 2005) 
(Christ et al., 2012) which revealed that disruption of LRP2 leads to loss of Shh in the ventral 
forebrain; preventing the formation of the SHH signaling center in the prechordal plate. 
Mechanistic studies using whole embryo culture, immunofluorescence and cell culture 
experiments demonstrated that LRP2 co-localizes with SHH and PTCH1 in the neuroepithelial 
cell surface of E8.5 embryos (Christ et al., 2012). These data suggested that LRP2 forms a co-
receptor complex with PTCH1 that is internalized upon HH ligand binding, which is mediated by 
clathrin (Christ et al., 2012). Immunofluorescence analysis with markers of different endocytic 
compartments suggested that the LRP2/SHH/PTCH1 complex undergoes recycling rather than 
degradation; allowing the re-secretion of the complex (Christ et al., 2012). Moreover, (McCarthy 
et al., 2002) and (Morales et al., 2006) showed that SHH ligand can be internalized in cell lines 
and efferent duct epithelial cells, respectively, and trafficked to the lysosome for potential 
degradation. Blockage of LPR2 via the antagonist RAP or anti-LRP2 antibody disrupts the 
internalization of SHH ligands (McCarthy et al., 2002; Morales et al., 2006). These studies 
demonstrated that LRP2 functions as endocytic receptor in certain epithelial cells to traffic SHH 
ligands. LRP2 function in SHH signaling has been further explored in other contexts; however, 
the data suggest that this co-receptor has tissue-specific functions that could also determine the 
fate of the internalized molecule [reviewed by (Christ et al., 2016)]. For example, in the optic 
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nerve where LRP2 is expressed in astrocytes, it mediates the transcytosis of SHH ligand from the 
apical to the basolateral side of the cells (Ortega et al., 2012). In contrast, in the murine retinal 
margin LRP2 functions as a HH antagonist, by sequestering SHH ligand and trafficked for 
lysosomal degradation (Christ et al., 2015). Overall these data indicate that LRP2 regulates HH 
signaling in a context-dependent manner. Even though these studies provide direct evidence that 
LRP2 functions as a clearance receptor in SHH signaling, is unclear the mechanism by which 




GPCs are glycoproteins from the heparan sulfate proteoglycan family, which can 
positively or negatively regulate HH signaling (Filmus and Capurro, 2014). These proteins are 
characterized by carrying glycosaminoglycan (GAG) chains, including heparan sulfate and 
chondroitin sulfate. Structurally, GPC are comprised of core protein with an N-terminal secretory 
signal peptide and a GPI anchor (Filmus and Selleck, 2001). These proteins also contain fourth 
teen highly conserved cysteine residues, and the GAG sites which are localized close to the C-
terminus (Filmus and Capurro, 2014; Filmus and Selleck, 2001). The number of GAG insertion 
sites vary among glypicans and this could have an effect on their mechanistic function (Filmus 
and Capurro, 2014). Additionally, GPCs can be secreted via cleavage of the GPI anchor from the 
plasma membrane by the notum enzyme or by the furin-like convertase (Filmus and Capurro, 
2014; Traister et al., 2008). One function of GPCs is to mediate interactions between cells and 
the extracellular matrix, primarily through their GAG side chains (Filmus and Capurro, 2014).  
Importantly, another key function for GPCs is to regulate signaling pathways such as Wnt, HH, 
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Fibroblast growth factor (FGF) and transforming growth factor-beta (Lin, 2004). GPCs are 
expressed throughout development in a tissue- and stage-specific manner (Filmus and Capurro, 
2014).  
The requirement for GPCs in HH signaling was first described in Drosophila (Lum et al., 
2003). Specifically, the GPC homologues Dally and Dally-like are required for HH ligand 
release and oligomerization (Eugster et al., 2007; Han et al., 2004). GPCs have also been 
demonstrated to function in vertebrate HH signaling. There are a total of six glypicans in 
mammals (GPC1-6) (Filmus and Selleck, 2001), which have been implicated in the regulation of 
Wnt, HH, FGF and BMP signaling. The first glypican to be implicated in SHH signaling was 
GPC3, which is expressed in a wide variety of endodermal, ectodermal and mesodermal tissues 
(Pellegrini et al., 1998). Additionally, GPC3 was the first GPC to be associated with Simpson-
Golabi-Behmel syndrome, which is characterized by a variable spectrum of developmental 
abnormalities including, distinctive craniofacial structures, skeletal abnormalities, heart defects 
and kidney defects (Li et al., 2001). Mice lacking Gpc3 display increased levels of HH signaling 
in the neural tube, the hindgut, and the limb, developmental overgrowth and cystic dysplastic 
kidneys (Capurro et al., 2008). In vitro and experiments also demonstrated that GPC3 binds to 
SHH ligand and competes with PTCH1 binding at the cell surface. HH ligand binding to GPC3 
results in endocytosis and degradation of this complex (Capurro et al., 2008). Moreover, 
(Capurro et al., 2008) showed that GPC3 membrane attachment is required to mediate SHH 
inhibition, while the heparan sulfate chains are not required to perform its regulatory effect, but 
they are optimal for its function. GPC3 also interacts with LRP1, which mediates the endocytosis 
of GPC3 and SHH through interactions with heparan sulfate (Capurro et al., 2012). GPC5 has 
also been implicated in HH signaling, by its upregulation in rhabdomomyosarcoma, a tumor that 
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arise from abnormal HH signaling (Li et al., 2011a). GPC5 is expressed in the developing 
kidney, limb and brain; it also binds to SHH (Li et al., 2011a; Saunders et al., 1997). In contrast 
to GPC3, coimmunoprecipitation experiments in HEK293T cells revealed that PTCH1 can bind 
GPC5, which significantly stimulates the SHH binding to PTCH1 (Li et al., 2011a). Importantly, 
GPC5 with mutations in the GAG binding sites cannot stimulate HH signaling or SHH ligand 
binding to PTCH1(Li et al., 2011a). These data suggest that GAG interactions are critical for 
GPC5 function in HH signaling, while they are dispensable for GPC3 function. In addition, 
GPC5 also functions in the reception of SHH ligands in cerebellar granule neural progenitor 
cells, where SHH signaling promotes proliferation and differentiation (Witt et al., 2013). Another 
GPC implicated in SHH signaling is GPC1. This GPC has been associated with SHH in two 
different contexts. In commissural neurons where SHH is required for axon guidance, GPC1 acts 
as a SHH co-receptor (Wilson and Stoeckli, 2013). Deletion of GPC1 in commissural axons 
disrupts axon guidance at the midline (Wilson and Stoeckli, 2013). GPC1 also regulates HH 
signaling in biliary atresia, a progressive proinflammatory disease in children involving the 
extrahepatic and intrahepatic biliary tree, where high HH activity has been reported in patients 
(Cui et al., 2013). Examination of copy number variants revealed that deletions at the 2q37.3 
locus results in a deletion of one copy of GPC1 (Cui et al., 2013). Studies in zebrafish that 
indicate that the downregulation of GPC1 results in developmental biliary defects (Cui et al., 
2013). Interestingly, injection of SHH lead to similar biliary defects in GPC1 zebrafish mutants 
(Cui et al., 2013). These data suggest that GPC1 can antagonize HH signaling; however, this has 
yet to be investigated in mice. The function of mammalian GPCs in HH signaling has also been 
compared to the function of the Drosophila glypicans Dally and Dally-like (Williams et al., 
2010). Specifically, (Williams et al., 2010) tested if the mammalian glypicans could enhance or 
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inhibit the HH response in a Drosophila cell culture assay. This study revealed that GPC4 and 
GPC6, enhanced the HH response in a dosage dependent manner (Williams et al., 2010). In 
contrast, GPC3, GPC2, GPC5 have trans-dominant negative activities (Williams et al., 2010). 
These data suggested that the activity of the mammalian GPCs is conserved from insects to 
mammals and that the GPCs could mediate stimulatory and inhibitory effects on HH signaling.  
However, this data contradicts the more recently described role for GPC5 in the reception of 
SHH ligands in cerebellar granule neural progenitor cells, where it positively regulates HH 
signaling (Witt et al., 2013). These differences could be explained by their tissue-specific 
functions. 
 
 1.3.3 HH ligand trafficking independent of cell surface proteins 
HH ligands can also be transported by additional mechanisms that do not require cell 
surface proteins. Multiple studies have identified that HH ligands can be trafficked with different 
carriers that are associated to the cell surface (Therond, 2012). For example, HH ligands can be 
released as soluble multimers, associated with lipoproteins or vesicles (Briscoe and Therond, 
2013; Therond, 2012). These carriers are essential for the spread of HH ligands in the 
hydrophilic environment of the extracellular matrix and to mediate long-range HH signaling. 
Most of these types of carriers have been described in invertebrates. However, there are some 
examples described in vertebrates, which will be briefly described below.  
 
Soluble oligomeric complexes 
 Soluble lipid modified HH ligands can self-assemble and form monomeric and/or 
oligomeric complexes that are released from the plasma membrane. Importantly, the assembly of 
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HH ligands on these structures is dependent on lipid modifications, heparan sulfate 
proteoglycans interactions and specific regions of the SHH ligand (Chen et al., 2004; Goetz and 
Anderson, 2010; Therond, 2012; Zeng et al., 2001). In vertebrates these oligomeric complexes 
have been reported by purification and biochemical analyses in different cell lines. Some of the 
vertebrate cell lines that form these complexes include, C3H10T1/2 cells, HEK, primary chicken 
chondrocyte cells, HeLa, CHO, and C17 cells (Chen et al., 2004; Dierker et al., 2009; Goetz et 
al., 2006; Therond, 2012; Zeng et al., 2001). Interestingly, SHH oligomeric complexes of 
different molecular weight oligomers have been detected and these can enhance HH signaling 
activity (Chen et al., 2004; Zeng et al., 2001). 
 
Exovesicles 
SHH ligands also are transported in exovesicles during vertebrate embryogenesis. 
Specifically, SHH ligands have been observed in exovesicles or “nodal vesicle particles” during 
symmetry breaking in mammalian embryos in the node (Tanaka et al., 2005). The nodal vesicle 
particles are comprised of a membrane sheath and a lipid core, allowing the lipophilic 
morphogens to be transported without being solubilized in water (Tanaka et al., 2005). These 
vesicles originate from the apical microvilli at the surface of the mouse ventral node, enabling a 
left to right gradient (Tanaka et al., 2005). This type of carrier also has been found to carry other 
important developmental signal molecules including, Notch and Wnt, indicating that is a 
common mechanism to transport signals (Therond, 2012).   
 
Specialized filopodia  
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SHH ligands and HH pathway components have been also reported to be transported in 
long and dynamic cytoplasmic extensions, called filopodia. Recent studies in Drosophila and 
vertebrates suggest that SHH ligands are transported through these extensions, without the need 
for cell surface proteins (Bischoff et al., 2013; Rojas-Rios et al., 2012; Sanders et al., 2013). The 
only study that have observed this in vertebrates, demonstrated that chicken wing buds have 
specialized actin based filopodia that direct long-range transport of SHH (Sanders et al., 2013). 
This specialized filopodia are also capable of transporting HH pathway components, specifically 
the HH co-receptors CDON and BOC, in HH-responding cells (Sanders et al., 2013). These 
results suggested that SHH-producing cells can distribute SHH ligand and create stabilized 
interactions with SHH-receiving cells (Sanders et al., 2013). Notably, this mechanism of HH 
trafficking could have been ignored before due to the technical challenges to detect filopodial 
extensions (Kornberg and Roy, 2014). However, further studies will be required to determine 
whether these filopodia can mediate long-range HH signaling, since only in vitro studies have 
provided evidence that these structures mediate signaling in other contexts (Kornberg and Roy, 
2014).  
 
1.3.4 HH ligand reception 
The cell surface regulators of the HH signaling pathway have significantly expanded in 
vertebrates since its discovery in Drosophila. A multitude of cell surface proteins that interact 
and bind to the HH ligands have been identified. These cell surface regulators can promote or 
antagonize HH signaling, creating signaling feedback loops to maintain the right level of HH 
function during embryogenesis and tissue homeostasis during adulthood.  In this section I will 
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focus on the description of the function of these proteins through the interactions with SHH, and 
how they regulate HH signaling during vertebrate embryogenesis. 
 
Patched1 (PTCH1) 
SHH ligands are primarily received at the cell surface by the multi-spanning 
transmembrane protein PCTH1, which resembles the RND family and Nieman-Pick type C1 
(NPC1) cholesterol transporter (Marigo et al., 1996; Qi et al., 2018b; Stone et al., 1996; Taipale 
et al., 2002; Yang et al., 2015; Zhang et al., 2018). PTCH1 possesses twelve transmembrane 
domains, two large extracellular domains, a C-terminal cytoplasmic domain and a conserved 
sterol sensing domain involved in cholesterol regulation (Carstea et al., 1997; Stone et al., 1996). 
During embryogenesis Ptch1 is expressed in the floor plate of the neural tube, the somites (cells 
closer to the notochord), the posterior limb bud, the diencephalon, the ventral telencephalon, the 
medial nasal process and the mandibular process of the craniofacial structures (Goodrich et al., 
1996; Kurosaka et al., 2014). Loss of Ptch1 in mouse embryos results in embryonic lethality 
around E9.5, possibly due to heart defects (Goodrich et al., 1997). Phenotypically, Ptch1-/- 
embryos fail to properly close the neural tube and exhibit overgrowth in the head folds, hindbrain 
and spinal cord (Goodrich et al., 1997). The expression of HH transcriptional targets in Ptch 
mutants, including Gli1 and Ptch1 itself are aberrantly expanded, demonstrating that PTCH1 is 
essential to repress genes activated by SHH (Goodrich et al., 1997). Mutations in the human 
PTCH1 locus have been identified in several cancers and birth defects associated to HH 
signaling. In cancer PTCH1 is the main driving mutation in Gorlin’s syndrome or basal cell 
nevus syndrome, which is characterized by a predisposition to develop basal cell carcinoma and 
medulloblastoma (Hahn et al., 1996; Johnson et al., 1996). Additionally, four mutations in 
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human holoprosencephaly patients with variable phenotypes have been identified in Ptch1 
(Ribeiro et al., 2006). These data demonstrate that PTCH1 is an essential regulator of HH 
signaling in development and disease. 
Functionally, PTCH1 plays dual roles in the regulation of HH pathway activity (Chen and 
Struhl, 1996). In absence of HH ligands, PTCH1 represses SMO resulting in the repression of 
HH transcriptional targets (ligand-independent antagonism) (Chen and Struhl, 1996; Jeong and 
McMahon, 2005). HH ligand binding to PTCH1 results in the de-repression of SMO and 
activation of HH transcriptional targets. Ptch1 itself is a HH transcriptional target (Agren et al., 
2004); Ptch1 upregulation leads to PTCH1-mediated sequestration of HH ligands that restrains 
HH signaling in responding tissues (ligand-dependent antagonism) (Hooper and Scott, 1989; 
Jeong and McMahon, 2005; Nakano et al., 1989). Notably, these dual activities of PTCH1 are 
conserved across organisms (Goodrich et al., 1996). However, as discussed in greater detail 
below there are additional, vertebrate-specific HH pathway antagonists that also contribute to 
both of these functions to maintain the proper levels of HH signaling (see PTCH2 and HHIP 
sections) (Holtz et al., 2013). 
Although PTCH1 is required for proper HH signal transduction, the mechanism by which 
HH ligands bind to PTCH1 and the mechanism of PTCH1-mediated SMO inhibition remain 
unclear. Recently, cryo-electron microscopy studies have revealed important structural 
information about PTCH1 and its interactions with SHH ligand (Gong et al., 2018; Qi et al., 
2018a; Qi et al., 2018b; Zhang et al., 2018). Specifically, (Qi et al., 2018a) and (Zhang et al., 
2018) reported that PTCH1 can from a dimer at the plasma membrane. Additionally, the 
structure of PTCH1 exhibits cholesterol-like densities in a central hydrophobic conduit or 
“tunnel” across the transmembrane domain of PTCH1 and the plasma membrane, that resembles 
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the structures used by RND proteins to transport substrates (Gong et al., 2018; Qi et al., 2018a; 
Zhang et al., 2018). Presumably, this tunnel is required to transport sterol-like molecules, such as 
cholesterol from the membrane and/or to the extracellular space (Gong et al., 2018; Qi et al., 
2018a; Zhang et al., 2018). Interestingly, Ptch1 overexpression in Ptch1-/- mouse embryonic 
fibroblasts reduces cholesterol activity in the inner leaflet of the plasma membrane; this 
reduction is rapidly restored by HH stimulation (Zhang et al., 2018). These data are supported by 
previous studies in the Drosphila wing imaginal disc, which showed that Ptc overexpression 
increases sterol mobilization from endosomal compartments (Khaliullina et al., 2009). Moreover, 
(Bidet et al., 2011) reported that Ptch1 overexpression in yeast (S. cerevisiae) increases the 
efflux of a cholesterol derivative. These data indicate that PTCH1 can directly transport 
cholesterol; however, further experiments will be required to determine whether (and how) this 
transport regulates SMO activity. 
These studies also showed that SHH ligands bind to PTCH1 through distinct interfaces 
that dependent on SHH lipid modifications. Dually-lipidated SHH ligand bind to the cavity 
between the extracellular domains I and II of PTCH1 via palmitate modification of SHH (Qi et 
al., 2018a; Qi et al., 2018b). This is the predominant interface for SHH ligand binding and it 
results in the obstruction of the tunnel of PTCH1(Qi et al., 2018a). In contrast, SHH ligand 
lacking the palmitate modification uses the opposite site of the ligand to bind the extracellular 
domain I of PTCH1(Gong et al., 2018; Qi et al., 2018b). Interestingly, this second interface is 
calcium-dependent and is where the ligand can interact with HH co-receptors (Beachy et al., 
2010; Gong et al., 2018; Izzi et al., 2011; Qi et al., 2018b). These discrepancies observed in the 
binding interfaces of the SHH ligand were clarified in (Qi et al., 2018a), where they 
demonstrated that a single SHH ligand molecule is capable of binding to both interfaces in a 
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PTCH1 dimer complex. Functional analyses indicate that point mutations on the palmitate or the 
calcium PTCH1 interfaces decreases HH signaling activity, demonstrating that they are essential 
for HH signal transduction (Izzi et al., 2011; Qi et al., 2018b). Based on these data, a model has 
been proposed (discussed in (Sommer and Lemmon, 2018)) where, in the absence of HH ligand, 
PTCH1 exports cholesterol (which is necessary for SMO activation) from the membrane. 
Depletion of cholesterol maintains SMO in an inactive state that is unable to transduce HH 
signaling. In the presence of SHH ligands, one molecule of SHH binds the PTCH1 dimer 
complex, resulting in the inhibition of cholesterol transport. The cholesterol available in the 
plasma membrane activates SMO, initiating a signal transduction cascade that culminates in the 
activation of HH transcriptional targets. It remains unclear how other cell surface regulators of 
HH pathway activity (discussed below) fit into this model.  
 
Patched 2 (PTCH2) 
Patched 2 (PTCH2) is a homologue of PTCH1, that was discovered in the newt eye and is 
conserved in zebrafish, chicken and mouse (Carpenter et al., 1998; Motoyama et al., 1998b; 
Takabatake et al., 1997). Human PTCH1 and PTCH2 share 54% amino acid identity (Carpenter 
et al., 1998; Kawamura et al., 2008). Despite the structural homology between PCTH1 and 
PTCH2, these proteins exhibit some differences in their domains. Specifically, PTCH2 possess a 
truncated C-terminal cytoplasmic domain which confers more stability to the protein and lacks 
one of the glycosylation sites observed in PTCH1(Carpenter et al., 1998). All three mammalian 
HH ligands, SHH, IHH and DHH, bind to PTCH2 with similar affinity to PTCH1(Carpenter et 
al., 1998). Interestingly, Ptch2 expression is similar but not identical to Ptch1. During early 
embryogenesis Ptch2 exhibits overlapping expression patterns with Ptch1 in the developing 
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central nervous system, the embryonic lung, stomach and intestine (Motoyama et al., 1998a). 
The highest levels of Ptch2 are detected in the skin (Carpenter et al., 1998). Another unique 
characteristic of Ptch2 is that is co-expressed with Shh in different tissues during mouse 
embryogenesis (Motoyama et al., 1998a). This distinct expression profile suggests that PTCH2 
could function differently from PTCH1. Ptch2-/- mutant embryos develop normally and do not 
display any defects in the patterning of the neural tube, limbs, hair follicles or testis 
(Nieuwenhuis et al., 2006). However, they exhibit a subtle increase of HH transcriptional targets 
in the limb bud and hair follicle (Nieuwenhuis et al., 2006). Adult Ptch2-/- mice display skin 
lesions that are characterized by alopecia, ulceration and epidermal hyperplasia (Nieuwenhuis et 
al., 2006). These defects are consistent with Ptch2 expression in the skin and indicates that 
PTCH2 plays an important role in maintaining skin homeostasis. Even though Ptch2 mutants do 
not have a predisposition to develop tumors, rare mutations have been identified in several cases 
of basal cell carcinoma and medulloblastoma (Lee et al., 2006; Smyth et al., 1999; 
Zaphiropoulos et al., 1999). Moreover, the deletion of Ptch2 in a Ptch1+/- background enhances 
tumor formation (basal cell carcinoma and medulloblastoma), indicating that both PTCH1 and 
PTCH2 can function as tumor suppressor genes (Lee et al., 2006).   
Genomic analysis of GLI binding sites, cell based assays, and overexpression studies in 
the chicken spinal cord demonstrated that Ptch2 is a direct transcriptional target of HH signaling 
(Holtz et al., 2013; Peterson et al., 2012; Vokes et al., 2007; Vokes et al., 2008). However, the 
lack of phenotype in Ptch2 mutants indicated that its dispensable for HH signaling during 
development (Goodrich et al., 1997; Nieuwenhuis et al., 2006). Thus, it was unclear if PTCH2 
had a role in HH signaling and if it was capable of antagonizing HH signaling as its homologue 
PTCH1. This was clarified by (Holtz et al., 2013), who demonstrated that PTCH2 is a HH 
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pathway antagonist that functions redundantly with Ptch1 and Hhip to restrict HH-dependent 
specification of ventral neural progenitors (Holtz et al., 2013). Further, PTCH2 antagonizes HH 
signaling in the developing chicken neural tube and in HH-responsive NIH/3T3 fibroblasts 
(Holtz et al., 2013). These results demonstrate that PTCH2 does play a role in ligand dependent 
antagonism of HH signaling. In vitro studies also have demonstrated that PTCH2 can mediate 
ligand independent antagonism (Alfaro et al., 2014). This was demonstrated in Ptch1-/- cells 
where Ptch2 mediates the residual responsiveness to SHH retained in these cells (Alfaro et al., 
2014). Genetic evidence also supports that PTCH2 could mediate this mechanism, however to a 
lesser extent than PTCH1. 
 
Hedgehog-Interacting Protein 1 (Hhip) 
HHIP is a secreted glycoprotein that was identified in a biochemical screen from E10.0 
mouse limb buds (Chuang and McMahon, 1999). Sequence comparisons showed that HHIP is 
conserved across organisms including zebrafish, chicken and mice, but not in Xenopus (Chuang 
and McMahon, 1999). HHIP is comprised of multiple functional domains: an N-terminal 
cysteine rich domain, a 6-bladed  b propeller domain, two proximal EGF repeats, a C-terminal 
hydrophobic region, and 4 N-linked glycosylation sites (Chuang and McMahon, 1999).  
Examination of Hhip expression in mouse embryos revealed that this protein is closely expressed 
to Shh (Chuang and McMahon, 1999). First, Hhip is detected at E8.75 in the ventral midline of 
the neural tube and the ventral medial somites, next to Shh expressing cells (Chuang and 
McMahon, 1999). Hhip is also expressed next to Shh expressing cells in the midbrain, gut 
mesenchyme and in the posterior half of the limb bud (Chuang and McMahon, 1999). At later 
stages of development Shh is expressed in multiple epithelial tissues, like the lung, hair, whiskers 
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and the gut, in which Hhip is expressed in the adjacent mesenchyme (Bitgood and McMahon, 
1995). Interestingly, this expression profile near the ligand sources, indicated that Hhip was a 
HH transcriptional target; this was later confirmed by the genomic characterization of Gli 
activator targets performed by (Chuang and McMahon, 1999) and (Vokes et al., 2007). This 
novel protein binds to all three mammalian HH ligands with similar affinity as PTCH1(Chuang 
and McMahon, 1999). Crystal structures revealed that the site of HH ligand binding in HHIP was 
localized in the  b propeller domain (Bishop et al., 2009; Bosanac et al., 2009). Subsequent 
biochemical analyses provided more insights about HHIP function in HH signaling. Initially 
HHIP was described by (Chuang and McMahon, 1999) as a membrane anchored protein in COS-
7 cells. In contrast (Coulombe et al., 2004) detected a secreted version of HHIP in HEK293T 
cells. More recently, a series of biochemical and overexpression experiments in the chick neural 
tube demonstrated that HHIP1 is a secreted protein that can be attached to the plasma membrane 
through cell type-specific interactions with heparan sulfate via its cysteine rich domain, which 
localizes HHIP to the basement membrane (Holtz et al., 2015). This was the first description of a 
secreted HH pathway antagonist that inhibits HH signaling in a non-cell autonomous manner 
(Holtz et al., 2015). Notably, this mechanism is not only restricted to the neural tube; HHIP is 
also secreted in the embryonic lung and in the developing diencephalon (Holtz et al., 2015). 
Hhip mutant mice die shortly after birth due to respiratory defects (Chuang et al., 2003). 
These mutants display developmental defects in lung branching morphogenesis, with a reduced 
number of lobes, and defects in the endochondral skeleton (Chuang et al., 2003). Other HH-
responsive tissues such as the craniofacial structures, limbs and the neural tube are 
phenotypically normal in these mutants (Chuang et al., 2003). The developing lungs of Hhip 
mutants display a slight upregulation and expansion of Ptch1 expression in the lung mesenchyme 
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(Chuang et al., 2003), suggesting that HHIP is a HH pathway antagonist. Further analyses 
indicated that the branching defects in Hhip mutants arise from loss of Fgf10 in the mesenchyme. 
SHH signaling is required in the mesenchyme to suppress Fgf10 and mediate proper branching 
morphogenesis (Litingtung et al., 1998; Pepicelli et al., 1998). Additionally, (Kawahira et al., 
2003) reported that Hhip mutants display defects in the pancreas, stomach and duodenum. 
Interestingly, in Hhip mutant pancreata display decreased levels of Fgf10 in the mesenchyme; 
the pancreas also requires SHH suppression for proper development (Kawahira et al., 2003). 
These data indicate that HHIP is required in certain tissues to inhibit HH signaling and maintain 
the proper levels of Fgf10. As an important regulator of lung development, HHIP also has been 
involved in a number of human lung diseases such as asthma, chronic obstructive pulmonary 
disease lung cancer and emphysema (Pillai et al., 2009) (Castaldi et al., 2014; Li et al., 2011b; 
Young et al., 2010; Zhou et al., 2012).  
The lack of defects observed in a variety of HH responsive tissues in Hhip mutants, 
suggested that HHIP antagonistic function was functionally redundant with PTCH1. Different 
genetic studies tested this possibility by simultaneously deleting Hhip in a Ptch+/-, Ptch1-/- 
background or in combination with the MtPtch1 transgene (which expresses Ptch1 at low levels 
from a metallothionein promoter) and subsequently analyzing HH transcriptional targets (Jeong 
and McMahon, 2005; Milenkovic et al., 1999). These compound mutants displayed variable 
phenotypes that ranged from increased overall embryo size to exencephaly, spina bifida, 
hyperplastic first branchial arches and subtle expansion of the ventral progenitor domains (Jeong 
and McMahon, 2005). The phenotypes were more severe in MtPtch1;Ptch1-/-;Hhip-/- embryos, 
where the entire brain was open, the branchial arches were expanded and the eyes were absent. 
Strikingly, MtPtch1;Ptch1-/-;Hhip1-/- mutants displayed the largest expansion of ventral neural 
 34 
progenitors and the reduction of  intermediate and dorsal progenitor domains (Jeong and 
McMahon, 2005). These phenotypes are consistent with increased HH activity and suggested 
that both HHIP and PTCH1 are redundant pathway components of the feedback control that 
regulate SHH signaling in the neural tube. The redundancy of HHIP and PTCH1 during neural 
tube patterning was further explored by (Holtz et al., 2013), which integrated into the analysis 
another HH pathway antagonist, PTCH2. First, this study addressed the possible redundancy 
between HHIP and PTCH2; these double mutant embryos do not display any apparent defects 
and display normal neural patterning at E10.5 (Holtz et al., 2013). However, the combined 
deletion of Ptch1 and Ptch2 (MtPtch1;Ptch1-/-;Ptch2-/- embryos)  results in midbrain and 
hindbrain exencephaly and significant expansion of SHH-dependent ventral neural progenitors; 
indicative of increased HH signaling (Holtz et al., 2013). Furthermore, (Holtz et al., 2013) also 
examined MtPtch1;Ptch1-/-;Ptch2-/-; Hhip-/- embryos which display a neural tube with only 
ventral neural progenitors, significant defects in size and neuro-epithelial outgrowths; the most 
striking phenotype among these compound mutants (Holtz et al., 2013). These experiments 
demonstrated that PTCH1, PTCH2, and HHIP are collectively required to mediate HH ligand-
dependent inhibition in the neural tube to properly specify all the neuronal progenitors in the 
neural tube. 
 
Growth arrest-specific 1 (GAS1) 
GAS1 is a GPI-anchored cell surface protein related to the glial cell-derived neurotrophic 
factor (GDNF) (Cabrera et al., 2006). GAS1 is composed of an N-terminal signal sequence 
peptide, two cysteine rich domains and a GPI anchor (Cabrera et al., 2006). Originally Gas1 was 
identified as a negative regulator of growth and mediator of cell death, however this function has 
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not been demonstrated in an animal model (Schneider et al., 1988). GAS1 is broadly expressed 
during mouse and chicken embryogenesis and its expression is first detected at E6.5 (Lee and 
Fan, 2001). Specifically, Gas1 is expressed in the neural tube, craniofacial structures, limbs, 
somites, optic and otic vesicles, among other structures (Lee and Fan, 2001). This protein was 
first implicated in SHH signaling as an antagonist by overexpression in presomitic cells and 
tooth explants (Cobourne et al., 2004; Lee et al., 2001a). Additionally, (Lee et al., 2001a) and 
(Martinelli and Fan, 2007) demonstrated that GAS1 binds SHH ligand. Later, multiple 
transcriptional profiling experiments from Smo and Ptch1 embryos at several embryonic stages 
identified Gas1 as a gene that is downregulated in response to SHH (Allen et al., 2007; Tenzen et 
al., 2006). Despite the antagonistic roles previously described for GAS1 in HH signaling, the 
examination of Gas1 null embryos revealed roles that are consistent with a role of GAS1 in the 
promotion of HH signaling. Specifically, Gas1 mutants display severe HPE defects, 
microphthalmia, cerebellar, limb and axon guidance defects (Allen et al., 2007; Martinelli and 
Fan, 2007; Seppala et al., 2007) (Liu et al., 2002; Liu et al., 2001). Examination of Gas1 
expression revealed that during early stages of development Gas1 is expressed within HH-
responsive cells, but as the levels of HH signaling increase, Gas1 becomes dorsally restricted, 
consistent with the idea that Gas1 is a negative target of SHH signaling (Allen et al., 2007; 
Martinelli and Fan, 2007).  Analysis of HH-dependent patterning in Gas1 null embryos, showed 
a significant decrease of Nkx2.1, a direct transcriptional target of HH signaling, in the 
craniofacial structures and decreased expression of the HH targets FOXA2, NKX2.2 and OLIG2 
in ventral neuronal progenitors (Allen et al., 2007). Conversely, ectopic expression of Gas1 by 
chicken in ovo eletroporations drives the ectopic expression of these genes in the developing 
chicken forebrain and neural tube (Allen et al., 2007). Further, reducing the dosage of Shh in a 
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Gas1 null background exacerbates the developmental defects in these mutants (Allen et al., 
2007; Seppala et al., 2007). In other HH-dependent tissues like the cerebellum, Gas1 is required 
to promote proliferation of cerebellar granule neuron progenitors (CGNPs) that reside in the 
proliferative external germinal layer (Izzi et al., 2011). These data demonstrated that Gas1 
positively regulates HH signaling during vertebrate embryogenesis.  
The requirement of Gas1 in SHH signal transduction was further elucidated by deleting it 
in combination with two other HH pathway components, the Cell adhesion molecule–
related/down-regulated by oncogenes (Cdon) and Brother of Cdon (Boc; discussed below). The 
simultaneous deletion of Gas1 with either Cdon or Boc also enhances the severity of the 
phenotypes observed in Gas1 null embryos in the craniofacial structures, the limbs, the 
cerebellum, and the neural tube (Allen et al., 2007; Izzi et al., 2011). These data demonstrate that 
GAS1 is part of a HH receptor complex essential for proper HH signal transduction. However, 
the variability in the severity of the of the phenotypes observed in Gas1-/- embryos, has made it 
difficult to interpret its individual contribution to HH signaling. For example, in the craniofacial 
structures the HPE phenotypes are dependent on the genetic background. In a 129Sv-C57BL/6J 
mixed genetic background, the craniofacial defects are mild, characterized by fused premaxillary 
incisor, synostic premaxilla, cleft secondary palate and defects in the basisphenoid bone (Seppala 
et al., 2007). When Gas1-/- mutants are maintained predominantly in a BL/6J background they 
display truncated maxilla, reduced parietal bone and disrupted tympanic bone (Allen et al., 
2007). In addition, there is some variability in the limbs defects of Gas1 null mutants, which lack 
digit 2 or 3 both in the forelimb and in the hindlimb (Allen et al., 2011). However, the variability 
in the limb defects has not been attributed to genetic background. Is still unclear why Gas 
mutants display highly variable phenotypes. These phenotypes suggest that the Gas1 locus can 
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be influenced by other unknown epigenetic and or environmental factors that affect its function. 
In the context of disease Gas1 has been involved in HPE, where patients with mutations in the 
Gas1 gene display highly variable clinical manifestations (Ribeiro et al., 2010). Gas1 is also 
implicated in pancreatic cancer, where it regulates the levels of HH signaling in a dosage 
dependent manner to regulate growth and angiogenesis (Mathew et al., 2014).  
The mechanism by which GAS1 regulates HH signaling is still unclear. However, 
different studies have elucidated important insights about GAS1 function. Co-
immunoprecipitation experiments have demonstrated that GAS1 interacts with PTCH1 and with 
PTCH2 (Holtz et al., 2013; Izzi et al., 2011). This interaction suggests that GAS1 can present the 
SHH ligand to PTCH1 or provide more stability to the receptor complex. Additionally, based on 
the digit specification defects (digits 2 and 3 which require low levels of HH activity) of Gas1-/- 
embryos and the expression of GAS1 in the limb bud, it is thought that GAS1 functions in areas 
of long range and low levels of SHH signaling (Allen et al., 2011; Martinelli and Fan, 2007). 
However, this type of regulation mediated by GAS1 might be restricted to specific tissues and be 
dependent on the levels of SHH. More recently, Gas1 also was implicated in primordial germ 
cell migration in mouse, where is suggested to form a complex with PTCH2 to induce the 
activity of GLI and the parallel activation of cAMP-responsive element binding protein and the 
Src tyrosine kinase (Kim et al., 2020). This study suggests that GAS1 could differentially 
regulate SHH signaling by interacting with other cell surface proteins.  
 
Cell adhesion molecule – related/down-regulated by oncogenes (CDON) and Brother of CDON 
(BOC) 
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CDON and BOC are two structurally similar related proteins from the immunoglobin (Ig) 
superfamily (Kang et al., 1997; Kang et al., 2002). CDON and BOC were initially described as 
cell adhesion molecules, which form complexes in a cis manner to enhance myogenic 
differentiation by a positive feedback loop with MyoD in myogenic precursors (Kang et al., 
1997; Kang et al., 2002). These proteins are comprised of an N-terminal signal peptide, four 
(BOC) or five (CDON) Ig domains followed by three fibronectin type III domains (FNIII), a 
single pass transmembrane domain and a cytoplasmic domain (Kang et al., 2002). The 
arrangement of Ig and FNIII domains of CDON and BOC resemble the Robo family of proteins, 
which are axon guidance receptors (Simpson et al., 2000). Despite the significant structural 
similarity between CDON and BOC, the amino acid identity of the single domains is variable 
ranging from 38% to 80% of homology (Kang et al., 2002). They also differ in the number of Ig 
domains (CDON (5) vs. BOC (4)) and their unique cytoplasmic domains that are not related to 
each other, and do not resemble any other known proteins (Kang et al., 2002). CDON was first 
associated with HH in an siRNA screen in cultured Drosophila cells, which identified CG2911, a 
fly homologue for CDON with unknown function in HH signaling (Lum et al., 2003; Yao et al., 
2006). In flies this gene was denominated as interference hedgehog (ihog). Additionally, another 
ihog family member CG32796 or brother of ihog (boi), a BOC homologue, was also linked to 
HH signaling (Lum et al., 2003; Yao et al., 2006). Genetic studies in Drosophila and in vitro 
biochemical studies elucidated that both ihog and boi are proteins that bind to SHH through their 
first FNIII domain and that they function at the level of PTC to collectively enhance the HH 
signaling (Camp et al., 2010; Camp et al., 2014; McLellan et al., 2008; Yao et al., 2006; Zheng et 
al., 2010). In addition, overexpression of boi in cells lacking ihog rescued the HH activity, 
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suggesting that ihog and boi act in a redundant manner to mediate the promotion of HH signaling 
in flies (Yao et al., 2006). 
 The role of Cdon and Boc in HH signal transduction is conserved from flies to 
vertebrates. These proteins were also identified in transcriptional profiling experiments from Smo 
and Ptch1 mouse mutants, with the aim of identifying novel cell surface proteins that could 
regulate HH signaling (Tenzen et al., 2006). Extensive expression characterization by in situ 
hybridization in the mouse and chicken embryo showed that Cdon and Boc are broadly and 
similarly expressed throughout development (Mulieri et al., 2002; Mulieri et al., 2000). Cdon and 
Boc are expressed in the neural tube, craniofacial structures, limbs, somites, urogenital system, 
among other tissues (Mulieri et al., 2002; Mulieri et al., 2000; Tenzen et al., 2006). Notably, in 
HH-responsive tissues they are expressed in opposition to the Shh ligand, consistent with the 
notion that they are negatively regulated by HH signaling. This was also confirmed by 
examining Cdon and Boc expression in Shh-/- and Smo-/- mutants, where their expression is 
enhanced and expanded closer to the SHH ligand source (Tenzen et al., 2006). In contrast, in 
Ptch1-/- mutants, their expression is lost or downregulated (Tenzen et al., 2006). These data 
suggest that Cdon and Boc are general negative targets of HH signaling. Interestingly, Boc was 
also identified as a positive target of Gli1 in a genome wide screen in medulloblastoma; 
indicating that Boc expression is regulated by SHH signaling (Lee et al., 2010). Analysis of 
Cdon-/- and Boc-/- mouse embryos revealed subtle defects in certain HH responsive tissues; 
interestingly the defects are not similar between these mutants. Cdon-/- embryos are 
embryonically lethal at E18.5 and display variable strain-specific HPE defects, as observed in 
Gas1 null mutants (Cole and Krauss, 2003; Zhang et al., 2006). In a mixed 129/Sv background 
Cdon-/- embryos display micorforms of HPE, displaying single median maxillary incisor, and 
 40 
defects in certain bones; while in a congenic BL/6J background the defects are enhanced 
resulting in midface hypoplasia, a single nostril and ocular hypotelorism (Cole and Krauss, 2003; 
Zhang et al., 2006). In contrast, Boc mutants are viable and fertile, and are phenotypically normal 
with no overt craniofacial defects regardless of the genetic background. Notably and different 
from Cdon mutants, Boc-/- embryos display defects in commissural axon guidance and have a 
smaller cerebellum with proliferation defects (Izzi et al., 2011; Okada et al., 2006). Interestingly, 
Cdon-/- and Boc-/- embryos do not display any limb patterning defects (Allen et al., 2011; Cole 
and Krauss, 2003). Detailed examination of ventral neural patterning of E10.5 single Cdon and 
Boc mutants revealed that only Cdon-/- embryos have neural patterning defects. Specifically, 
these mutants display decreased numbers of FOXA2 positive cells resulting in defects in floor 
plate specification (Allen et al., 2011; Tenzen et al., 2006). The absence of phenotypes in Boc 
null mutants suggested that as observed in Drosophila, Cdon and Boc have redundant roles in 
vertebrate HH signaling. To further elucidate this possibility in vertebrates, several groups 
examined the defects observed in different tissues of Cdon-/-;Boc-/- embryos. In the absence of 
both Cdon and Boc, the patterning defects in the craniofacial structures and in the neural tube are 
exacerbated, while the limbs are unaffected; demonstrating that these proteins display 
overlapping roles in certain tissues (Allen et al., 2011; Zhang et al., 2011). Based on their similar 
expression patterns and transcriptional signatures, the genetic interactions of Gas1, Cdon and 
Boc were analyzed as compound mutants. Gas1;Cdon mutants display a striking reduction in 
SHH signaling, resulting in severe HPE with fusion of the forebrain, a single nostril and near 
complete loss of HH-dependent ventral neural patterning (Allen et al., 2007). Similarly, 
Gas1;Boc mutants display loss of ventral neural patterning, however the craniofacial defects are 
not as severe as the ones observed in Gas1;Cdon mutants (Allen et al., 2011; Seppala et al., 
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2014). Surprisingly, severe digit specification defects are only observed in the Gas1;Boc double 
mutants, lacking digit 2 and showing fusion of digits 3 and 4 (Allen et al., 2011). Despite Cdon 
expression in the developing limb, the deletion of Cdon in a Boc or Gas1 null background does 
not result in any defects in digit specification (Allen et al., 2011). These data suggest that CDON 
does not play a role in HH-dependent limb patterning, in comparison to GAS1 and BOC. 
Further, the simultaneous deletion of Gas1, Cdon and Boc resulted in even more striking defects, 
with embryonic lethality at E10.5, complete loss of ventral neural patterning, cyclopia, HPE, and 
heart looping defects (Allen et al., 2011).  The phenotypes observed in single, compound and 
triple mutants demonstrate that GAS1, CDON and BOC are essential during development by 
collectively regulating HH signaling. Given their essential requirement during development, 
mutations in Cdon and Boc have been identified in human HPE patients (Bae et al., 2011; Hong 
et al., 2017). CDON and BOC are not only active during development. Their expression has also 
been detected in the stroma of pancreatic lesions, were their deletion affect the levels of HH 
signaling (Mathew et al., 2014). In addition, Boc expression is upregulated in a subset of human 
medulloblastoma tumors in which it regulates their proliferation rate (Mille et al., 2014).  
Even though CDON and BOC are essential during development to mediate HH signal 
transduction, the mechanisms by which they regulate HH signaling are poorly understood. 
Similar to their fly homologues, CDON and BOC also bind to SHH ligand; however, the 
interaction occurs in a different manner. Biochemical, biophysical, X-ray structural studies and 
cell culture binding assays demonstrated that SHH binds directly to the third FNIII domain of 
CDON and BOC, and that this interaction requires calcium (McLellan et al., 2008; Tenzen et al., 
2006; Yao et al., 2006). Furthermore, other studies have performed structure function analysis to 
determine which domains of CDON and BOC are necessary to promote HH signaling activity. 
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Biochemical experiments showed that CDON and BOC establish interactions with PTCH1 
through their first and second fibronectin domains, and they also bind to PTCH2 (Bae et al., 
2011; Izzi et al., 2011) (Holtz et al., 2013). Recently, in vivo gain-of-function experiments in the 
chicken neural tube dissected novel and distinct requirements for CDON and BOC in HH signal 
transduction (Song et al., 2015). Specifically, both proteins require membrane attachment, the 
third FNIII domain, and the first or second FNIII domain to promote HH signaling in the spinal 
cord (Song et al., 2015). Additionally, BOC exhibits some unique requirements like the Ig-FNIII 
linker region and an extracellular cleavage event at the linker that connects the FNIII and integral 
membrane attachment (Song et al., 2015). Conversely, CDON does not require the Ig-FNIII 
linker, does not undergo extracellular cleavage, and just requires peripheral membrane 
attachment (Song et al., 2015). Interestingly, in both proteins the cytoplasmic domain is 
dispensable. Notably, this domain is required in CDON but not in BOC during myogenesis 
(Kang et al., 2002; Song et al., 2015). In contrast, this domain in BOC is required for interactions 
with specific proteins in axon guidance and neuronal differentiation (Makihara et al., 2018; 
Vuong et al., 2017). Overall, these studies demonstrate that CDON and BOC utilize different 
domains to promote HH signaling.  
 
1.3.6 HH ligand-independent cell surface regulators 
While HH ligand-binding proteins comprise the largest class of cell surface regulators, a 
second class of cell surface HH pathway components exists that functions independently of HH 
ligands. These proteins transduce HH signaling through the modulation of downstream HH 
pathway components. In this section I discuss HH ligand-independent cell surface regulators of 
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the pathway, how they regulate HH signaling, how they are influenced by HH ligand-dependent 
cell surface regulators, and their role in HH-driven disease.  
 
Smoothened (SMO) 
The Smoothened (smo) gene was identified in a Drosophila genetic screen, where it was 
described as a segment polarity gene, originally named Smooth (Nusslein-Volhard et al., 1984). 
However, the name Smooth was already used to name another locus, and the new gene was 
renamed Smoothened (Lindsley and Zimm, 2012). Drosophila larvae lacking smo display 
variable segment polarity cuticle phenotypes resembling Hh mutant larvae, suggesting a role in 
HH signaling (Nusslein-Volhard et al., 1984; van den Heuvel and Ingham, 1996). SMO was 
identified and characterized as a HH transducer by two different studies, (Alcedo et al., 1996) 
and (van den Heuvel and Ingham, 1996), which demonstrated that smo was necessary for the 
response of cells to HH signaling by performing molecular and genetic experiments in 
Drosophila. Due to the relevance of SMO in HH signal transduction in Drosophila, the role of 
Smo was also explored during vertebrate embryogenesis.  
Deletion of Smo in mice results in embryonic lethality at E9.5– Smo mutants display 
severe developmental defects including cyclopia and HPE, similar to phenotypes observed in 
Shh mouse mutants (Chiang et al., 1996; Zhang et al., 2001). Smo homozygous mutants also fail 
to undergo embryonic turning, closure of the ventral midgut and normal heart looping (Zhang et 
al., 2001). Additionally, (Zhang et al., 2001) performed genetic experiments that demonstrated 
that Smo is epistatic to Ptch1 and that SMO is essential to transduce both SHH and IHH ligands. 
Specifically, in absence of HH ligands, SMO is constitutively inhibited by PTCH1. HH ligand 
binding to PTCH1 releases SMO inhibition in a catalytic manner that does not require the 
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interaction of these proteins (Taipale et al., 2002). The mechanism of SMO inhibition by PTCH1 
remains unclear. Various studies suggest that this inhibition occurs through an indirect 
mechanism, potentially by regulating the availability of small molecules that bind to SMO 
(Ingham et al., 2000; Taipale et al., 2002). Recent cryo-electron microscopy studies revealed the 
structures of PTCH1, which displayed a “tunnel” that could transport cholesterol from within the 
membrane to the extracellular space (Qi et al., 2018a). These data suggest a model in which 
PTCH1 inhibits SMO by depleting cholesterol, which is required for SMO signaling; ligand 
biding to PTCH1 occludes cholesterol transport and allows for SMO activation [reviewed by 
(Sommer and Lemmon, 2018)]. These data demonstrate a potential mechanism that directly links 
ligand reception to downstream signaling. 
The Smo gene encodes a protein that display typical characteristics of the G-protein 
coupled receptors (GPCR) superfamily, which are closely related to the Frizzled family of Wnt 
receptors (Alcedo et al., 1996; Dann et al., 2001; Fredriksson et al., 2003; van den Heuvel and 
Ingham, 1996). The GPCR-like structure of SMO suggests that this protein could be functioning 
through heterotrimeric G proteins to transduce HH signaling. Several studies have demonstrated 
that SMO utilizes the Gαi heterotrimeric G proteins to regulate HH pathway activity (DeCamp et 
al., 2000; Kasai et al., 2004; Ogden et al., 2008; Riobo et al., 2006). However, there is limited 
evidence in how SMO directly binds to these proteins and how they influence HH activity. 
Moreover, recent studies have suggested that vertebrate SMO can regulate HH signaling in a G 
protein-independent manner [reviewed by (Arensdorf et al., 2016)], suggesting that SMO could 
be regulating HH signaling through multiple mechanisms.  
Structurally, SMO contains a cysteine rich (CRD) domain in the extracellular N-terminal 
region, three extracellular and three intracellular loops, seven transmembrane domains, and a 
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intracellular carboxyl-terminal tail (Alcedo et al., 1996; van den Heuvel and Ingham, 1996; 
Zhang et al., 2001). This receptor is conserved across organisms, but there is structural 
divergence in some of the SMO domains (Huangfu and Anderson, 2006). Comparisons of 
invertebrate and vertebrate SMO sequences indicate that the transmembrane domains are 
relatively conserved, while the major differences are in the intracellular carboxyl-terminal tail 
[reviewed by (Huangfu and Anderson, 2006)]. Over the years, different studies have focused on 
elucidating the functions of the different structural domains of SMO that serve as binding sites 
for different small molecules or domains, which can undergo posttranslational modifications that 
alter HH pathway activity [reviewed by (Arensdorf et al., 2016)].  
Recently, (Nachtergaele et al., 2013) solved the crystal structure of the zebrafish SMO 
CRD domain, identifying a conserved hydrophobic groove rich in cysteine amino acids that is 
analogous to the Frizzled and Frizzled-like CRDs that bind to the palmityl modification of Wnt 
ligands and small hydrophobic ligands. This hydrophobic groove serves as binding site for 
oxysterols, which can activate SMO in the absence of HH ligands in certain tissues (Corcoran 
and Scott, 2006; Dwyer et al., 2007; Nachtergaele et al., 2013). Other studies have focused on 
the seven transmembrane domains of SMO, which foster stabilizing interactions with the amino-
terminal linker domain and the first and third extracellular loops to ensure proper positioning of 
the CRD domain (Wang et al., 2013). Additionally, the seven transmembrane domains possess a 
binding site for cyclopamine, a plant alkaloid that inhibits HH signaling (Chen et al., 2002a). 
This specific binding site also binds to a variety of small molecules that modulate HH activity, 
including SMO agonists (SAG) and antagonists (SANT-1 and Vismodegib) (Chen et al., 2002b; 
Frank-Kamenetsky et al., 2002; Robarge et al., 2009). Finally, the carboxyl-terminal tail of SMO 
also regulates HH pathway function. This domain is hyperphosphorylated upon HH pathway 
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activation by Protein kinase A (PKA), Casein kinase I (CK1𝛼) and the G protein coupled 
receptor kinase 2 (GRK2) (Chen et al., 2011; Jia et al., 2004). Subsequently, this causes a 
conformational change in SMO that in Drosophila results in the translocation of SMO to cell 
membrane, while in vertebrates it goes to the primary cilium to initiate a signaling transduction 
cascade that results in differential processing of the Ci/GLI transcription family (Denef et al., 
2000; Hui and Angers, 2011; Zhao et al., 2007). The levels of these phosphorylation events 
positively correlate with the levels of SMO at the cell surface an at the primary cilia and HH 
pathway activity. The SMO carboxyl-terminal domain can also be ubiquitylated in Drosophila  
and in MEFs, preventing the accumulation of SMO at the cell surface and primary cilia 
respectively, negatively impacting the activation of HH transduction by SMO (Desai et al., 2020; 
Xia et al., 2012).  
Given the implications of HH signaling in cancer, mutations in signal transduction 
components like SMO can lead to the hyperactivation of the pathway and consequently 
tumorigenesis. Activating mutations in the human SMO gene have been identified in sporadic 
basal cell carcinoma, where SMO functions as an oncogene (Xie et al., 1998). The identified 
mutations affect multiple domains of SMO including the carboxyl-terminal tail, transmembrane 
domains of SMO, and the biding pocket of the transmembrane domains [reviewed by (Arensdorf 
et al., 2016)]. SMO is an attractive therapeutic target of HH signaling due to its multiple biding 
sites, which could be targeted to regulate aberrant activity in HH-dependent cancers. Taking 
advantage of this, pharmacological treatments like GDC-0449 (Vismodegib) targeting SMO 
have been developed (Robarge et al., 2009). Vismodegib is the first targeted inhibitor of the HH 
signaling pathway approved by the United States Food and Drug Administration [reviewed by 
(Rudin, 2012)]. This treatment produced promising anti-tumor responses, causing tumor 
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regression in different cancers like basal cell carcinoma and medulloblastoma  (Von Hoff et al., 
2009; Yauch et al., 2009). However, certain tumors become drug resistant after treatment with 
Vismodegib, due to a point mutation that disrupted the binding of the drug (Rudin et al., 2009; 
Yauch et al., 2009). This resistance results from outgrowth of drug-resistant clones from the 
original tumor or from de novo mutations (Sharpe et al., 2015). New therapies are being 
developed to avoid this drug-resistance by developing other drugs that bind SMO at sites distinct 
from Vismodegib, or by targeting HH signaling downstream of SMO (Long et al., 2014).  
 
G-protein coupled receptor 161 (GPR161) 
GPR161 is an orphan class A conserved GPCR, identified in a screen of cultured IMCD3 
cells, with the purpose of identifying novel receptors that negatively regulated SHH signaling 
(Mukhopadhyay et al., 2013). This receptor was previously implicated as a locus that encodes 
the vacuolated lens mutation, which causes congenital cataracts and neural tube defects 
(Matteson et al., 2008). GPCRs are part of large superfamily of proteins that contain seven 
transmembrane spanning domains, and the capacity to modulate intracellular metabolism 
through the activation of heterotrimeric GTP-binding proteins (Gainetdinov et al., 2004). At 
early stages of mouse development, Gpr161 is ubiquitously expressed (Matteson et al., 2008; 
Mukhopadhyay et al., 2013). At mid-gestation Gpr161 is restricted to the brain, spinal cord, 
dorsal ganglia, and at lower levels in the hindlimb (Mukhopadhyay et al., 2013). In a variety of 
ciliated cell types, GPR161 localization is confined to the primary cilium (Mukhopadhyay et al., 
2013), a structure required for proper HH signal transduction (Goetz and Anderson, 2010). 
Homozygous Gpr161 mutant mouse embryos are embryonically lethal at E10.5 (Mukhopadhyay 
et al., 2013). Phenotypically, these embryos exhibit extensive craniofacial abnormalities, open 
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forebrain/midbrain region, a ventralized neural tube and lack of limbs buds (Mukhopadhyay et 
al., 2013). Gpr161 mutants resemble embryos lacking TULP3 (Tubby-like protein)/Intrafagellar 
transport-A mutants (IFT-A), which mediate the trafficking of GPCR proteins to the primary 
cilium and also regulate GPR161 (Mukhopadhyay et al., 2010; Svard et al., 2006). Additionally, 
GPR161 has been implicated in the restriction of the medulloblastoma pathogenesis, a cancer 
that originates in the cerebellum from dysregulation of SHH signaling (Shimada et al., 2018). All 
these characteristic phenotypes and expression patterns of Gpr161 suggested that this protein 
could negatively regulate HH signaling during vertebrate embryogenesis. This was further 
confirmed by the upregulated levels of Gli1 and Ptch1 detected in E9.5 and E10.5 Gpr161 
mutant embryos by in situ hybridization and qPCR (Mukhopadhyay et al., 2013). Additionally, 
these embryos display a striking expansion of HH-dependent ventral neuronal progenitors in the 
neural tube, and defects in the processing of GLI2 and GLI3 (Mukhopadhyay et al., 2013). 
Overexpression of GPR161 results in increased levels of cyclic adenosine monophosphate 
(cAMP), which in turn activates protein kinase A (PKA), which regulates GLI processing 
(Mukhopadhyay et al., 2013; Tuson et al., 2011). Specifically, GPR161 regulates the levels of 
GLI3 by processing it into its repressor form (Mukhopadhyay et al., 2013). Recently, other 
studies have also reported GPR161 can repress HH signaling in other tissues like the forebrain 
and limb, where it is required for proper patterning (Hwang et al., 2018; Shimada et al., 2019). 
Overall, these studies demonstrate that GPR161 is a negative regulator of the SHH signaling 




NRPs are transmembrane glycoproteins from the semaphorin family, initially identified 
in Xenopus tadpoles neuronal screens as targets of monoclonal antibodies against the optic 
tectum (Takagi et al., 1987). Based on the name of the monoclonal antibody that identified this 
novel protein, originally it was named A5. Subsequent studies identified that the target 
recognized by the A5 monoclonal antibody, encoded a 140kDa protein that was highly conserved 
among organisms, including chicken and mouse (Kawakami et al., 1996) (Takagi et al., 1991; 
Takagi et al., 1995). However, later it was renamed NRP1 due to its characteristic expression in 
the nerve terminals, or neuropils of the optic nerve and other specific regions of the nervous 
system [reviewed by (Fujisawa et al., 1997)]. Mammals possess two NRP genes, NRP1 and 
NRP2, which share 44 % amino acid identity homology and possess similar structural domains 
(Chen et al., 1997; Kolodkin et al., 1997). Structurally NRPs are comprised of a large 
extracellular domain that contains five sub domains known as  a1/a2, b1/b2 and c, a 
transmembrane domain and a short cytoplasmic domain (Takagi et al., 1991). The extracellular 
domain of NRPs consist of two CUB motifs (a1/a2), which share sequence homology to C1r and 
C1s proteins, two domains that are homologous coagulation factors V and VIII (b1/b2), and a 
membrane-proximal meprin MAM domain (c) (Kawakami et al., 1996; Takagi et al., 1991). The 
extracellular domains a1/a2 and b1/b2 serve as binding sites for two unrelated families of 
ligands; class 3 Semaphorin (SEMA) ligands and vascular endothelial growth factor (VEGF), 
which bind to NRP1 and NRP2 with different specificity (Chen et al., 1997; Giger et al., 1998; 
Gluzman-Poltorak et al., 2000; He and Tessier-Lavigne, 1997; Kolodkin et al., 1997; Makinen et 
al., 1999; Migdal et al., 1998; Soker et al., 1998; Takahashi et al., 1998). The NRP 
transmembrane domain is responsible for mediating dimerization and oligomerization through a 
double GXXXG motif, which stabilizes the formation of signaling complexes (Roth et al., 2008). 
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While the NRP cytoplasmic domain does not resemble any other protein motif and does not 
perform any catalytic activity, this domain does possess a C-terminal SEA (serine-glutamine-
alanine) motif that interacts with intracellular proteins containing a PSD-95/Dlg/ZO-1 (PDZ)-
domain.  
The major function ascribed to NRPs has been a central role in axon guidance as part of 
the SEMA signaling pathway. In this context, NRPs function as co-receptors with the plexin 
(PLXN) family of proteins to mediate SEMA signal transduction [reviewed by (Zhou et al., 
2008)]. These proteins can preferentially form different complexes, which function in a specific 
manner during axonal growth cone, regulating attraction and repulsion during axon guidance, 
[reviewed by (Tata, 2015) (Zhou et al., 2008)].  
NRPs also function as co-receptors, along with VEGF receptors (VEGFR), for VEGF 
ligands. VEGF interactions with NRP VEGFR induce angiogenesis by forming distinct receptor 
complexes that enhance VEGF ligand binding and subsequently activate downstream signaling 
[reviewed by (Klagsbrun et al., 2002)].  
During mouse embryogenesis NRPs are expressed in the axons of actively growing 
neurons of specific neuron al populations, the cardiovascular and skeletal system, and in the limb 
at different developmental stages (Kawakami et al., 1996; Kitsukawa et al., 1995; Kolodkin et 
al., 1997). Notably, despite the structural similarity between NRP1 and NRP2, their expression 
patterns are not completely overlapping. Multiple studies have shown that there are various 
transmembrane and truncated isoforms of NRPs that are generated from alternative splicing, 
which exhibit tissue-specific expression, suggesting distinct roles for these isoforms (Cackowski 
et al., 2004; Gagnon et al., 2000; Rossignol et al., 2000). Deletion of Nrp1 in mice results in 
embryonic lethality around E12.5-E13.5 due to cardiovascular defects (Kawasaki et al., 1999). 
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Specifically, Nrp1 mutants embryos display severe disruption in the vasculature of the yolk sac, 
the CNS and the peripheral nervous system, heart outflow tracts defects and disorganized 
branchial arch arteries and great vessels (Kawasaki et al., 1999). Additionally, these mutants 
exhibit defects in the trajectory of the cranial and spinal efferent fibers which express NRP1 
(Kitsukawa et al., 1997). In contrast, Nrp2 mutants are viable, with normal vascular phenotypes; 
but they display defects in axonal projections in CNS and peripheral nervous system (Chen et al., 
2000; Giger et al., 2000). Mouse embryos lacking both NRPs die in utero at E8.5 with some 
mutants that die at even earlier embryonic stages (Takashima et al., 2002). E8.5 Nrp1-/-;Nrp2-/- 
embryos display severe growth defects, abnormal blood vessel development and totally avascular 
yolk sacs (Takashima et al., 2002). Together, NRP1 and NRP2 are important regulators of axon 
guidance and angiogenesis; nonetheless, their function is not limited to these biological 
processes.  
NRPs also regulate mammalian HH signaling.  An RNAi screen in HH-responsive 
fibroblasts revealed a requirement for Nrp1 and Nrp2 in HH pathway activation (Hillman et al., 
2011). Further, morpholino knockdown of Nrp1a in zebrafish embryos resulted in ventral body 
curvature and U-shaped somites, a phenotype consistent with HH pathway loss-of-function 
(Hillman et al., 2011). More recently, the tissue-specific deletion of Nrp1 in cerebellar granular 
progenitors (CGNP), a HH-responsive cell type,  in a Nrp2 null background, results in decreased 
levels of Gli1 transcript and protein, and reduced CGNP proliferation  (Ge et al., 2015).  
Conversely overexpression of NRP1 and NRP2 in NIH3T3 fibroblasts increased HH 
pathway activity after stimulation with HH ligand (Hillman et al., 2011; Pinskey et al., 2017). 
However, combined stimulation of SHH with SEMA3A or SEMA3F in NIH3T3 fibroblasts, 
significantly enhanced the SHH-induced transcription of Gli1 (Ge et al., 2015). Although, SEMA 
 52 
ligands do not induce Gli1 expression by themselves, disruption of the NRP-SEMA3 interaction 
with function-blocking NRP antibodies in the presence of HH ligand, decreases the levels of 
Gli1 in NIH3T3 cells (Ge et al., 2015). These data suggest that NRPs can enhance HH signal 
transduction in presence of HH ligands, and through SEMA3 ligands. However, more studies 
will be necessary to understand the requirement of the SEMA3 ligands in HH signal 
transduction, since there are some contradictory results regarding the NRPs domains that 
promote HH activity. (Ge et al., 2015) demonstrated that the a1/a2 domains and the cytoplasmic 
domains of NRP1 are required to promote HH signaling, while the b1/b2 domains are 
dispensable. In contrast, (Pinskey et al., 2017) demonstrated that the cytoplasmic domain and 
transmembrane domain are necessary and sufficient to activate HH pathway function. Moreover, 
(Pinskey et al., 2017) identified a novel 12-amino acid motif within the membrane-proximal half 
of the NRP-1 cytoplasmic domain that is critical for HH activity promotion. Despite the 
discrepancies in the requirements for the SEMA 3 ligands, several studies suggest that NRPs 
regulate HH signaling through the modulation of GLI activity. Initially, (Hillman et al., 2011) 
suggested that Nrps regulate HH signaling at the level of Suppressor of Fused (SUFU); a 
negative regulator of the pathway. (Ge et al., 2015) proposed a model where NRPs function 
downstream of SUFU by regulating GLI phosphorylation through interactions with 
phosphodiesterase 4D (PDE4D), which inhibits PKA, a negative regulator of HH signaling. In 
contrast, (Pinskey et al., 2017) suggested that NRPs promote HH signaling selectively at the 
level of GLI and independently of PKA phosphorylation. Based on these results, the cytoplasmic 
domain of NRP is critical to mediate HH signaling transduction, but additional mechanistic 
experiments will be required to understand the how the cytoplasmic domain interacts and recruits 
different proteins and how they regulate HH signaling collectively. 
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NRPs have been also implicated in various HH driven cancers including human 
medulloblastoma (Ge et al., 2015; Hayden Gephart et al., 2013; Snuderl et al., 2013), where both 
Nrp1 and Nrp2 are highly expressed (Snuderl et al., 2013). In medulloblastoma (Snuderl et al., 
2013), suggested that tumor-secreted SHH stimulates the stromal production of the Placental 
Growth Factor (PlGF), a VEGF family member, which promotes the growth and spread of 
medulloblastoma. Additionally, pharmacological inhibition of the PDE4D enzyme inhibited 
tumor growth in mouse medulloblastoma tumors resistant to SMO inhibitors (Ge et al., 2015). 
These data establish NRPs as positive regulators of HH signaling during development and 
identify NRPs as potential novel therapeutic targets for HH-driven cancers. 
 
1.4 Tissue specific roles for GAS1, CDON and BOC  
GAS, CDON and BOC are generally known as HH co-receptors based on their collective 
requirement to promote HH signaling, similar expression profiles during development and their 
capability to bind to HH ligands (Allen et al., 2011; Bae et al., 2011; Izzi et al., 2011; Lee et al., 
2001a; Lee and Fan, 2001; McLellan et al., 2008; Mulieri et al., 2002; Mulieri et al., 2000). 
Genetic evidence in mice and Drosophila demonstrate that these proteins are essential to mediate 
HH signal transduction and in some cases function redundantly (Allen et al., 2011; Allen et al., 
2007; Yao et al., 2006; Zheng et al., 2010). However, there are several lines of evidence that 
indicate that these proteins could regulate HH signaling in a tissue-specific manner. First, even 
though these co-receptors are expressed similarly throughout development, there are differences 
in their spatiotemporal expression (Lee and Fan, 2001; Mulieri et al., 2002; Mulieri et al., 2000). 
In mice, their expression is first detected during different early embryonic stages, Gas1 at E6.5, 
Cdon at E7.0 and Boc at E.7.5 (Lee and Fan, 2001; Mulieri et al., 2002; Mulieri et al., 2000). 
 54 
Throughout development their expression patterns are mostly restricted to the same structures. 
However, the extent of their expression domains and their expression in relation to HH ligand 
source varies among tissues. GAS1 is broadly expressed in the neural tube, craniofacial 
structures, limbs (Figure 2.2). In contrast, CDON expression domains in these same tissues are 
more restricted; while BOC expression is similar to GAS1, however it extends closer to the HH 
ligand source (Figure 2.2). These subtle expression differences will provide critical information 
to understand how these proteins regulate HH signaling and how they could interact with other 
proteins. The differential expression of GAS1, CDON and BOC during development suggest that 
these proteins could mediate distinct functions in certain tissues.  
The HH co-receptors can also interact with PTCH1 and PTCH2 and form distinct SHH 
receptor complexes; suggesting that they could function independently of each other (Bae et al., 
2011; Holtz et al., 2013; Izzi et al., 2011). This is also supported by non-overlapping functions of 
GAS1, CDON and BOC in different tissues. For example, some unique roles for the HH co-
receptors include: GAS1 as a regulator of enteric axon projections, CDON as a dependence 
receptor to promote apoptosis in absence of SHH, and BOC as regulator of SHH-dependent axon 
guidance (Jin et al., 2015; Kang et al., 2002; Okada et al., 2006). Additionally, CDON and BOC 
can form complexes in a cis fashion through the interactions of their extracellular and 
intracellular domains; the significance of this interaction for HH signaling has yet to be 
determined (Kang et al., 2002). The interactions of the HH co-receptors with other cell surface 
regulators could provide different combinations of SHH receptor complexes that could 
differentially regulate HH signaling in different tissues. 
GAS1, CDON and BOC have been extensively analyzed as positive regulators of HH 
signaling. However, there is evidence that in certain tissues HH co-receptors can function as HH 
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pathway antagonists. Initially the first co-receptor described to antagonize HH signaling was 
GAS1, in presomitic mesoderm and tooth bud explants in mice (Cobourne et al., 2004; Lee et al., 
2001a; Ohazama et al., 2009). Additionally, it has been shown that Cdon can antagonize HH 
signaling in the optic vesicle of chicken and zebrafish embryos (Cardozo et al., 2014). Lastly, 
recent studies suggest that Boc can antagonize HH signaling in the zebrafish lower jaw 
(Bergeron et al., 2011). However, this study does not show direct evidence that Boc is a HH 
pathway antagonist (Bergeron et al., 2011). Their analysis is limited to the description of a 
phenotype and does not examine the levels of the HH transcriptional targets. Is still unknown 
how the HH co-receptors can differentially regulate HH signaling across different tissues and 
organisms. These dual (promotion/inhibition) functions of the HH co-receptors could explain 
how the HH signaling pathway patterns different structures during vertebrate embryogenesis. 
 
1.5 Conclusion 
The expression patterns of the HH co-receptors, their different phenotypes in HH 
responsive tissues, and their identified dual roles, suggest that these proteins are not functionally 
redundant. This raises the possibility that the HH co-receptors function in a tissue-specific 
manner to differentially regulate HH signaling. In this dissertation, my main objectives were to: 
1) investigate novel tissue-specific roles for the HH co-receptors and 2) elucidate HH co-receptor 
function during vertebrate embryogenesis. Chapter two will focus on exploring HH co-receptor 
function in craniofacial development. In this chapter I provide evidence that indicates that BOC 
works in opposition to GAS1 and CDON during craniofacial development, by antagonizing HH 
signaling. Also, I demonstrate that this novel antagonistic role mediated by BOC is restricted to 
the craniofacial structures. Further, I show that the deletion of Boc in a Gas1 null mutant 
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background ameliorates the HPE phenotype observed in Gas1 single mutants. Chapter 3 
provides evidence for a novel role for CDON during HH-dependent digit specification. In this 
chapter, I utilize a novel Cdon conditional allele to simultaneously delete Gas1, Cdon and Boc, 
specifically in the limb. In Chapter 4, I discuss the interpretation of my data and propose future 
directions for my work. Overall the data presented here demonstrates that HH co-receptors are 






Figure 1.1 Summary of vertebrate HH signal transduction 
(Left panel) In the absence of HH ligand, PTCH1 inhibits SMO, resulting in the processing of GLI transcription factors into 
repressors that inhibit HH target gene expression. (Right panel) In the presence of HH ligand, HH binds to PTCH1, leading to de-
repression of SMO and subsequent processing of GLI transcription factors into activators that induce HH target gene expression. 







Figure 1.2 Shh expression and function in E10.5 mouse tissues. 
(Top panel) Shh expression in E10.5 mouse forebrain, neural tube, and limb bud. Colors denote mesenchyme (yellow), 
neuroepithelium (purple), surface ectoderm (green) and Shh expression domain (red). At E10.5 Shh is expressed in the following 
structures: in the forebrain is expressed the ventral telencephalon and the medial nasal process; in the neural tube is expressed in 
the notochord and floorplate and in the limb bud in the posterior mesenchyme (zone of polarizing activity).  (Bottom panel) 








Figure 1.3 Cell surface regulation of HH signaling. 
(First panel) Cell surface proteins that regulate HH ligand release and trafficking, Dispatched (DISP1) and Signal sequence-CUB 
domain-epidermal growth factor like-related 2 (SCUBE2). (Second panel) Cell surface proteins that regulate HH ligand reception 
and trafficking, Low-density lipoprotein receptor- related protein 2 (LRP2) and Glypicans (GPC1-6). (Third panel) Cell surface 
proteins that regulate HH ligand reception, Patched 1 (PTCH1), Patched 2 (PTCH2), HH-interacting protein (HHIP), Growth 
arrest-specific 1 (GAS1), Cell adhesion molecule – related /down-regulated by oncogenes (CDON) and Brother of Cdon (BOC). 
(Fourth panel) Cell surface proteins that regulate HH signal transduction, Smoothened (SMO), G-protein couple receptor 161 
(GPR161) and Neuropilin1/2 (NRP1/2). Note that common domains of these proteins are not represented by the same shape 
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Chapter 2 The Hedgehog Co-Receptor BOC Differentially Regulates SHH Signaling 




The Hedgehog (HH) pathway controls multiple aspects of craniofacial development. HH 
ligands signal through the canonical receptor PTCH1, and three co-receptors:  GAS1, CDON and 
BOC. Together, these co-receptors are required during embryogenesis to mediate proper HH 
signaling. Here we investigated the individual and combined contributions of GAS1, CDON and 
BOC to HH-dependent mammalian craniofacial development. Notably, individual deletion of 
either Gas1 or Cdon results in variable holoprosencephaly phenotypes, even on a congenic 
background. In contrast, we find that Boc deletion results in facial widening that correlates with 
increased HH target gene expression. Additionally, Boc deletion in a Gas1 null background 
partially ameliorates the craniofacial defects observed in Gas1 single mutants; a phenotype that 
persists over developmental time, resulting in significant improvements to a subset of 
craniofacial structures. This contrasts with HH-dependent phenotypes in other tissues that 
significantly worsen following combined deletion of Gas1 and Boc. Together, these data indicate 
that BOC acts as a multi-functional regulator of HH signaling during craniofacial development, 




Hedgehog (HH) signaling regulates the patterning and growth of nearly every tissue in 
the body (Briscoe and Therond, 2013; McMahon et al., 2003). Aberrant HH pathway activity 
results in severe birth defects including Holoprosencephaly (HPE), a defect characterized by the 
failure of the division of the embryonic forebrain into two cerebral hemispheres (Muenke and 
Beachy, 2000). HPE is one of the most common birth defects in humans, estimated to affect as 
many as 1 in 250 embryos (Hong and Krauss, 2018). The clinical manifestations of HPE are 
highly heterogeneous, consisting of a wide phenotypic spectrum of defects (Schachter and 
Krauss, 2008). Notably, 80% or more of HPE cases will display facial defects in addition to the 
forebrain malformations (Schachter and Krauss, 2008).  
  Multiple mutations associated with developmental signaling pathways such as HH, have 
been identified in human HPE patients (Roessler and Muenke, 2010). Specifically, mutations in 
Sonic Hedgehog (SHH) account for 6%-8% of sporadic HPE (Roessler et al., 2009). During 
craniofacial development Shh regulates the establishment of forebrain identity, and patterns the 
face primordia (Schachter and Krauss, 2008). Moreover, disruption of Shh in mice results in 
abnormal dorsoventral patterning in the neural tube, defective axial skeleton formation and 
alobar HPE (Chiang et al., 1996).  
SHH ligands signal through the twelve-pass transmembrane receptor Patched (PTCH1) 
(Marigo et al., 1996). However, SHH also binds three co-receptors, growth arrest-specific 1 
(GAS1), CAM-related/downregulated by oncogenes (CDON) and brother of CDON (BOC) 
(Allen et al., 2011; Allen et al., 2007; Beachy et al., 2010; Izzi et al., 2011; Lee et al., 2001; 
McLellan et al., 2008; Tenzen et al., 2006; Yao et al., 2006; Zhang et al., 2011; Zhang et al., 
 87 
2006). CDON and BOC are structurally similar members of the immunoglobulin superfamily 
that are conserved from Drosophila to mammals (Beachy et al., 2010; Kang et al., 1997; Kang et 
al., 2002; Lum et al., 2003). GAS1 is a vertebrate-specific, GPI-anchored protein with structural 
resemblance to GDNF receptors (Cabrera et al., 2006). In the absence of SHH ligand, PTCH1 
inhibits the activity of the GPCR-like protein Smoothened (SMO). SHH ligand binding to 
PTCH1 and GAS1, CDON or BOC releases SMO inhibition leading to a signal transduction 
cascade that leads to modulation of the GLI family of transcriptional effectors (Hui and Angers, 
2011). Together, GAS1, CDON and BOC are required for HH signal transduction during 
embryogenesis (Allen et al., 2011; Allen et al., 2007; Cole and Krauss, 2003; Izzi et al., 2011; 
Martinelli and Fan, 2007; Tenzen et al., 2006; Zhang et al., 2011; Zhang et al., 2006)  
Similar to Shh mutants, simultaneous genetic removal of Gas1, Cdon and Boc, results in 
alobar HPE (Allen et al., 2011). Further, multiple mutations in these HH co-receptors have been 
identified in human HPE patients (Bae et al., 2011; Hong et al., 2017; Ribeiro et al., 2010), 
suggesting that these proteins play key roles in craniofacial development. This is supported by 
multiple studies in mice demonstrating a role for these genes during HH-dependent craniofacial 
development (Cole and Krauss, 2003; Seppala et al., 2007; Seppala et al., 2014; Zhang et al., 
2011; Zhang et al., 2006). Gas1 and Cdon single mutants display microforms of HPE, in which 
the severity of the phenotype is dependent on the genetic background of the mouse model (Allen 
et al., 2007; Cole and Krauss, 2003; Seppala et al., 2007; Zhang et al., 2006). In contrast, in 
mixed genetic backgrounds Boc deletion does not result in any HPE phenotypes, although these 
animals do display defects in SHH-dependent commissural axon guidance (Okada et al., 2006; 
Seppala et al., 2014; Zhang et al., 2011). More recently, Boc has been demonstrated to function 
as silent HPE modifier gene that, in the context of other HPE mutations, can modify the severity 
 88 
of the HPE phenotype (Hong and Krauss, 2018). It has been proposed that modifier genes like 
Boc contribute to the phenotypic differences observed in different genetic backgrounds.  
 GAS1, CDON and BOC have generally been described as positive regulators of the HH 
signaling pathway. However, in certain contexts these co-receptors can act to restrain HH 
signaling. For example, Gas1 can antagonize HH signaling in presomitic mesoderm explants 
(Lee et al., 2001), and restricts HH signaling during tooth development in mice (Cobourne et al., 
2004; Ohazama et al., 2009). Similarly, Cdon negatively regulates HH pathway function in the 
optic vesicle of zebrafish and chick embryos (Cardozo et al., 2014). It remains unclear how these 
co-receptors differentially regulate HH signaling in these different contexts. 
 Here we investigated the contributions of GAS1, CDON and BOC to HH-dependent 
mammalian craniofacial development. Specifically, we examined the individual and combined 
deletion of different HH co-receptors on a congenic C57BL/6J background. Surprisingly, we 
found that Boc mutants display facial widening and increased HH target gene expression in the 
nasal processes. Additionally, deletion of Boc in a Gas1 null background partially ameliorates 
the craniofacial defects observed in Gas1 single mutants, while other HH-dependent phenotypes 
in these mutants are significantly worsened. Interestingly, the rescue of the craniofacial defects 
in Gas1;Boc mutants persists over developmental time, but is restricted to the nostrils and the 
soft tissues of the craniofacial structures. Finally, we provide evidence that BOC selectively 
restricts neural crest-derived mesenchymal proliferation. Together, our data indicate that BOC 
acts as a multi-functional regulator of HH signaling during craniofacial development, alternately 
promoting or restraining HH pathway activity in a tissue-specific fashion. 
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2.3 Results  
To define the expression of the HH pathway co-receptors Gas1, Cdon and Boc during 
early craniofacial development, we utilized lacZ (Gas1 and Cdon) and Alkaline phosphatase 
(AP; Boc) reporter alleles (Figure 2.1) (Cole and Krauss, 2003; Martinelli and Fan, 2007; Zhang 
et al., 2011). At E8.5 Gas1, Cdon and Boc are primarily expressed in the cranial neural folds, the 
somites and the neural tube (Figure 2.1A-D). During this stage Cdon is the only co-receptor 
expressed in the prechordal plate (PCP; see arrowhead in Figure 2.1C inset), a major signaling 
center during craniofacial development that secretes SHH ligand, which patterns the ventral 
forebrain (Cordero et al., 2004; Rubenstein and Beachy, 1998; Zhang et al., 2006). As 
development progresses, these expression patterns are maintained in the somites and neural tube, 
and expand to additional structures. At E9.5 the HH co-receptors are all expressed in the 
frontonasal prominence (FNP), maxillary process (MXP) and mandibular process (MP; Figure 
2.1E-H). Differences in Gas1, Cdon and Boc expression in craniofacial structures are revealed by 
analysis of E10.5 embryos (Figure 2.1I-T).  
 En face views of whole-mount stained E10.5 embryos (Figure 2.1M-P) demonstrate 
broad expression of Gas1, Cdon and Boc in the forebrain. X-Gal and AP staining in coronal 
sections of E10.5 embryos reveals that all three co-receptors are present in the surface ectoderm 
and in the forebrain neuroepithelium (NE) in a dorso-ventral gradient (Figure 2.1Q-T; Figure 
2.2A-D). Notably, the ventral extent of Cdon expression in the NE is greatly restricted compared 
to Gas1 and Boc. Similarly, Gas1 and Boc display broad expression in the olfactory epithelium 
(OE), while Cdon expression is limited to a subset of cells in the medial OE of the LNP (see 
arrowhead in Figure 2.1S, Figure 2.2G). 
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 At E10.5, Gas1 is the only co-receptor expressed in the MP and in the MXP (Figure 2.1J, 
N).  Further differences in the expression of the HH co-receptors are detected in the medial nasal 
and lateral nasal processes (MNP and LNP). All three co-receptors are expressed in the LNP 
(Figure 2.1Q-T). However, Gas1 and Boc are expressed throughout the LNP mesenchyme, while 
Cdon expression is restricted to the most dorsal aspect of the LNP mesenchyme (Figure 2.1S, 
Figure 2.2G). In the MNP, Gas1 and Boc are broadly expressed at lower levels in the 
mesenchyme; in contrast, Cdon is only expressed in mesenchymal cells that are proximal to the 
NE (Figure 2.1S, Figure 2.2G). The expression of Gas1, Cdon and Boc in the craniofacial 
structures is consistent with their general negative transcriptional regulation by the HH signaling 
pathway (Allen et al., 2007; Tenzen et al., 2006). In addition to the differences in expression of 
the HH co-receptors in craniofacial structures, their expression in other HH-responsive tissues 
such as the forelimb bud (Figure 2.2J–L), and the neural tube (Figure 2.2N-P) is also not 
identical. In particular, the expression domains of Boc in the forebrain neuroepithelium (Figure 
2.2H) and in the neural tube (Figure 2.2 P) extend further ventrally, and closer to the sources of 
Shh expression in these tissues, namely the ventral telencephalon and the notochord/floor plate, 
respectively. These data raise the question of whether these co-receptors, and BOC in particular, 
may differentially contribute to HH-dependent craniofacial development. 
  To address the individual contributions of Gas1, Cdon, and Boc to craniofacial 
development, we examined single mutant embryos at mid-gestation on a congenic C57BL/6J 
background (Figure 2.3). At E10.5 Gas1-/- and Cdon-/- embryos display a spectrum of HPE 
phenotypes that range from proper telencephalic vesicle (TV) division with normal MNP 
separation, to no TV division with no MNP separation (Figure 2.4). Most of these mutants 
exhibit incomplete TV division (76% of Gas1-/- embryos, and 50% of Cdon-/- embryos), while a 
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smaller portion (12% and 17%, respectively) of these mutants fails to divide the TV (Figure 
2.4H). Gas1-/- and Cdon-/- embryos predominantly show either incomplete MNP separation (47% 
of Gas1-/- embryos, and 33% of Cdon-/- embryos) or no MNP separation (29% and 42%, 
respectively; Figure 2.4I). Notably, a minority of Gas1 and Cdon mutants have more mild 
phenotypes that are characterized by normal TV division (Figure 2.4H) and either normal or 
reduced MNP separation (Figure 2.4I). In contrast, Boc-/- embryos do not manifest any gross 
craniofacial defects (Figure 2.3J-L), with 100% of embryos displaying normal TV division and 
normal MNP separation (Figure 2.4H-I). Together, these data indicate that even on a congenic 
C57BL/6J genetic background there remains a spectrum of HPE phenotypes observed in Gas1 
and Cdon mutants. Strikingly, and despite the broad expression of Boc in multiple HH-
responsive cell types in the developing forebrain (Figure 2.1), we do not observe any HPE 
phenotypes in Boc mutants maintained on a C57BL/6J background.  
 To further characterize the spectrum of HPE phenotypes, we quantified the internasal 
distance in E10.5 embryos. Consistent with our initial assessment, this quantitation revealed 
significant reductions in the internasal distance in both Gas1 and Cdon mutant embryos (Figure  
2.3M). Surprisingly, this quantitation also revealed an unexpected subtle, but significant increase 
in the internasal distance in Boc mutant embryos compared to wildtype embryos (443µm in 
wildtype embryos, and 496µm Boc-/- embryos; Figure 2.3M). These data suggest potentially 
opposing roles for Gas1 and Cdon compared to Boc during mammalian craniofacial 
development. One explanation for these counterintuitive results is that the increased internasal 
distance in Boc embryos was due to an overall increase in embryo size. Therefore, we measured 
the crown-rump length (CRL) in E10.5 wildtype and mutant embryos (Figure 2.5A-E). While 
Gas1 mutants are significantly smaller than their wildtype littermates, both Cdon and Boc mutant 
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embryos have similar CRL as wildtype embryos (Figure 2.5F). These data support the notion that 
the MNP widening observed in Boc mutants at E10.5 reflects differences in the contribution of 
this HH co-receptor to craniofacial development. Interestingly, widening or duplication of 
midfacial tissues is associated with increased levels of HH signaling (Brugmann et al., 2010; Hu 
and Helms, 1999).  
 To determine if the variable craniofacial defects observed in these HH co-receptor mutant 
embryos correlates with HH pathway activity, we performed in situ hybridization for Gli1, a 
general and direct transcriptional target of HH signaling (Dai et al., 1999). Gli1 is expressed in 
multiple craniofacial structures, including the MNP, MXP and MP (Figure 2.6A). Gas1-/- and 
Cdon-/- embryos with less severe HPE phenotypes maintain Gli1 expression in the MNP, but 
embryos with increasingly severe HPE phenotypes display a loss of Gli1 expression in the MNP 
(Figure 2.6D-F, G-I). In contrast, in Boc-/- embryos Gli1 expression is maintained in the MNP 
across all Boc mutant embryos (Figure 2.6J-L). To quantify changes in Gli1 expression we 
performed qRT-PCR in E11.5 nasal processes (Figure 2.3N). Boc-/- embryos display a significant 
increase in Gli1 expression, consistent with the internasal distance widening (Figure 2.3M). In 
contrast, and consistent with the in situ hybridization data, Gas1-/- embryos display a significant 
decrease in Gli1 (Figure 2.3N). We also explored if changes in Gli1 mRNA translated into 
protein level differences (Figure 2.3O). Boc mutants maintain similar levels of GLI1 protein as 
wildtype embryos, while GLI1 protein is reduced in Gas1 mutants. While these changes do not 
reach the level of statistical significance (Figure 2.5G), these results are consistent with both the 
Gli1 in situ hybridization and qRT-PCR results. Taken together, these data indicate that HPE 
severity in Gas1 and Cdon mutant embryos correlates with Gli1 loss in the nasal processes, and 
demonstrate that, in contrast to Gas1 and Cdon, Boc mutants display increased Gli1 expression 
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in the nasal processes. These data suggest an antagonistic role for BOC during HH-dependent 
craniofacial development. 
 Previous studies have suggested that combinatorial deletion of Gas1, Cdon, or Boc results 
in more severe HPE phenotypes (Allen et al., 2011; Allen et al., 2007; Seppala et al., 2014; 
Zhang et al., 2011), suggesting that HH co-receptors positively regulate HH signaling during 
craniofacial development. In contrast, the midface widening that we observe in Boc-/- embryos 
(Figure 2.3M) is consistent with a role for Boc as a potential HH antagonist during craniofacial 
development. To explore this possibility, we deleted Boc in combination with Gas1 deletion on a 
congenic C57BL/6J background.  
 Analysis of E10.5 Gas1-/-;Boc-/- embryos revealed a spectrum of HPE phenotypes, as 
observed in Gas1-/- embryos (Figure 2.7). Importantly, the HPE phenotypes observed in 
Gas1;Boc double mutants are less severe than those observed in Gas1 single mutants (cf. Figure 
2.7B and 2.7D). Specifically, we observed an increase in the percentage of Gas1;Boc double 
mutants with normal TV division compared to Gas1 single mutants (31% vs. 12%, respectively; 
Figure 2.7E). Further, we found that 50% of Gas1;Boc double mutants display MNP separation 
compared to 24% of Gas1 mutants (Figure 2.7F). To investigate whether this rescue was due to 
increased overall embryo size, we measured the CRL of Gas1-/-;Boc-/- embryos (Figure 2.8A-E). 
We find that Gas1-/-;Boc-/- embryos tend to be smaller than Gas1-/- embryos (Figure 2.8F); while 
not statistically significant, these data rule out increased embryo size as an explanation for the 
rescue of the HPE phenotypes. Overall, these data suggest that Boc deletion in a Gas1 mutant 
background partially rescues TV and MNP separation in E10.5 embryos.  
 To determine if the phenotypes observed in Gas1;Boc mutants correlate with changes in 
HH pathway activity, we performed in situ hybridization for the direct HH transcriptional target 
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Gli1 in E10.5 wildtype, Gas1-/-, Boc-/-, and Gas-/-;Boc-/- embryos (Figure 2.7G-J). Gas1-/-;Boc-/- 
embryos that display increased MNP separation also display increased Gli1 expression in the 
MNP (Figure 2.7J), consistent with the notion that Boc antagonizes HH pathway activity during 
craniofacial development. Similarly, Gas1;Boc mutants that do not display the rescue of the 
craniofacial defects, exhibit decreased Gli1 levels, indicating that the rescue is HH-dependent 
(Figure 2.6M-O). We also examined Gli1 expression in the forelimb bud from these same 
embryos (Figure 2.7G’-J’). While we do not observe significant differences in Gli1 gene 
expression, or GLI1 protein levels in Gas1 or Boc single mutants (Figure 2.9), we do detect 
decreased Gli1 expression in Gas1;Boc double mutant embryos (cf. Figure 2.7G’, H’, J’). 
Together these data suggest that loss of Boc partially and selectively rescues HPE phenotypes 
observed in Gas1 mutant embryos, through increased HH pathway activity specifically in 
craniofacial structures. 
To examine the consequences of Boc deletion on additional targets of the HH pathway, 
and to begin to dissect possible tissue-specific contributions to craniofacial development, we 
investigated HH-dependent neural patterning in both the developing forebrain and spinal cord 
(Figure 2.10). Specifically, we used whole mount immunofluorescence to analyze the expression 
of NKX2.1, a direct HH transcriptional target in the ventral telencephalon (Pabst et al., 2000) 
(Figure 2.10E-H,M). In E10.5 Gas1-/- embryos the expression domain of NKX2.1 is significantly 
reduced (Figure 2.10F), while NKX2.1 expression in Boc-/- embryos is unchanged compared to 
wildtype embryos (cf. Figure 2.10E,G). Notably, compared to Gas1-/- embryos (Figure 2.10F), 
Gas1-/-;Boc-/- embryos maintain similar levels of NKX2.1 expression (Figure 2.10H). 
Quantitation confirms that NKX2.1 is not significantly altered in Gas1-/-;Boc-/- embryos 
compared to Gas1-/- embryos (Figure 2.10M). We also confirmed that NKX2.1 is not 
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significantly different in Boc-/- embryos (Figure 2.10M). Together, these data suggest that, 
despite its broad expression in the forebrain neuroepithelium (Figure 2.1T), Boc does not 
positively contribute to HH-dependent patterning in this tissue. These data do raise the question 
of whether Boc can regulate HH signaling in the developing telencephalon, or whether it may be 
playing an antagonistic role. To address these possibilities, we used chicken in ovo telencephalon 
electroporations to assess Boc function during HH-dependent neural patterning in the forebrain 
(Figure 2.11). Expression of GFP (pCIG, empty vector) in the chicken telencephalon does not 
affect NKX2.1 expression (Figure 2.11A-D). In contrast, expression of SmoM2 (a constitutively 
active form of SMO) (Xie et al., 1998), which drives high levels of HH pathway activity, induces 
ectopic NKX2.1 expression (Figure 2.11E-H). Similarly, expression of Boc also induces ectopic 
NKX2.1 expression (Figure 2.11I-L). These data demonstrate that Boc can promote HH-
dependent patterning in the developing chicken forebrain, and suggests that Boc does not play an 
antagonistic role in the forebrain neuroepithelium. 
 We also analyzed HH-dependent neural patterning in the spinal cord of wildtype, Gas1-/-, 
Boc-/-, and Gas1-/-;Boc-/- embryos (Figure 2.10I-L,N). We examined the expression of NKX2.2 
and OLIG2, two direct HH transcriptional targets that are activated in response to high and 
moderate levels of SHH signaling, respectively (Briscoe et al., 2000; Dessaud et al., 2008). At 
E10.5, Gas1-/- embryos display a significant reduction in the number of NKX2.2+ cells 
compared to wildtype embryos (Figure 2.10J,N). In contrast, the number of NKX2.2+ cells are 
not significantly reduced in Boc-/- embryos (Figure 2.10K,N). Strikingly, Gas1-/-;Boc-/- embryos 
have a very severe phenotype– OLIG2 expression is completely absent (Figure 2.10L), and we 
observe a near complete absence of NKX2.2 expression (Figure 2.10L,N). In some sections from 
Gas1;Boc mutants we could detect a few NKX2.2+ cells (Figure 2.10L, inset). Overall, these 
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data are consistent with previous studies (Allen et al., 2011), and further demonstrate that Boc 
selectively contributes to spinal cord, but not forebrain neural patterning. 
Given that E10.5 Gas1-/-;Boc-/- mutants manifest a partial rescue of the craniofacial 
defects observed in Gas1 single mutants, we investigated whether this rescue is maintained over 
developmental time. This question is particularly relevant since a prior analysis of Gas1-/-;Boc-/- 
embryos maintained on a mixed 129sv/C57BL/6/CD1 background demonstrated severe 
craniofacial defects such as clefting of the lip, palate and tongue, and disruption of the maxillary 
incisor (Seppala et al., 2014). To address this question, we examined craniofacial development in 
E18.5 wildtype and mutant embryos (Figure 2.12A-D). Consistent with previous work, E18.5 
Gas1-/- embryos display a range of craniofacial defects, while Boc-/- embryos appear 
phenotypically normal (Figure 2.12A-C, Figure 2.13A-B, H-I) (Allen et al., 2011; Allen et al., 
2007; Martinelli and Fan, 2007; Seppala et al., 2007; Seppala et al., 2014; Zhang et al., 2011). 
Gas1-/- and Gas1-/-;Boc-/- embryos share defects that include microphthalmia, midface and 
mandible hypoplasia, and cleft palate (Martinelli and Fan, 2007). Strikingly, and similar to what 
was observed during earlier developmental stages, E18.5 Gas1-/-;Boc-/- mutants display a less 
severe phenotype in specific craniofacial structures (Figure 2.12D,P). Specifically, Gas1-/-;Boc-/- 
mutants display  a wider maxilla and partial separation of the nasal pits; in comparison, Gas1-/- 
embryos have a smaller maxilla and no separation of the nasal pits (cf. black and white arrows in 
Figure 2.12B,D). Skeletal preparations (Figure 2.12E-L) confirm that Gas1-/-;Boc-/- mutants 
exhibit separation of the nasal capsule, while in Gas1-/- single mutants the nasal capsule is not 
separated (Figure 2.12F,H). In addition to the nasal capsule, some Gas1-/-;Boc-/- embryos exhibit 
widening of the premaxilla, although in others it is hypoplastic (see red arrow in Figure 2.12H 
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and inset in Figure 2.13J). These data suggest that the amelioration of the craniofacial defects 
observed at E10.5 in Gas1;Boc mutant embryos persists over developmental time.  
 In contrast to the nasal capsule and premaxilla, Gas1-/-;Boc-/-  embryos exhibit a shortened 
mandible and truncated meckel’s cartilage compared to Gas1-/- embryos (Figure 2.12J,L). The 
mandible of Gas1-/-;Boc-/- mutants also exhibit ectopic bone duplications on the posterior inferior 
side of the mandible (Figure 2.12L). Occasionally, Gas1-/- mutants with severe HPE phenotypes 
display a similar phenotype (Figure 2.12J inset). Bone duplications have been associated with 
loss of HH signaling in the mandibular neural crest derived mesenchyme (Jeong et al., 2004; Xu 
et al., 2019). Gas1-/-;Boc-/- mutants also display severe defects in the maxilla, palatine bone and 
the occipital bone (Figure 2.13J). We also evaluated SHH-dependent digit specification in these 
embryos (Figure 2.13G’-J’). Consistent with previous work (Allen et al., 2011), combined loss of 
Gas1 and Boc results in severe digit specification defects (Figure 2.13J’). These results suggest 
opposing and tissue-specific contributions of Boc to HH-dependent craniofacial development. 
 To further investigate these phenotypes, we analyzed three (3D) dimensional 
reconstructions from micro-computed tomography (µCT) images (Figure 2.12M’-P’, Figure 
2.13A’-D’). Specifically, we focused on the nasal bone, where we observed the partial rescue in 
Gas1;Boc mutants. The 3D reconstructions indicated that the nasal bone in Gas1-/-;Boc-/-  
embryos is reduced in size and partially fused when compared to wildtype embryos (Figure 
2.12M’, P’). As we observed at E10.5 (Figure 2.7), there is a spectrum of HPE phenotypes in 
Gas1 mutants, ranging from reduced and fused nasal bone to fragments of nasal bone (Figure 
2.12N’, Figure 2.13A-D). Gas1;Boc mutants display an intermediate nasal bone phenotype when 
compared to the spectrum of phenotypes in Gas1 single mutants (Figure 2.12N’,P’, Figure 
2.13A’-D’).  
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 Quantitation of head width in E18.5 embryos demonstrates that Gas1;Boc mutants 
display a significantly narrower head compared to Gas1 mutants (Figure 2.14A-B), consistent 
with our observations at E10.5 that Gas1;Boc mutant embryos trend smaller overall than Gas1 
single mutants (Figure 2.8F). Accounting for this size difference, Gas1;Boc mutant embryos 
exhibit a significant increase in interocular distance when compared to Gas1 mutant embryos 
(Figure 2.14A, C).  Examination of nostril frequency at E18.5 revealed that 100% (8/8 embryos) 
of Gas1-/-;Boc-/- embryos display two partially fused nostrils; in contrast only 58% (7/12 
embryos) of Gas1-/- embryos exhibit two partially nostrils, while 42% (5/12 embryos) display a 
single nostril (Figure 2.14E). Finally, Gas1;Boc mutants exhibit a significantly wider medial lip 
notch distance at E18.5 than Gas1 mutants (Figure 2.14F). Taken together these data 
demonstrate that Boc deletion in a Gas1 mutant background significantly ameliorates several 
craniofacial defects at later developmental stages, consistent with the phenotypes observed at 
E10.5.  
To investigate the mechanisms that could explain the partial rescue observed in Gas1-/-
;Boc-/- embryos, we analyzed tissue-specific proliferation in the forebrain of E10.5 wildtype and 
mutant embryos. Specifically, we performed immunofluorescence for Phospho-Histone H3 
(PH3), and co-stained with E-CADHERIN (E-CAD) and PDGFRa to discriminate between the 
surface ectoderm, forebrain neuroepithelium, and craniofacial mesenchyme (Figure 2.15A-E). 
Coronal sections of E10.5 Gas1-/- mutant embryos display normal numbers of PH3+ cells across 
the surface ectoderm and forebrain neuroepithelium (Figure 2.15B,F-G). In the craniofacial 
mesenchyme Gas1 mutant embryos display a subtle increase in PH3+ cells that fails to reach 
statistical significance (Figure 2.15H). Cdon-/- embryos do not exhibit any significant changes in 
proliferation in any of the craniofacial tissues (Figure  2.15F-H). Similarly, Boc-/- embryos do not 
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display any apparent changes in proliferation in the surface ectoderm or in the neuroepithelium 
(Figure 2.15F,G). However, Boc-/- embryos do display a significant increase in craniofacial 
mesenchymal proliferation compared to wildtype embryos (Figure 2.15D,H). These results 
suggest that Boc negatively regulates proliferation specifically in craniofacial mesenchyme.   
 We also investigated tissue-specific proliferation in Gas1-/-;Boc-/- mutant embryos. 
Notably, the levels of proliferation in the surface ectoderm and the forebrain neuroepithelium are 
not significantly different when compared to wildtype or Gas1-/- embryos (Figure 2.15F-G). In 
contrast, proliferation is significantly increased in the craniofacial mesenchyme of Gas1;Boc 
mutants when compared to wildtype embryos, although not when compared with Gas1 mutants. 
(Figure 2.15H). Surprisingly, this effect on proliferation appears to be quite selective, as there are 
no significant changes in proliferation in either the neural tube or the forelimb mesenchyme 
(Figure 2.16). Overall, these data suggest that Boc functions in a non-redundant manner to 
restrict proliferation in the craniofacial mesenchyme. 
 
2.4 Discussion 
 Here we investigated the individual and combined contributions of the HH co-receptors 
Gas1, Cdon and Boc during HH-dependent craniofacial development. We found that Boc 
displays a significantly broader expression pattern than Gas1 and Cdon in multiple craniofacial 
structures. Surprisingly, and distinct from Gas1 and Cdon, loss of Boc results in facial widening 
and increased HH pathway activity in the nasal processes (Brugmann et al., 2010; Hu and Helms, 
1999). Further, analysis of Gas1;Boc double mutants revealed an amelioration of the craniofacial 
phenotype observed in Gas1 single mutants, corresponding with increased HH pathway activity, 
and consistent with the notion that loss of Boc can counterintuitively drive increased HH 
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signaling. Notably, this improvement is restricted to a subset of craniofacial structures, but 
persists throughout embryonic development. Mechanistic analyses suggest that Boc selectively 
restricts proliferation in neural crest-derived mesenchyme and limits HH pathway activity in the 
nasal processes. Taken together, these data demonstrate that Boc regulates HH signaling in a 
tissue-specific manner, and suggests that, in certain tissues, BOC works in opposition to other 
HH co-receptors to restrain HH pathway function.  
 
2.4.1 Genetic background-dependent phenotypic differences in HH co-receptor mutants 
 Understanding the molecular mechanisms that underlie HPE is confounded by the 
significant phenotypic variability observed in this disease, and the complex genetics that 
contribute to proper craniofacial development. Our data indicate that, even when maintained on a 
congenic C57BL/6J background, Gas1 and Cdon mutants display a range of HPE phenotypes. 
These phenotypes vary from microforms of HPE to semilobar HPE, and their severity correlates 
with HH pathway activity as assessed by Gli1 expression. The variability in the HPE phenotypes 
of our mutants could be explained due to multiple genetic and non-genetic risk factors (Hong and 
Krauss, 2018). In particular, the variable severity across the phenotypes in our mutants could 
arise from stochastic changes in the establishment or response to the SHH morphogen gradient in 
the neuroepithelium, neural crest-derived mesenchyme and/or surface ectoderm. In early 
craniofacial structures Shh is expressed sequentially, initiating in the prechordal plate, followed 
by the diencephalon and telencephalon, subsequently in the surface ectoderm of the frontonasal 
prominence, and finally in the pharyngeal endoderm of the first branchial arch (Aoto et al., 2009; 
Cordero et al., 2004; Marcucio et al., 2005; Rubenstein and Beachy, 1998; Xavier et al., 2016a). 
This complex developmental expression sequence of Shh, which is required to properly pattern 
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the craniofacial structures (Krauss, 2007), combined with the differential expression of multiple 
HH receptors could generate an inherent variability that affects the severity of the HPE 
phenotypes.  
 The lack of craniofacial defects in Boc mutants maintained on different genetic mixed 
backgrounds (Okada et al., 2006; Seppala et al., 2014; Zhang et al., 2011) suggested a minor, 
redundant role for Boc in HH-dependent craniofacial development. This notion of Boc as a silent 
HPE modifier gene is supported by studies where Boc deletion in a Gas1 or Cdon null 
background enhances HPE severity and decreases the levels of HH pathway targets (Seppala et 
al., 2014; Zhang et al., 2011). However, our data indicate that Boc mutants on a C57BL/6J 
background exhibit internasal distance widening in E10.5 embryos and increased Gli1 expression 
specifically in the nasal processes. These data suggest an antagonistic role for Boc in HH 
signaling during craniofacial development. Previous studies described Boc as a potential HH 
pathway antagonist in the zebrafish lower jaw (Bergeron et al., 2011). However, this study is 
limited to a brief phenotypic description of the thickening and expansion of the cartilage 
elements in the lower jaw of Boc (umleitung) zebrafish mutants, and does not examine the effects 
of Boc deletion on HH pathway activity in this tissue. While we do not observe any mandible 
phenotypes in Boc-/- embryos, species-specific differences in craniofacial development between 
mouse and fish likely limit our ability to draw a direct connection. Alternatively, our analysis of 
Boc in the developing mandible may not be comprehensive enough to reveal this function. 
Regardless, our data reveal a novel, antagonistic role for Boc during aspects of craniofacial 
development, and raises the question of whether BOC may work in concert with other known 
redundant HH pathway antagonists, including PTCH1, PTCH2 and HHIP1, to maintain the 
balance between HH pathway activation and inhibition (Holtz et al., 2013) in the craniofacial 
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structures. Additionally, our data suggest that HH co-receptors can function to alternately 
promote or antagonize HH signaling depending on the context. In support of this notion, Gas1 
can antagonize HH signaling in presomitic mesoderm explants (Lee et al., 2001), and restricts 
HH signaling during tooth development in mice (Cobourne et al., 2004; Ohazama et al., 2009). 
Similarly, Cdon negatively regulates HH pathway function in the optic vesicle of zebrafish and 
chick embryos (Cardozo et al., 2014).  
 Boc deletion partially rescues the HPE phenotypes of Gas1 single mutants. Specifically, 
Gas1;Boc double mutants display increased MNP separation at E10.5 and increased interocular 
distance, partially restored nostril frequency, and broader medial lip notch distance at E18.5. 
Importantly, these phenotypes correlate with increased Gli1 levels in the MNP and increased 
proliferation in the neural crest mesenchyme. While the combination of these tissue-specific 
effects could mediate the rescue of the craniofacial defects in Gas1;Boc mutants, the incomplete 
penetrance of the rescue indicates that the variable HPE phenotypes observed in Gas1 single 
mutants also impacts the degree of rescue. Overall, this suggests a more complex mechanism, 
where genetic, epigenetic, and environmental cues all contribute to proper craniofacial 
development. Along these lines, our data partially contrast with previous work (Seppala et al., 
2014), in which Gas1;Boc mutants on a 129Sv-C57BL/6/CD1 genetic background display more 
severe phenotypes than those observed in Gas1 mutants (Seppala et al., 2014). Although 
Gas1;Boc mutants on a C57BL/6J background display severe defects in the majority of the bones 
of the skull and cleft palate as previously reported (Seppala et al., 2014), we never observe 
clefting of the lip in these mutants. Given that the lip is formed by the fusion of the MXP and the 
nasal processes (Jiang et al., 2006), this result is consistent with the partial rescue mediated by 
Boc deletion in the nasal bone and nasal capsule.  
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2.4.2 Tissue-specific functions of Boc in HH signal transduction  
 Analysis of HH transcriptional targets revealed that Boc deletion results in differential 
changes in HH-dependent gene expression in a tissue-specific fashion (Figure 2.17A). 
Specifically, our data suggest that BOC promotes the expression of the direct HH transcriptional 
target, NKX2.2, in the spinal cord neuroepithelium, but does not contribute to expression of 
NKX2.1 in the telencephalon neuroepithelium. These data suggest that BOC differentially 
regulates HH-dependent neural patterning at distinct axial levels. In the surface ectoderm, BOC 
does not impact proliferation; further experiments will be required to determine if BOC 
contributes to patterning of this tissue (Figure 2.17A). Further, BOC promotes Gli1 expression in 
the limb bud mesenchyme, but antagonizes Gli1 expression in the forebrain mesenchyme. 
Notably, Boc appears to selectively impact HH-dependent patterning, but not proliferation in the 
developing limb bud; conversely, Boc selectively inhibits proliferation in the neural crest-derived 
mesenchyme of the craniofacial structures (Figure 2.17A). This is consistent with previous work 
by (Xavier et al., 2016b) suggesting that Boc contributes to mesenchymal proliferation in the 
palatal shelf. Taken together, these data argue that BOC regulates patterning and proliferation in 
a tissue-specific manner and raises the possibility that BOC performs multiple, and in some 
cases, opposing roles in HH signal transduction. 
 
2.4.3 Boc as a multi-functional regulator of HH signaling 
 Based on our data, and the work of others, we propose a model whereby BOC acts as a 
multi-functional receptor to contribute to vertebrate embryogenesis (Figure 2.17B). Specifically, 
we propose that BOC can act to: 1) promote HH signaling through interactions with HH ligands 
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and the canonical receptor PTCH1; 2) antagonize HH signaling, either through ligand 
sequestration, or perhaps through the formation of an inhibitory complex with PTCH1; 3) 
contribute to HH-dependent signaling via its unique cytoplasmic domain; 4) function 
independently of the HH pathway.  
 BOC physically interacts with PTCH1 in a SHH-independent manner (Izzi et al., 2011). 
In craniofacial structures PTCH1 and BOC are both expressed in the MNP (Seppala et al., 2014). 
The differential interaction of these proteins could allow the formation of a receptor complex that 
alternately activates or inhibits HH pathway activity. Alternatively, BOC binding to HH ligands 
via its extracellular domain (Beachy et al., 2010; McLellan et al., 2008; Yao et al., 2006) raises 
the possibility that BOC can sequester SHH ligand in areas of low SHH concentration, and 
subsequently antagonize HH signaling. Consistent with this notion, Boc expression in HH-
responsive tissues generally extends closer to the source of SHH ligand than either Gas1 or 
Cdon. In particular, at E10.5 Boc is expressed in the surface ectoderm of the MNP, where Shh is 
also expressed (Xavier et al., 2016a). Loss of Boc in the MNP could allow for the expansion of 
SHH protein distribution, resulting in increased pathway function, and subsequently in widening 
of the midface. This putative increased range of SHH could similarly explain the partial rescue of 
craniofacial defects in Gas1;Boc mutants compared to Gas1 single mutants.  
 BOC displays a unique cytoplasmic domain that does not resemble any other protein or 
motif (Kang et al., 2002). Recently work suggests that the BOC cytoplasmic domain binds to the 
non-receptor tyrosine kinase ABL (Vuong et al., 2017) and to the adaptor protein ELMO1 
(Makihara et al., 2018). Thus, this domain could be critical to mediate tissue-specific, HH-
dependent signals, or to perform HH-independent functions through the activation of 
downstream signaling cascades. Future work will be required to determine potential 
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contributions of these mechanisms to BOC tissue-specific functions during craniofacial 
development. Overall, this work identifies multiple and distinct roles for BOC in HH-dependent 
craniofacial development. 
 
2.5 Materials and methods 
Reagents 
General reagents (Table 2.1), primary and secondary antibodies for immunofluorescence (Table 
2.2), western blot analysis antibodies (Table 2.3) and qRT-PCR Primers (Table 2.4).  
 
Animal Models 
Gas1lacZ (Martinelli and Fan, 2007), CdonlacZ-2 (Cole and Krauss, 2003), and BocAP (Zhang et al., 
2011) mice have been all described previously. Gas1, Cdon, and Boc mutants were backcrossed 
for at least ten generations to create lines on a congenic C57BL/6J background. CdonlacZ-1 mice 
(Cole and Krauss, 2003) were maintained on a mixed 129/Sv/C57BL/6 background for 
expression analysis. For embryonic dissections, noon of the day on which a vaginal plug was 
detected was considered as E0.5. For precise staging, somites were counted during the 
dissection. Embryos with 34-38 somites were considered E10.5 embryos. Fertilized eggs were 
obtained from the Poultry Teaching & Research Center at Michigan State University. To obtain 
Hamburger-Hamilton (HH) stage 11 chicken embryos, the fertilized eggs were incubated 39-40 
hours at 37°C in a GQF 1550 hatcher incubator with normal humidity settings (45%-55%). All 
animal procedures were reviewed and approved by the Institutional Animal Care and Use 




Embryos were dissected in 1X PBS, pH 7.4, and fixed (1% formaldehyde, 0.2% glutaraldehyde, 
2mM MgCl2, 5mM EGTA, 0.02% NP-40) on ice for 10-60 minutes depending on the embryonic 
stage. Subsequently, the embryos were washed 3 x 5 minutes with 1X PBS, pH 7.4 + 0.02% NP-
40 for permeabilization. ß-Galactosidase activity was detected with X-Gal staining solution 
(5mM K3Fe(CN)6, 5mM K4Fe(CN)6, 2mM MgCl2, 0.01% Na deoxycholate, 0.02% NP-40, 
1mg/mL X-gal). The signal was developed from 25 minutes to 24 hours at 37° C depending on 
the lacZ allele. After staining, the embryos were washed 3 x 5 minutes with 1X PBS, pH 7.4 at 
4°C, and post-fixed in 4% paraformaldehyde for 20 minutes at room temperature, followed by 3 
x 5 minute washes in 1X PBS, pH 7.4. Finally, embryos were stored and photographed in 1X 
PBS, pH 7.4 + 50% glycerol. X-gal staining of sections (20µm) was performed as described 
above for whole mount embryos. After staining, sections were washed 3 x 5 minutes with 1X 
PBS, pH 7.4, counterstained with nuclear fast red for 5 minutes and dehydrated in an ethanol 
series (70% ethanol, 95% ethanol, 100% ethanol and 100% Xylenes) followed by application of 
coverslips with permount mounting media (Thermo Fisher Scientific).  
 
Alkaline Phosphatase Staining 
Embryos were dissected in 1X PBS, pH 7.4, and fixed (1% formaldehyde, 0.2% glutaraldehyde, 
2mM MgCl2, 5mM EGTA, 0.02% NP-40) on ice for 10-60 minutes depending on the embryonic 
stage on ice. Subsequently, the embryos were washed 3 x 5 minutes with 1X PBS, pH 7.4. To 
deactivate endogenous alkaline phosphatases, embryos were incubated in 1X PBS, pH 7.4 at 
70°C for 30 minutes. Then the embryos were rinsed with 1X PBS, pH 7.4 and washed for 10 
minutes in alkaline phosphatase buffer (100mM NaCl, 100mM Tris-HCl pH9.5, 50mM MgCl2, 
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1% Tween-20) at room temperature. Embryos were stained with BM purple from 2 to 3 hours at 
37°C depending on the embryonic stage. After staining, the embryos were washed 3 x 5 minutes 
with 1X PBS, pH 7.4 at 4°C, and post-fixed in 4% paraformaldehyde for 20 minutes at room 
temperature, followed by 3 x 5 minute washes with 1X PBS, pH 7.4. Finally, embryos were 
stored and photographed in 1X PBS, pH 7.4 + 50% glycerol. Alkaline phosphatase staining of 
sections (20µm) was performed as described above for whole mount embryos. After staining, 
sections were washed 3 x 5 minutes with 1X PBS, pH7.4, counterstained with nuclear fast red 
for 5 minutes and dehydrated in an ethanol series (70% ethanol, 95% ethanol, 100% ethanol and 
100% xylenes for five minutes each) followed by application of coverslips with permount 
mounting media.  
 
Whole-Mount Digoxigenin in situ Hybridization  
Whole-mount digoxigenin in situ hybridization was performed as previously described in (Allen 
et al., 2011; Wilkinson, 1992). In brief, embryos were dissected in 1X PBS, pH 7.4 and fixed in 
4% paraformaldehyde overnight on a rocking platform. After fixation, embryos were dehydrated 
in a methanol/PBST (1X PBS, pH 7.4 + 0.1 % Tween) series (25% methanol, 50 %methanol, 
75% methanol) and stored in 100% methanol at -20°C until the experiment was performed for up 
to 6 months. Embryos were digested with 10µg/mL proteinase K at RT for 2 minutes. 
Hybridization was performed with the indicated digoxigenin probe with a concentration of 
1ng/µL for 16-19 hours at 70°C. The embryos were incubated in alkaline phosphatase-
conjugated anti-DIG antibody at a dilution of 1:4,000. AP-anti-DIG was detected with BM 
purple, and signal was developed for 3.5 hours at room temperature. Embryos were cleared in 




Section immunofluorescence was performed as in (Allen et al., 2011). Embryos were dissected 
in 1X PBS, pH 7.4 and fixed for 1 hour in 4% paraformaldehyde on ice, followed by 3 x 5 
minutes washes with 1X PBS, pH 7.4 and cryoprotected for 24-48 hours in 1X PBS + 30% 
sucrose. Embryos were embedded in OCT compound and sectioned on a Leica cryostat 
(CM1950) (12 µm thick forebrain and forelimb neural tube sections). Sections were blocked in 
blocking buffer (3% bovine serum albumin, 1% heat-inactivated sheep serum, 0.1% TritonX-100 
in 1X PBS, pH 7.4) for 1 hour. Primary antibodies were diluted in blocking buffer incubated 
overnight at 4 °C in a humidified chamber. A list of all the primary and secondary antibodies 
used in this study is provided in (Table 2.2). Secondary antibodies were diluted in blocking 
solution and incubated for 1 hour at room temperature, followed by 3 x 5 minute washes with 1X 
PBS, pH 7.4. All Alexa Fluor Dyes secondary antibodies were used at a 1:500 dilution. Nuclei 
were labeled with DAPI for 10 minutes at room temperature and slides were mounted with 
coverslips using Immu-mount aqueous mounting medium. Sections were visualized on a Leica 
upright SP5X confocal microscope. 
 
Whole-Mount Immunofluorescence 
Embryos were dissected in 1X PBS, pH 7.4, fixed with 4% paraformaldehyde for 2 hours at 4°C, 
and washed 2 x 10 minutes washes with PBTX (1X PBS + 0.1% Triton X-100). Subsequently, 
embryos were blocked for 1 hour in PBTX + 10% goat serum. Primary antibodies were diluted 
in PBTX + 10% goat serum and incubated overnight at 4 °C on a rocking platform. A list of all 
the primary and secondary antibodies used in this study is provided in (Table 2.2). The next day 
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the embryos were rinsed 2 x 5 minutes with PBTX, followed by 3 x 1 hour washes with PBTX 
on a rocking platform at 4°C. After the washes, embryos were incubated overnight with 
secondary antibodies diluted in PBTX+ 10% serum. All Alexa Fluor Dyes secondary antibodies 
were used at a 1:500 dilution. Next, embryos were washed as described for the primary antibody 
above, and cleared with ClearT2 (25% Formamide/10%PEG for one hour; 50% 
Formamide/20%PEG for 72 hours) (Kuwajima et al., 2013). Finally, embryos were visualized on 
a Nikon SMZ1500 microscope. With the ClearT2 reagent we did not observed any tissue 
expansion. (Protocol courtesy of Jean-Denis Bénazet, UCSF) 
 
Micro Computed Tomography (Micro CT) 
E18.5 embryos were skinned and eviscerated. Subsequently, embryos were fixed overnight in 
100% ethanol, and maintained in 70% ethanol until ready to scan. The scans were performed 
using embryos covered with a 1X PBS, pH 7.4-soaked kim wipe and scanned over the entire 
length of the skull using the µCT100 system (Scanco Medical, Bassersdorf, Switzerland). Scan 
settings were as follows: 12 µm voxel size, 55 kVp, 109 µA, 0.5 mm AL filter, and 500 ms 
integration time. Micro CT scans were analyzed with the Amira software (Thermo Fisher 
Scientific). The Micro CT scans were uploaded as DICOM files into the software and the three-
dimensional reconstructions were generated using the isosurface feature. The individual bones 
were manually segmented using the extract surface and buffer tools of Amira (Ho et al., 2015). 




Skeletons were prepared as previously described before in (Allen et al., 2011). E18.5 embryos 
were skinned and eviscerated. Subsequently, embryos were fixed in 100% ethanol, followed by 
100% acetone for 24 hours respectively at room temperature. Cartilage and bone were stained 
with alcian blue/alizarin red staining solution (5% alcian blue, 5% alizarin red, 5% glacial acetic 
acid and 70% ethanol) for 4 days at room temperature. The remaining tissue was digested with 
several washes of 1% potassium hydroxide. The skeletons were cleared by 24 hour washes of a 
gradient of glycerol (20%, 50%, and 80%) in 1% potassium hydroxide, and photographed in 
80% glycerol. 
 
In ovo chicken electroporations 
Chicken electroporations were performed as previously described in (Allen et al., 2011; Tenzen 
et al., 2006). The indicated construct (pCIG plasmid -1 µg/µl in 1X PBS, pH7.4, with 50ng/µl 
fast green) was injected into the forebrain cavity of Hamburger-Hamilton stage 11 chicken 
embryos. L-shaped electrodes were made with platinum wire, 8mm long (3mm were bent to 
form the L shape) and spaced 1mm apart. Electrodes (L-shaped part) were placed in front of the 
forebrain of the embryo (pulsed five times at 25 V for 50 ms with a BTX electroporator). The 
electroporated embryos were screened for GFP expression after 48 hours at Hamburger-
Hamilton stage 21-22 and processed for immunofluorescence. 
 
RNA isolation and qRT-PCR 
RNA was isolated from micro-dissected nasal processes (without the forebrain neuroepithelium) 
and forelimb buds of E11.5 wildtype and mutant embryos. RNA was extracted with a Quick-
RNA micro prep (Zymo Research). cDNA was generated from 500ng and 1µg of total RNA 
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from the nasal process and forelimb bud mesenchyme, respectively, with a High Capacity cDNA 
reverse transcription kit (Applied Biosystems). qRT-PCR was performed with PowerUP SYBR 
Green Master Mix (Applied Biosystems) in a Step One Plus Real-Time PCR System (Applied 
Biosystems). qRT-PCR primers utilized in this paper are listed in (Table 2.4). Gene expression 
was normalized to Gapdh , and relative expression analyses were performed using the 2(-ddCT) 
method. For qRT-PCR analysis at least three biological replicates were analyzed in triplicate.  
      
Western Blot Analysis 
E11.5 embryos were dissected in 1X PBS pH7.4. Nasal processes and forelimb buds were micro-
dissected and incubated for 15 minutes and lysed in radioimmunoprecipitation assay buffer 
(50mM Tris-HCl, pH7.2, 150mM NaCl, 0.1% Triton X-100, 1% sodium deoxycholate, 5mM 
EDTA), containing a protease inhibitor cocktail (Roche). Samples were sonicated using a sonic 
dismembrator (model 500, Thermo Fisher Scientific) with 10 pulses of 1s at 10 % amplitude. 
Extracts were cleared by centrifugation at 15,000 rpm (21,130 g) for 20 min at 4C°. Total protein 
concentration was determined with the Pierce BCA protein assay kit (Thermo Fisher Scientific), 
utilizing 10μg of each sample. Lysates were mixed with 6X Laemmli buffer, and boiled for 10 
minutes at 95C°. Proteins were separated using SDS-PAGE in 5% gels and transferred onto 
Immuno-Blot PVDF membranes (Bio-Rad). Membranes were blocked for 1hr at room 
temperature in western blocking buffer [30g/liter bovine serum albumin with 0.2% NaN3 in 
TBST (Tris-buffered saline, 0.5% tween-20)]. Blots were probed with the indicated primary 
antibodies (Table 2.3) diluted in western blocking buffer and incubated overnight. After 
incubation in primary antibody, the membranes were rinsed 3 x in TBST, followed by 3 x 10 
minutes washes in TBST. Peroxidase conjugated secondary antibodies (Table 2.3) were diluted 
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in western blocking buffer and incubated for 1hr at room temperature and washed as the primary 
above. Membranes were incubated with Amersham ECL Prime Western Blotting Detecting 
Reagent GE Healthcare) for 5 minutes, and exposed to HyBlot CL autoradiography film 
(Denville) and developed using a Konica Minolta SRX-101A medical film processor. Relative 
expression values were obtained by normalizing the mean gray value of each band in the blot, 
subtracting the background and normalizing to the mean gray value of VINCULIN. For relative 
expression analysis at least three biological replicates were analyzed.  
 
Quantitation and statistical analysis  
All the data are represented as mean ± standard deviation. All statistical analyses were performed 
using GraphPad statistic calculator (GraphPad Software, La Jolla California USA, 
www.graphpad.com). Statistical significance was determined using two-tailed Student’s t-test or 
the Fisher’s Exact test. Bonferroni correction was employed to account for multiple comparisons 
in each dataset. In brief, to account for multiple comparisons using the Bonferroni correction, the 
original α-value (0.05) is divided by the number of comparisons in each dataset, generating a 
new adjusted α-value, that will determine the significance of the results. For all the experimental 
analyses a minimum of 3 embryos of each genotype were examined, each n represents an 
embryo. All the statistical details (statistical test used, adjusted p-value, statistical significance 
and exact value of each n) for each experiment are specified in the figure legends.      
 
Telencephalic division and medial nasal process classification  
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Frontal pictures of E10.5 mouse embryos were photographed with a Nikon SMZ1500 
microscope. Blind classification of the telencephalic division and media nasal process separation, 
was performed by a blinded evaluator according the categories showed in (Figure 2.4A-F). 
 
Internasal distance and crown-rump length quantitation 
Pictures of the nasal processes and whole E10.5 embryos were taken in 1X PBS, pH7.4 with a 
Nikon SMZ1500 microscope. Internasal distance was defined as the distance between the edges 
of the medial nasal process. Crown rump length was defined as the top of the crown of the 
midbrain, bisecting the forelimb bud to the curvature at the bottom c-shaped part of the embryo. 
Blind quantitation of the interasal distance and crown-rump length was performed manually by a 
single evaluator using the scale bar tool of the NIS-Elements software (Nikon) annotations and 
measurements feature.  
 
Immunofluorescence quantitation 
To quantify immunofluorescence images, we examined a minimum of 3 embryos per genotype 
and 2 sections from each embryo.   
 
NKX2.1 quantitation: Side view pictures of whole mount immunofluorescent wildtype and 
mutant embryos were taken in ClearT2 with a Nikon SMZ1500 microscope. The NKX2.1 area of 
expression was quantified using the area measure plugin of ImageJ (Schneider et al., 2012). Each 
image was thresholded automatically by ImageJ before the area of expression was quantified. 
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NKX2.2 quantitation: Pictures of transverse sections of wildtype and mutant neural tubes stained 
with antibodies directed against NKX2.2 were merged with their respective DAPI images. 
NKX2.2 positive cells were quantified with the point tool of ImageJ (Schneider et al., 2012). 
 
Phospho-histone H3 quantitation:  
All phospho-histone H3 quantitation was performed with the point tool and analyze particle 
feature of ImageJ (Schneider et al., 2012). In the forebrain, the phospho-histone H3 positive cells 
were quantified in different tissue compartments. The phospho-histone H3 images were merged 
with markers specific to each tissue: E-CADHERIN (surface ectoderm), and PDGFRα 
(mesenchyme). The neuroepithelium was identified morphologically. The dorsal telencephalic 
midline was excluded from this analysis. After identifying each tissue compartment with these 
markers and based on their morphology, we manually isolated the mesenchyme of the lateral and 
medial nasal process, the surface ectoderm of the olfactory epithelium and the forebrain 
neuroepithelium with the clear outside tool of ImageJ. Each image was manually thresholded and 
the analyze particle feature of was used to automatically quantify the phospho-histone H3+ cells. 
DAPI+ cells were also quantified as described above to normalize the number of phospho-
histone H3+ cells. For the neural tube quantitation, the phospho-histone H3 cells were quantified 
along the entire neural tube with the point tool. Finally, in the forelimb bud, the phospho-histone 
H3 positive cells were quantified with the point tool, specifically in a selected area of equal size 
in wildtype and mutant embryos.      
      
MicroCT Nasal Bone width quantitation 
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To measure the nasal bone width of E18.5 wildtype and mutant embryos, micro CT scans were 
imported as DICOM files into MicroView (Parallax Innovations). Three-dimensional 
reconstructions were generated using the Isosurface tool. All the 3D reconstructions were equally 
thresholded. To measure distance width, we utilized the built-in measure function of Parallax 
MicroView and measured the widest point of each nasal bone. 
 
Quantitation of anatomical landmarks and nostril frequency  
Frontal pictures of E18.5 mouse embryos were photographed in 1X PBS, pH7.4 with a Nikon 
SMZ1500 microscope. Head width was defined as the widest length of the head above the eyes 
(Figure 2.14A). Interocular distance was defined as the distance between the eyes (Figure 
2.14A). Snout width was denoted as the distance between the second line of most ventral 
vibrissae from left to right (Figure 2.14A). The interocular distance and snout width was 
normalized to the head width. Quantitation was performed manually by a single evaluator using 
the scale bar tool of the NIS-Elements software (Nikon) annotations and measurements feature 
or using the line tool in Adobe Illustrator. The frequency of the nostrils was quantified according 
to the presence of partially fused nostrils with nasal pigment or a single nostril without pigment 
(Figure 2.14E, left panel).  
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Table 2.1 General reagents 
Reagent Vendor Catalog number 
Alcian Blue Millipore Sigma A5268 
Alizarin Red Millipore Sigma A5533 
Amersham ECL Prime Western Blotting Detection 
Reagent GE Healthcare 
RPN2232 
 
Anti-Digoxigenin-Ap, Fab fragments Roche 11 093 274 910 
BM purple Roche 11442074001 
BSA Millipore Sigma A7906 
Complete mini Protease Inhibitor Cocktail Roche 1836153 
DAPI Thermo Fisher Scientific D1306 
EGTA Millipore Sigma E3889 
EDTA Thermo Fisher Scientific S311-500 
Fast green Millipore Sigma EM-4510 
Formaldehyde VWR EMD-FX0410-5 
Formamide Millipore Sigma 4650-500ML 
Glacial Acetic Acid Thermo Fisher Scientific BP2401-500 
Glutaraldehyde Millipore Sigma G5882 
Glycerol VWR EMGX0185-5 
Goat serum Thermo Fisher Scientific 16210064 
High capacity cDNA reverse transcription kit Applied Biosystems 4368814 
Hyblot CL Autoradiography Film Denville E3018 
Igepal (NP-40) Millipore Sigma I8896 
Immu-mount Thermo Fisher Scientific 9990412 
Immuno-Blot PVDF membranes Bio-Rad 162-0177 
K3Fe(CN)6 Millipore Sigma PX1455 
K4Fe(CN)6 Millipore Sigma P9387 
MgCl2 VWR 0288-500G 
NaCl Millipore Sigma SX0420-3 
Na deoxycholate VWR SX0480-2 
OCT Thermo Fisher Scientific 23730571 
Paraformaldehyde Thermo Fisher Scientific 50980489 
Permount Thermo Fisher Scientific SP15100 
Pierce BCA protein assay kit Thermo Fisher Scientific PI23225 
Polyethyleneglycol Millipore Sigma 91893-1L-F 
Potassium hydroxide VWR PX1490-1 
PowerUP SYBR Green Master Mix Applied Biosystems A25742 
Proteinase K Roche 03115836001 
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Quick-RNA micro prep Zymo Research R1055 
Sheep serum Bioworld 30611168-1 
Tris VWR JT4109-2 
Triton X-100 VWR 9410 
Tween-20 VWR 9480 
X-gal Goldbio X4281C 
Xylenes VWR XX00555 



























































Primary antibodies Vendor Catalog number Dilution 
NKX2.1 (rabbit IgG) Abcam ab76013 1:200 
E-CADHERIN (mouseIgG2a) BD Biosciences 610181 1:500 
NKX2.2 (mouseIgG2b) Developmental Studies Hybridoma Bank 74.5A5 1:20 
OLIG2 (rabbit IgG) Millipore Sigma AB9610 1:2,000 
NKX6.1 (mouseIgG1) Developmental Studies Hybridoma Bank F55A10 1:20 
Phospho-histone H3 (rabbit IgG) Millipore Sigma 06-570 1:1,000 
Phospho-histone H3 (mouse IgG1) Cell Signaling Technology 9706S 1:100 
PDGFRa (rabbit IgG) Cell Signaling Technology 3174S 1:100 
Secondary antibodies Vendor Catalog number Dilution 
Alexa Fluor 488 (Goat anti-Rabbit IgG) 
Thermo Fisher Scientific 
A-11008 
1:500 
Alexa Fluor 555 (Goat anti-Mouse 
IgG2b) A-21147 
Alexa Fluor 488 (Goat anti-Mouse 
IgG2a) A-21131 
Alexa Fluor 555- (Goat anti-Rabbit 
IgG) A-21428 
Alexa Fluor 488 (Goat anti-Mouse 
IgG1)  A-21121 
Alexa Fluor 555 (Goat anti-Mouse 
IgG2a) A-21137 
Alexa Fluor 647 (Goat anti-Mouse 
IgG1)  A-21240 
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 Table 2.3 Western blot antibodies  
Primary antibodies Vendor Catalog number Dilution 
Gli1 (V812) (rabbit IgG) Cell signaling Technology #2354 1:1,000 
Vinculin (E1E9V) XP (rabbit IgG) Cell Signaling Technology #13901 1:1,000 
Secondary antibodies Vendor Catalog number Dilution 
Peroxidase conjugated AffiniPure 
F(ab)2 Fragment Donkey Anti- 
Rabbit IgG 
Jackson ImmunoResearch 711-036-152 1:10,000 
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Gene Sequence  Source 
Gli1-F GTGCACGTTTGAAGGCTGTC 
(Han et al., 2017) Gli1-R GAGTGGGTCCGATTCTGGTG 
Gapdh-F GGTGAAGGTCGGTGTGAACG 
(Lewandowski et al., 2015) 
Gapdh-R CTCGCTCCTGGAAGATGGTG 
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2.9 Figures  
 
Figure 2.1 The HH co-receptors Gas1, Cdon and Boc are expressed throughout early craniofacial development. 
Analysis of HH co-receptor expression using lacZ (Gas1, Cdon) and hPLAP (Boc) reporter alleles (A-T). Whole mount X-Gal 
and Alkaline Phosphatase staining of E8.5 (A-D), E9.5 (E-H), and E10.5 (I-L), wildtype (A, E, I, M, Q), Gas1lacZ/+ (B, F, J, N, 
R), CdonlacZ/+ (C, G, K, O, S), and BocAP/+ (D, H, L, P, T) embryos is shown. Somite number (s) is indicated in the lower right 
corner of each panel. Dorsal views of the cranial neural folds of E8.5 embryos are shown in insets (A-D); black arrowheads 
denote the prechordal plate (PCP). Frontal view of craniofacial structures of E10.5 embryos (M-P). White arrows denote LNP 
and MNP and yellow arrows denote MXP and MP (M). Coronal sections of E10.5 forebrains (Q-T); arrowhead denotes a subset 
of cells expressing Cdon in the olfactory epithelium. Scale bars, (A-P) 500 µm, insets (A-D) 50 µm and (Q-T) 200 µm. 
Abbreviations: cranial neural fold (CNF), somites (S), neural tube (NT), pre-chordal plate (PCP), frontonasal prominence (FNP), 
maxillary process (MXP), mandibular process (MP), forebrain (F), forelimb (FL), hindlimb (HL), medial nasal process (MNP), 
lateral nasal process (LNP), surface ectoderm (SE), neuroepithelium (NE) and olfactory epithelium (OE).  
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Figure 2.2 Gas1, Cdon and Boc are differentially expressed across multiple HH-responsive tissues. 
Analysis of HH co-receptor expression using lacZ (Gas1, Cdon) and hPLAP (Boc) reporter alleles in HH-responsive tissues (A-
P). High magnification pictures of coronal sections of E10.5 forebrains, from wildtype (A, E), Gas1lacZ/+ (B, F), CdonlacZ/+ (C, G), 
and BocAP/+ (D, H) embryos are shown. E10.5 forebrain neuroepithelia (A-D) and nasal processes (E-H). Arrowhead in (G) 
denotes a subset of cells expressing Cdon in the olfactory epithelium. Black arrowhead in (H) identifies the extended ventral 
expression of Boc closer to the telencephalon source of Shh expression. White arrowhead in (H) denotes Boc expression in the 
olfactory epithelium. Whole mount X-Gal and Alkaline Phosphatase staining of E10.5 forelimb buds (I-L) from wildtype (I), 
Gas1lacZ/+ (J), CdonlacZ/+ (K), and BocAP/+ (L) embryos. Transverse sections of E10.5 neural tubes (M-P) from wildtype (M), 
Gas1lacZ/+ (N), CdonlacZ/+ (O), and BocAP/+ (P) embryos. Black brackets denote the expression domain of the HH co-receptors in 
the neural tube. Double-headed arrow in (O) indicates Cdon expression in the floor plate and notochord. Heat inactivation of 
endogenous alkaline phosphatase at E10.5 in wildtype (Q) and BocAP/+ (S) animals demonstrates the specificity of alkaline 
phosphatase staining. Somite number (s) is indicated in the lower right corner (Q-S). Scale bars, (A-H) 100µm, (I-L) 200µm, (M-
P) 50µm, (Q-S) 500µm. Abbreviations: surface ectoderm (SE), neuroepithelium (NE), lateral nasal process (LNP), medial nasal 
process (MNP), olfactory epithelium (OE).  
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Figure 2.3 Loss of Boc results in midface widening and increased Gli1 expression on a congenic C57BL/6J background. 
En face view of E10.5 mouse embryos (A-L). Somite number (s) is indicated in the lower right corner of each panel. Brackets 
indicate internasal distance. Black triangles denote fusion of the MNP. E10.5 wildtype (A,E,I),  Gas1-/- (B-D), Cdon-/- (F-H), and 
Boc-/- (J-L) embryos. Note that Gas1 and Cdon mutants display a range of craniofacial defects (increasing in severity from left to 
right), while Boc mutants do not display any gross morphological changes. Scale bar (A), 500 µm. Internasal distance 
quantitation in wildtype (n= 23), Gas1-/- (n=17), Cdon-/- (n=12), Boc-/- (n=36) embryos (M; in µm). Relative expression of Gli1 by 
qRT-PCR in the nasal processes (N) of E11.5 wildtype (n=5), Gas1-/- (n=3) and Boc-/- (n=5) embryos normalized to Gapdh. 
Biological replicates were analyzed in triplicate.  Data are represented as the mean ± standard deviation. P-values were 
determined by a two-tailed Student’s t-test. The Bonferroni correction was employed to account for multiple comparisons in each 
dataset; (M) not significant (n.s.; p>0.016), significant (p≤0.0166) and (N) n.s. (p>0.0250), significant (p≤0.0250). Western blot 
analysis of endogenous GLI1 protein in the nasal processes from E11.5 wildtype, Gas1-/- and Boc-/- embryos (O). VINCULIN 
was used as loading control, three biological replicates were analyzed. 
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Figure 2.4 Telencephalic vesicle division and MNP separation in Gas1, Cdon and Boc mutants. 
En face view of E10.5 embryos (A-C). The telencephalic vesicles are pseudocolored in green and surrounded by a dotted line. 
Telencephalic vesicle division classification categories:  normal division (A), incomplete division (B), no division (C). Midface 
view of E10.5 embryos (D-G). The lateral and medial nasal processes are pseudocolored in orange and red, respectively, and are 
surrounded by a dotted line. Medial nasal process (MNP) classification categories:  normal separation (D), reduced separation 
(E), incomplete separation (F), and no separation (G). Scale bars (A, D), 500µm. Telencephalic vesicle (TV) division frequency 
in E10.5 wildtype (n=23), Gas1-/- (n=17), Cdon-/- (n=12), and Boc-/- (n=36) embryos (H). Medial nasal process (MNP) separation 










Figure 2.5 Gas1, but not Cdon or Boc, mutant embryos exhibit decreased embryo size at E10.5. 
Sagittal views of E10.5 wildtype (A), Gas1-/- (B), Cdon-/-(C), and Boc-/-(D) embryos. Scale bar (A), 500 µm.  Schematic sagittal 
view of an E10.5 mouse embryo (E); the red diagonal line denotes crown-rump length. Crown-rump length quantitation of E10.5 
wildtype (n= 18), Gas1-/- (n=8), Cdon-/- (n=7), Boc-/- (n=27) embryos (F). Quantitation of GLI1 levels in nasal processes isolated 
from E11.5 wildtype (n=3), Gas1-/- (n=3) and Boc-/- (n=3) embryos (G). Data are mean±s.d. P-values were determined by a two-
tailed Student’s t-test. The Bonferroni correction was employed to account for multiple comparisons in each dataset; (F) non-








Figure 2.6 The Spectrum of HPE phenotypes correlates with changes in Gli1 expression. 
In situ hybridization detection of Gli1 expression in E10.5 forebrains (A-O). En face views of E10.5 forebrains from wildtype (A-
C), Gas1-/- (D-F), Cdon-/- (G-I), Boc-/- (J-L) and Gas1-/-;Boc-/- (M-O) embryos are shown. Somite number (s) is indicated in the 
lower right corner of each panel. Black dotted lines outline nasal processes. Notice that as the HPE phenotypes worsen (from left 
to right) in Gas1 and Cdon mutants, the expression of Gli1 in the MNP is lost. Boc mutants display equal levels of Gli1 in the 
MNP and do not display any gross craniofacial defects. Gas1;Boc double mutants with ameliorated craniofacial defects (from left 
to right) maintain Gli1 expression in the MNP,  while Gli1 expression is lost in mutants that display severe craniofacial defects. 




Figure 2.7 Tissue-specific rescue of HH signaling in E10.5 Gas1;Boc double mutant embryos. 
En face view of E10.5 embryos (A-D). Somite number (s) is indicated in the lower right corner of each panel. Brackets indicate 
internasal distance. Black triangles denote fusion of the medial nasal process. E10.5 wildtype (A), Gas1-/- (B), Boc-/- (C), and 
Gas1-/-;Boc-/- (D) embryos. Telencephalic vesicle (TV) division frequency in E10.5 wildtype (n=23), Gas1-/- (n=17) and Gas1-/-
;Boc-/- (n=16) (E) embryos. TV division was classified according to the following categories:  normal division, incomplete 
division and no division (see Figure 2.4A-C for representative examples of each category). Medial nasal process (MNP) 
separation frequency in E10.5 wildtype (n=23), Gas1-/- (n=17) and Gas1-/-;Boc-/- (n=16) (E) embryos. MNP separation in each 
embryo was classified according to the following categories:  normal separation, reduced separation, incomplete separation and 
no separation (see Figure 2.4D-G for representative examples of each category). In situ hybridization detection of Gli1 
expression in E10.5 forebrains (G-J) and their corresponding forelimbs (G’-J’). En face view of E10.5 forebrains and dorsal view 
of E10.5 forelimbs in wildtype (G, G’), Gas1-/- (H,H’), Boc-/- (I,I’), and Gas1-/-;Boc-/- (J,J’) embryos. Somite number (s) is 
indicated in the lower right corner of each panel. Black dotted lines outline nasal processes. Note that Gli1 is differentially 
regulated in the MNP and forelimb of Gas1;Boc mutants. Scale bar in A and G, 500μm; G’, 100μm. 
 129 
 
Figure 2.8 Reduced Crown-Rump Length in E10.5 Gas1;Boc double mutant embryos. 
Sagittal view of E10.5 wildtype (A), Gas1-/- (B), Boc-/- (C), and Gas1-/-;Boc-/- (D) embryos. Schematic sagittal view of an E10.5 
mouse embryo; the red diagonal line denotes the crown-rump length (E). Crown-rump length quantitation in wildtype (n= 18), 
Gas1-/- (n=8), Boc-/- (n=27), and Gas1-/-;Boc-/- (n=12) embryos (F). Scale bar in A, 500μm. Data are mean±s.d. P-values were 
determined by a two-tailed Student’s t-test. The Bonferroni correction was employed to account for multiple comparisons in each 




Figure 2.9 Reduced Gli1 mRNA and protein levels in E10.5 Gas1 mutant forelimb buds 
Relative expression of Gli1 by qRT-PCR in forelimb buds (A) of E11.5 wildtype (n=5), Gas1-/- (n=3) and Boc-/- (n=5) embryos 
normalized to Gapdh. Biological replicates were analyzed in triplicate. Western blot analysis of GLI1 endogenous protein in 
forelimb buds (B). Anti-VINCULIN was used as loading control, three biological replicates were analyzed. Quantitation of GLI1 
levels in forelimb buds (C) of E11.5 wildtype (n=3), Gas1-/- (n=3) and Boc-/- (n=3) embryos. Data are mean±s.d. P-values were 
determined by a two-tailed Student’s t-test. The Bonferroni correction was employed to account for multiple comparisons in each 








Figure 2.10 Selective contribution of Boc to patterning of the neural tube, but not the forebrain neuroepithelium. 
En face view of E10.5 embryos (A-D). Somite number (s) is indicated in the lower right corner of each panel. Brackets indicate 
internasal distance. Black triangles denote fusion of the MNP. E10.5 wildtype (A), Gas1-/- (B), Boc-/- (C), and Gas1-/-;Boc-/- (D) 
embryos are shown. Whole-mount immunofluorescent antibody detection of E-CADHERIN (green; E-H) and NKX2.1 (red; E-
H) in E10.5 wildtype (E), Gas1-/- (F), Boc-/- (G), and Gas1-/-;Boc-/- (H) embryos. Antibody detection of OLIG2 (green; I-L) and 
NKX2.2 (red; I-L) in transverse sections of E10.5 forelimb level neural tubes from wildtype (I), Gas1-/- (J), Boc-/- (K), and Gas1-/-
;Boc-/- (L) embryos. Quantitation of NKX2.1 expression in wildtype (n=4), Gas1-/- (n=5), Boc-/- (n=6), and Gas1-/-;Boc-/-  (n=5) 
embryos (M). Quantitation of NKX2.2+ cells (2 sections/embryo) for wildtype (n=7), Gas1-/- (n=5), Boc-/- (n=7), and Gas1-/-;Boc-
/- (n=5) embryos (N).Data are represented as the mean ± standard deviation. P-values were determined by a two-tailed Student’s 
t-test. The Bonferroni correction was employed to account for multiple comparisons in each dataset; (M,N) non-significant (n.s.; 
p>0.0166), significant (p≤0.0166). Note that NKX2.2+ cells are only present in a subset of sections from Gas1-/-;Boc-/- embryos 
(inset in M). Scale bars in A and E, 500µm; I, 25 µm. 
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Figure 2.11 Boc promotes HH-dependent neural patterning in the developing chicken 
Coronal sections of Hamburger-Hamilton stage 21-22 chicken forebrains electroporated with empty vector (pCIG; A-D), SmoM2 
(E-H), and Boc (I-L). DAPI (grayscale; A,E,I) denotes nuclei. GFP+ cells (green; B,F,J) identify electroporated cells. Antibody 
detection of NKX2.1 (red; C,G,K) reads out HH pathway activity. Merged images are shown in (D,H,L). The number of 
electroporated embryos that display ectopic NKX2.1 expression is indicated in the lower right corner (D,H,L). White arrowheads 





Figure 2.12 Partial rescue of HPE phenotypes persists through E18.5 in Gas1;Boc mutant embryos. 
En face view of E18.5 wildtype (A,M), Gas1-/- (B,N), Boc-/- (C,O), and Gas1-/-;Boc-/- (D,P) embryos. Black arrowheads denote the 
nasal pits (NP), white arrowheads mark the maxilla (MX), and yellow arrowheads identify the mandible (M). E18.5 craniofacial 
structures stained with Alcian Blue and Alizarin Red to visualize cartilage and bone, respectively (E-L). Dorsal views of the nasal 
capsule (NC) and premaxilla (PMX) of E18.5 wildtype (E), Gas1-/- (F), Boc-/- (G), and Gas1-/-;Boc-/- (H) are shown. Black 
arrowheads indicate the nasal capsule and red arrowheads mark the premaxilla. Dorsal views of the mandible of E18.5, wildtype 
(I), Gas1-/- (J), Boc-/- (K), and Gas1-/-;Boc-/- (L) are shown. Asterisks identify ectopic bone duplications in the posterior part of the 
mandible and black arrows denote Meckel’s cartilage (MC). Inset in J, shows ectopic bone in a Gas1-/- mutant embryo. Three 
dimensional reconstructions of microCT images of isolated nasal bones from E18.5 wildtype (M’), Gas1-/- (N’), Boc-/- (O’), and 




Figure 2.13 HPE phenotypes and digit specification defects in E18.5 Gas1;Boc mutant embryos. 
En face view of E18.5 Gas1-/- (A,B) and Gas1-/-;Boc-/- (C,D) embryos. Black arrowheads denote the nasal pits. Three dimensional 
reconstructions of microCT images of isolated nasal bones from E18.5 Gas1-/- (A’,B’) and Gas1-/-;Boc-/- (C’,D’) embryos. 
A←→P specifies the anterior to posterior axis in (A’-D’,E). MicroCT image of an isolated nasal bone from E18.5 wildtype 
embryo (E); the red horizontal line denotes the nasal bone width. Nasal bone width quantitation in wildtype (n=5), Gas1-/- (n=4), 
Boc-/- (n=3), and Gas1-/-;Boc-/- (n=4) embryos (F). Data are mean±s.d. P-values were determined by a two-tailed Student’s t-test. 
The Bonferroni correction was employed to account for multiple comparisons in each dataset; (F) non-significant (n.s.; 
p>0.0250), significant (p≤0.0250). Ventral views of E18.5 cranial vaults from wildtype (G), Gas1-/- (H), Boc-/- (I), and Gas1-/-
;Boc-/- (J) embryos, stained with Alcian Blue and Alizarin Red. Red double arrows denote the cleft palate in Gas1-/- and Gas1-/-
;Boc-/- embryos and black arrowheads mark occipital bone. Inset in (J) indicates hypoplastic premaxilla in Gas1-/-;Boc-/- embryos. 
Forelimbs of E18.5 wildtype (G’), Gas1-/- (H’), Boc-/- (I’), and Gas1-/-;Boc-/- (J’) embryos, stained with Alcian Blue and Alizarin 
Red. Numbers denote specific digits where 1 is the most anterior and 5 is the most posterior. Insets in (H’) demonstrate variable 
digit specification phenotypes in Gas1-/- embryos, which display either partial fusion of digits two and three (left), or the absence 
of either digit two or three (right). Gas1-/-;Boc-/- embryos exhibit a more severe limb phenotype where only digits 1 and 5 can be 







Figure 2.14 E18.5 Gas1;Boc mutants display partially ameliorated midfacial defects. 
Quantitation of anatomical landmarks in E18.5 embryos (A-F). Representative measurements of head width (HW), interocular 
distance (ID), snout width (SW) in E18.5 embryos (A). White dotted lines denote the measured distance. Head width quantitation 
in wildtype (n=7), Gas1-/- (n=12), Boc-/- (n=7) and Gas1-/-;Boc-/- (n=8) embryos (B). Interocular distance quantitation, normalized 
to the head width in wildtype (n=7), Gas1-/- (n=12), Boc-/- (n=7) and Gas1-/-;Boc-/- (n=8) embryos (C). Snout width quantitation, 
normalized to the head width in wildtype (n=7), Gas1-/- (n=12) and Gas1-/-;Boc-/- (n=8) embryos (D). Nostril frequency in Gas1-/- 
(n=12) and Gas1-/-;Boc-/- (n=8) embryos (E). Left panel, representative images of two partially fused nostrils and a single nostril. 
Black arrowheads denote two nostrils and a single nostril. Right panel, observed nostril frequency. Medial lip notch distance 
quantitation in wildtype (n=7), Gas1-/- (n=12), Boc-/- (n=7) and Gas1-/-;Boc-/- (n=8) embryos (F). Left panel, representative images 
of medial lip notch and no medial lip notch. Right panel, medial lip notch quantitation. White arrowhead denotes the lack of a 
medial lip notch. Data are mean±s.d. P-values were determined by a two-tailed Student’s t-test (B-D, F) or a Fisher’s Exact test 





Figure 2.15 Boc selectively inhibits mesenchymal proliferation during craniofacial development. 
Immunofluorescent analysis of proliferation in E10.5 forebrain coronal sections from wildtype (A), Gas1-/- (B), Cdon-/- (C), Boc-/- 
(D), and Gas1-/-;Boc-/- (E) embryos. Antibody detection of E-CADHERIN (ECAD, green), PDGFRa (blue) and phospho-histone 
H3 (PH3,red). Quantitation of PH3+ cells (2 sections/embryo) normalized to the total number of DAPI+ cells in the quantified 
areas, surface ectoderm (F), forebrain neuroepithelium (G), and craniofacial mesenchyme (H), of E10.5 wildtype (n=6), Gas1-/- 
(n=5), Boc-/- (n=6), and Gas1-/-;Boc-/- (n=4). Data are represented as the mean ± standard deviation. P-values were determined by 
a two-tailed Student’s t-test. The Bonferroni correction was employed to account for multiple comparisons in each dataset; (F-H) 
non-significant (n.s.; p>0.0100), significant (p≤0.0100). Note that Boc-/- embryos display increased proliferation in the 







Figure 2.16 Boc does not contribute to neural tube or forelimb mesenchyme proliferation. 
Immunofluorescent analysis of proliferation in E10.5 neural tube (A-E) and forelimb (F-J) transverse sections from E10.5, 
wildtype (A,F), Gas1-/- (B,G), Cdon-/- (C,H), Boc-/- (D,I), and Gas1-/-;Boc-/- (E,J) embryos. Antibody detection of E-CADHERIN 
(E-CAD, green, F-J), PDGFRa (blue, F-J), and phospho-histone H3 (PH3, red, A-J). Nuclei are stained with DAPI (blue, A-E). 
Quantitation of PH3+ cells (2 sections/embryo) in the neural tube (K) from E10.5 wildtype (n=7), Gas1-/- (n=5), Cdon-/- (n=4), 
Boc-/- (n=6) and Gas1-/-;Boc-/- (n=5) embryos. Quantitation of PH3+ cells (2 sections/limb) in forelimb buds (L) from E10.5 
wildtype (n=7), Gas1-/- (n=7), Cdon-/- (n=5), Boc-/- (n=9) and Gas1-/-;Boc-/- (n=6) embryos. Data are mean±s.d. P-values were 
determined by a two-tailed Student’s t-test. The Bonferroni correction was employed to account for multiple comparisons in each 





Figure 2.17 BOC is a multi-functional regulator of HH signaling. 
Summary of BOC contributions to HH signaling (A). Green indicates promotion of HH signaling, red denotes HH pathway 
antagonism, gray suggests no effect, and yellow is unknown. Proposed mechanisms of action for BOC in HH signal transduction 
(B). 1. Complex formation with PTCH1.The interaction of PTCH1 and BOC that allows the formation of a receptor complex that 
alternately activates or inhibits HH pathway activity. 2. Ligand sequestration. BOC binds HH ligands through its extracellular 
domain and could antagonize HH signaling by sequestering SHH in areas of low SHH concentration. 3. Cytoplasmic domain 
contributions. The unique cytoplasmic domain of BOC could regulate additional downstream signaling cascades that enable its 
tissue-specific functions. 4. HH-independent activity. BOC could mediate yet to be identified HH-independent functions that 
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The Hedgehog (HH) signaling pathway regulates the patterning, proliferation and 
differentiation of multiple tissues during development. HH ligands primarily signal through 
PTCH1 and three co-receptors, GAS1, CDON and BOC. These co-receptors are essential during 
vertebrate embryogenesis. Interestingly, during limb pattering functional roles for only GAS1 
and BOC, but not CDON have been demonstrated during HH-dependent digit specification. A 
collective role for these co-receptors has not been explored during limb development due to 
embryonic lethality of Gas1;Cdon;Boc mutants at E9.5, prior to the onset of limb development.  
Here I explore a role for Cdon in digit specification by using a Cdon conditional allele in 
combination with a limb-specific Prx1Cre driver in a Gas1;Boc null background. The limb-
specific ablation of Cdon in a Gas1;Boc null background allows for survival until E18.5, and for 
the assessment of potential contributions of Cdon to HH-dependent digit specification. 
Combined deletion of Cdon, Gas1 and Boc in the limb results in severe digit specification 
defects, as well as patterning defects in the radius, ulna, tibia, and fibula. Taken together, these 




The Hedgehog (HH) signaling pathway is a critical regulator of tissue patterning and 
growth in both invertebrate and vertebrate embryos (Briscoe and Therond, 2013; McMahon et 
al., 2003). In mammals, HH signaling contributes to the patterning of multiple tissues including, 
craniofacial structures, spinal cord and limbs (Briscoe and Therond, 2013; McMahon et al., 
2003). Defective HH signaling results in various birth defects such as holoprosencephaly, spina 
bifida, and polydactyly, as well as numerous cancers including pancreatic cancer, 
medulloblastoma, and basal cell carcinoma (Roessler et al., 1996; Vortkamp et al., 1992; 
Vortkamp et al., 1991) (Murdoch and Copp, 2010; Teglund and Toftgard, 2010).  
HH ligands are regulated at the cell surface by the twelve-pass transmembrane protein 
Patched 1 (PTCH1) (Marigo et al., 1996). However, HH ligands are multivalent, and can also 
signal through three HH co-receptors, growth arrest specific-1 (GAS1), CAM-
related/downregulated by oncogenes (CDON) and brother of CDON (BOC) (Allen et al., 2011; 
Allen et al., 2007; Beachy et al., 2010; Izzi et al., 2011; Lum et al., 2003; McLellan et al., 2008; 
Tenzen et al., 2006; Yao et al., 2006). CDON and BOC are structurally similar single pass 
transmembrane proteins from the immunoglobin superfamily, while GAS1 is a GPI linked 
protein with resemblance to the GDNF receptors (Cabrera et al., 2006; Kang et al., 2002). In 
absence of HH ligands, PTCH1 constitutively inhibits the activity of the GPCR-like receptor 
Smoothened (SMO). HH ligand binding to PTCH1, along with GAS1, CDON and BOC results 
in the de-repression of SMO, and subsequent modulation of the GLI family of transcription 
factors (Hui and Angers, 2011). GLIs are comprised of three genes, Gli1, Gli2, and Gli3 (Briscoe 
and Therond, 2013; Hui and Angers, 2011). GLI1 is exclusively a transcriptional activator that is 
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also a target of the HH pathway and is responsible for amplifying the HH transcriptional 
response, while GLI2 and GLI3 function primarily as activators and repressors, respectively 
(Briscoe and Therond, 2013; Dai et al., 1999; Hui and Angers, 2011).  
The HH co-receptors, GAS1, CDON and BOC, display similar expression patterns 
throughout development, they interact with PTCH1 and function in a variety HH-dependent 
patterning processes (Allen et al., 2011; Bae et al., 2011; Izzi et al., 2011; Lee and Fan, 2001; 
Mulieri et al., 2002; Mulieri et al., 2000). Their function has been extensively explored during 
craniofacial development and ventral neural tube patterning, where they are essential for proper 
HH signal transduction (Allen et al., 2011; Allen et al., 2007; Cole and Krauss, 2003; Seppala et 
al., 2007; Seppala et al., 2014; Tenzen et al., 2006; Zhang et al., 2011; Zhang et al., 2006). 
However, their roles in limb development and digit specification remain understudied.  
During limb patterning, one of the three mammalian HH ligands, Sonic Hedgehog (SHH) 
is secreted as a morphogen from the zone of polarizing activity (ZPA) to regulate anterior-
posterior patterning (Echelard et al., 1993; Riddle et al., 1993; Saunders, 1968). Importantly, 
SHH not only regulates anterior-posterior patterning, but also cell survival and proliferation in 
the limb bud (Bastida et al., 2004). Specifically, SHH dictates the specification of digits in the 
limbs, 1 to 5, or thumb to pinky (Harfe et al., 2004). Multiple detailed studies in chicken 
embryos and mice, have demonstrated that digit specification is dictated both by the 
concentration of SHH ligand and time of exposure that HH-responding cells receive. [reviewed 
by (Tickle, 2006)]. The SHH morphogen gradient establishes digit identity by autocrine (digits 5, 
4, and part of 3) and paracrine (part of digit 3 and digit 2) signaling (Harfe et al., 2004). 
Additionally, this process is influenced by a GLI3 repressor anterior-posterior gradient, which 
maintains proper levels of HH signaling in the developing limb (te Welscher et al., 2002; Wang 
 147 
et al., 2000). Genetic deletion of Shh results in the complete absence of digits 2-5 and fusion of 
the tibia and the fibula in the hindlimb (Chiang et al., 1996). Digit 1, the most anterior digit in 
these mutants is unaffected, as its patterning is SHH-independent (Chiang et al., 1996).  
Genetic ablation of HH co-receptors results in variable digit specification phenotypes. 
Interestingly, Only Gas1-/- and Gas1-/-;Boc-/- embryos display digit specification defects (Allen et 
al., 2011). In contrast, Boc-/-, Cdon-/-, and Cdon-/-, Boc-/- embryos exhibit normal digit 
specification (Allen et al., 2011). These data suggest that GAS1 is a major contributor to HH-
dependent digit specification, with a smaller, redundant role for Boc in this process. Strikingly, 
despite a requirement for Cdon in multiple other SHH-responsive tissues such as craniofacial 
structures and the ventral neural tube, its function appears dispensable in SHH-dependent digit 
specification (Allen et al., 2011; Allen et al., 2007; Cole and Krauss, 2003; Tenzen et al., 2006; 
Zhang et al., 2011). However, a redundant function for CDON could be masked by the collective 
overlapping roles of GAS1 and BOC during SHH-dependent digit specification. Unfortunately, 
the simultaneous deletion of Gas1, Cdon and Boc results in near complete loss of HH signaling 
and embryonic lethality at E9.5, thus precluding a definitive analysis of a role for CDON in HH-
dependent digit specification and limb patterning (Allen et al., 2011). 
In this study I investigate the role of CDON in SHH-dependent digit specification during 
limb patterning. Specifically, I utilized a novel Cdonfl/fl conditional allele in combination with the 
Prx1-Cre transgene in a Gas1;Boc null background (Bae et al., 2020; Logan et al., 2002) to 
assess the consequences of combined GAS1, CDON and BOC removal on limb development. I 
find that limb-specific Cdon deletion in a Gas1;Boc null background results in severe digit 
specification defects and patterning defects in the radius, ulna, tibia, and fibula in the forelimbs 
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To assess a potential role for CDON during limb development, I first examined the 
expression of Gas1, Cdon and Boc in E10.5 forelimb buds using lacZ (Gas1 and Cdon) and 
Alkaline phosphatase (AP; Boc) reporter alleles (Figure 3.1) (Cole and Krauss, 2003; Martinelli 
and Fan, 2007; Zhang et al., 2011). As previously shown, Gas1, Cdon and Boc are all expressed 
in the E10.5 limb bud, although their expression is confined to the anterior part of the E10.5 
forelimb buds (Figure3.1B-D) (Allen et al., 2011; Allen et al., 2007; Tenzen et al., 2006). 
Interestingly, the expression domain of Cdon is more anteriorally and proximally restricted in the 
forelimb bud (Figure 3.1C) than either Gas1 or Boc expression (Figure 3.1B, D). Overall, the 
expression of the HH co-receptors is similar, but not identical in the forelimb buds and is 
consistent with their general negative transcriptional regulation by the HH signaling pathway, as 
observed in other tissues (Allen et al., 2011; Allen et al., 2007; Tenzen et al., 2006). However, it 
is yet to be determined if Cdon expression remains restricted to the most proximal region of the 
developing limb over time, and whether there might be differences in forelimb and hindlimb 
expression. 
The individual deletion of HH co-receptors results in phenotypes of variable severity 
across HH-responsive tissues, including the craniofacial structures and the ventral neural tube 
(Allen et al., 2011; Allen et al., 2007; Cole and Krauss, 2003; Seppala et al., 2007; Tenzen et al., 
2006). To determine the individual contribution of the HH co-receptors to SHH-digit 
specification and to asses variability across different mutants, we examined the levels of the 
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general HH target Gli1 by in situ hybridization. Gas1-/- embryos display decreased variable 
expression levels of Gli1 in the developing forelimb bud (Figure 3.1F-H). These data suggest 
that variable digit specification defects observed in E18.5 Gas1 mutants could arise from 
differences in HH pathway activity (Allen et al., 2011; Martinelli and Fan, 2007). Cdon-/- 
embryos also display variable reduced Gli1 levels, but to a lesser extent than Gas1-/- embryos 
(Figure 3.1J-L).  Conversely, Boc-/- embryos, exhibit normal and consistent levels of Gli1 when 
compared to wildtype embryos (Figure 3.1N-P). These data suggest that GAS1 is the primary co-
receptor that functions in SHH-dependent digit specification. However, further examination of 
Gli1 levels in of double co-receptor mutants revealed that the deletion of Boc or Cdon in a Gas1 
null background, significantly reduces Gli1 expression in the developing forelimb bud (Figure 
3.2B-D). Interestingly, Cdon-/-;Boc-/- mutants do not display any changes in Gli1 expression 
(Figure 3.2D). Thus, these data suggested that GAS1 appears to be playing a more significant 
role, based in its broad expression when compared to Cdon and Boc.   
 Analysis of skeletal patterning and digit specification in E18.5 Gas1, Cdon and Boc 
single and compound mutants performed by (Allen et al., 2011) (Reprinted here as Figure 3.3, 
with permission of (Allen et al., 2011)) is consistent with the reduced Gli1 levels observed at 
E10.5. Gas1-/- embryos display a loss of digits 2 or 3 in both forelimbs and hindlimbs (Allen et 
al., 2011; Martinelli and Fan, 2007) (Figure 3.3A,G). However, despite the subtle variability of 
Gli1 levels in Cdon mutant embryos, this does not result in any digit specification defects (Figure 
3.3B,H). In contrast, Boc-/- embryos do not exhibit any digit specification abnormalities (Figure 
3.3C,I) (Allen et al., 2011; Cole and Krauss, 2003). These data are consistent with the notion that 
Gas1 is the primary co-receptor contributor to HH signaling in the limb bud, while Cdon and 
Boc appear to play smaller roles, if at all. However, the deletion of Boc in a Gas1 null 
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background enhances the severity of the phenotypes observed in Gas1-/- embryos, resulting in the 
formation of digits 1 and 5, along with an unidentified digit that could be a fusion of digits 3 and 
4 (Figure 3.3D,J) (Allen et al., 2011). In contrast, the deletion of Cdon in a Gas1 background 
does not enhance the digit specification defects, instead phenocopying Gas1-/- embryos (Figure 
3.3E,K) (Allen et al., 2011). Further, Cdon-/-;Boc-/- embryos display overtly normal digit 
specification in both forelimbs and hindlimbs (Figure 3.3F,L ) (Allen et al., 2011). The lack of 
phenotypes observed at E18.5 in Cdon single mutants and lack of enhanced severity in Cdon;Boc 
and Gas;Cdon mutants, suggests that CDON does not play a role during digit specification. 
However, the reduction in Gli1 expression in Cdon and Gas1;Cdon mutants, along with the clear 
contribution of Boc to digit specification in a Gas1 null background, suggests a potential role for 
Cdon that could be masked by functional compensation by Gas1 and/or Boc.  
Gas1;Cdon;Boc triple mutants exhibit severe developmental defects such as cyclopia, 
heart looping defects and complete loss of ventral neural patterning (Allen et al., 2011). These 
striking developmental defects result in embryonic lethality at E9.5, which precludes the analysis 
of digit specification at later embryonic stages (Allen et al., 2011). To define the role of Cdon in 
SHH-dependent digit specification and to circumvent the embryonic lethality observed in 
Gas1;Cdon;Boc triple mutants, we utilized a novel floxed allele of Cdon (Cdonfl/fl) (Figure 
3.4B). This allele was generated by (Bae et al., 2020), and is a targeted trap allele with a lacZ 
reporter-tagged insertion. In the presence of Cre, the Cdonfl/fl allele deletes exon 9, which 
truncates the CDON protein (Figure 3.4C). This allele has been previously crossed with two 
different Cre lines, Pax7CreERT2 and Meox2-Cre, both of which resulted in efficient deletion of 
Cdon (Bae et al., 2020). To conditionally delete Cdon in the developing limb, we utilized the 
Prx1-Cre transgene (Logan et al., 2002). To define which cell types are labeled by the Prx1-Cre, 
 151 
I examined Prx1-Cre;tdTomato embryos at E10.5 (Figure 3.5). At this stage, Prx1-Cre induces 
recombination in a variety of tissues including the midbrain, the heart and the limbs (Figure 
3.5D,F,H), while no recombination is detected in the neural tube, another HH-responsive tissue 
(Figure 3.5J). Specifically, Prx1-Cre drives recombination through the forelimb and the hindlimb 
bud by E9.5 (Logan et al., 2002). The expression of Prx1-Cre is restricted to the lateral plate-
derived mesoderm, which gives rise to the limb bones, tendons and muscle connective tissue 
(Figure 3.6 B,C,E) and is excluded from the forelimb bud epithelium (Figure 3.6B,D,E) (Logan 
et al., 2002). Furthermore, is Prx1-Cre recombination is not detected in the HH-responsive 
paraxial mesoderm surrounding the neural tube (Figure 3.6G-I).   
To investigate the combined contributions of Gas1, Cdon and Boc to limb development, I 
generated Prx1-Cre;Gas1+/-;Cdonfl/fl;Boc-/-, which display normal limb patterning (Figure 3.7E-
F), and are viable and fertile. These data are consistent with a primary role for Gas1 in HH-
dependent digit specification. I then crossed Prx1-Cre;Gas1+/-;Cdonfl/fl;Boc-/- animals with 
Gas1+/-;Cdonfl/fl;Boc-/- mice to generate Prx1-Cre;Gas1-/-;Cdonfl/fl;Boc-/- embryos. At E18.5, the 
deletion of Cdon in a Gas1;Boc  null background, results in severe limb patterning defects. 
Grossly, these mutants display a forelimb that resembles a bird wing or a small fish fin (Figure 
3.7A), while the hindlimb resembles Gas1;Boc mutants hindlimbs (Figure 3.7B and Figure 
3.3D,J). Skeletal preparation from these mutants reveal variable phenotypes in the digit 
specification in the forelimbs. Specifically, these mutants display digit 1 and another digit with 
unidentifiable identity (Figure 3.7C). In some cases, I observe digit 1 and 5, and a middle digit 
with unknown identity (Figure 3.7C inset); which we also observe in the hindlimb (Figure3.7D). 
Notably, even in mutants where we detect a similar number of digits as observed in Gas1;Boc 
mutants, the long bone morphology is dramatically different. Along these lines, Prx1-Cre;Gas1-/-
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;Cdonfl/fl;Boc-/- embryos exhibit severe patterning defects and bone shortening in the radius, ulna, 
tibia and fibula of both forelimb and hindlimb (Figure 3.7C,D); a severe phenotype that is not 
observed in any previously published single or compound HH co-receptor mutant. Notably, these 
mutants also display severe patterning defects in the carpals, metacarpals, tarsal and metatarsal 
bones in both forelimb and hindlimbs (Figure 3.7C,D). Overall these data demonstrate that Cdon 
does play a role in limb patterning and digit specification. However, further experiments will be 
required to elucidate the mechanism by which it regulates HH signaling during digit 
specification and long bone patterning.  
 
3.4 Discussion 
In this study I defined a novel role for Cdon in SHH-dependent digit specification and 
limb patterning. Cdon is expressed in the E10.5 forelimb bud, where it is primarily confined to a 
more anterior and proximal domain of mesenchyme compared to the other HH co-receptors, 
Gas1 and Boc. Limb-specific deletion of Cdon with Prx1-Cre in a Gas1;Boc null background 
results in severe digit specification defects and shortening and patterning defects in the radius, 
ulna, tibia and fibula. Notably, these phenotypes arise only in the absence of Gas1 and Boc, 
suggesting that these proteins share redundant functions. Taken together, these data demonstrate 
that Cdon plays a role in the promotion of SHH signal transduction during digit specification and 
limb patterning. In addition to their role in digit specification, I have also identified a new role 
for the HH co-receptors in the development of the radius, ulna, tibia and fibula. 
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3.4.1 Novel role for CDON during digit specification and limb development 
During vertebrate embryogenesis Cdon regulates a variety of HH-dependent processes 
including, the patterning of the craniofacial structures and the ventral neural tube (Allen et al., 
2011; Cole and Krauss, 2003; Zhang et al., 2011; Zhang et al., 2006). The lack of limb patterning 
and digit specification defects in Cdon mutants suggested that this co-receptor was not required 
for SHH-dependent digit specification (Allen et al., 2011; Cole and Krauss, 2003). However, 
these data are also consistent with a redundant function of CDON, along with the other HH co-
receptors, GAS1 and BOC, which play redundant roles in certain tissues, such as in the mouse 
neural tube and in the developing cerebellum (Izzi et al., 2011) (Allen et al., 2011). Here I 
provide evidence that Cdon has a role in digit specification and limb development, as 
demonstrated by the limb-specific deletion of Cdon in a Gas1;Boc null background. Compared 
to Gas1;Boc mutants, which display the most severe limb phenotype of the different double co-
receptor mutants (cf. Gas1;Cdon and Cdon;Boc mutants) , the Prx1-Cre;Gas-/-;Cdonfl/fl;Boc-/- 
embryos exhibit an even more severe digit specification defect, although with incomplete 
penetrance, and restricted to the forelimb. Interestingly, the morphology of the remaining digits 
and limb bones in Prx1-Cre;Gas-/-;Cdonfl/fl;Boc-/- is different from Gas1-/-;Boc-/- mutants, even 
when they have the same number of digits. Specifically, the digits in Prx1-Cre;Gas-/-
;Cdonfl/fl;Boc-/-  look like uninterrupted cartilaginous elements, lacking the joints between the 
phalanges. This characteristic phenotype has also been reported in Indian Hedgehog (Ihh) 
mutants, which regulates joint formation (Koyama et al., 2007).  
To properly interpret these results, it will be imperative to validate the efficiency of the 
deletion of Cdon by qPCR and western blot. Additionally, examining the levels of Gli1 and other 
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transcriptional targets associated with digit specification in the developing limb buds of Prx1-
Cre;Gas-/- ;Cdonfl/fl;Boc-/- embryos. To further define the role of Cdon in limb patterning it will 
be useful to investigate the consequences of Cdon deletion on proliferation and apoptosis, which 
are both regulated by SHH (Bastida et al., 2004; Zhu et al., 2008). The patterning defects in the 
radius, ulna, tibia and fibula of Prx1-Cre;Gas-/-;Cdonfl/fl;Boc-/-  mutants, revealed a novel role for 
Gas1, Cdon and Boc in the patterning of long bones. Since this severe phenotype is not observed 
in any of the double mutants, these data suggested that the HH co-receptor play redundant roles 
during the development of the long bones of the limb. Interestingly, long bone defects are also 
observed in Ihh mutants (St-Jacques et al., 1999). Ihh is critical for proper skeleton development, 
where it regulates proliferation and differentiation of chondrocytes and long bone formation 
(Amano et al., 2015; St-Jacques et al., 1999). Although the interactions of Cdon and Ihh are 
currently unexplored, based on the defects observed in Prx1-Cre;Gas-/-;Cdonfl/fl;Boc-/-  it will be 
essential to define their interactions during limb development. The characteristic restriction of 
Cdon expression to the proximal limb bud in comparison to Gas1 and Boc suggests a more 
limited function in the developing limb; which can be compensated by the broad expression and 
function of Gas1 and Boc. Overall, thsese data demonstrate novel roles for Cdon in both SHH-
dependent digit specification and IHH-dependent long bone growth. 
 
3.4.2 Forelimb and hindlimb phenotypic differences 
The differences observed in digit specification of forelimbs and hindlimbs of Prx1-
Cre;Gas-/-;Cdonfl/fl;Boc-/- embryos could have multiple explanations. One technical explanation 
is that to achieve limb-specific deletion of Cdon we utilized the Prx1-Cre transgene, which 
exhibits mosaic recombination in the hindlimb at E9.5 (Logan et al., 2002). This could result in 
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variability in the timing of recombination, altering the levels of Cdon and subsequently 
impacting the levels of HH signaling in the developing hindlimb. Alternatively, this could also 
be explained by differences in the recombination efficiency of the Prx1-Cre allele. However, 
despite the differences observed in the digit specification defects in the forelimbs and hindlimbs 
of the Prx1-Cre;Gas-/-;Cdonfl/fl;Boc-/- embryos, we consistently observe defects in the patterning 
of the radius, ulna, tibia and fibula. These phenotypes suggest that Prx1-Cre mediates similar 
recombination efficiency in both forelimb and hindlimb. Interestingly, (Amano et al., 2015) 
utilized the Prx1-Cre transgene to perform the conditional deletion of Ihh, which resulted in the 
same phenotype in both forelimb and hindlimb, and it was similar to Ihh germline mutants.  (St-
Jacques et al., 1999). These data suggest the possibility that Cdon could differentially regulate 
digit specification in the hindlimb. This could be achieved by functioning independently of HH 
signaling or by the function of additional HH co-receptors that function to promote HH signaling 
in the hindlimb. Another possibility is that Cdon is differentially expressed between the forelimb 
and the hindlimb.  Further analyses using different Cre drivers (Hoxb6-CreER;(Schughart et al., 
1991)) and a careful characterization of Cdon expression in the developing limb will be essential 
to understand the differences between forelimb and hindlimb phenotypes. 
 
3.4.3 Role of Gas1, Cdon and Boc in SHH-dependent digit specification  
The mechanism by which SHH digit specification occurs in the developing limb is still 
unclear. Several studies have proposed multiple models which integrate SHH levels, time of 
exposure, cell survival and proliferation [reviewed by (Tickle, 2006)]. Even though the HH co-
receptor mutants display digit specification and limb pattern defects the mechanisms by which 
they regulate HH signaling in this process are unknown. The differences in digit identity in the 
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HH co-receptor mutants suggest that GAS1, CDON and BOC could transduce different levels of 
HH signaling in the developing limb. Additionally, their subtle expression differences suggest 
different spatiotemporal functions that can explain their contribution to both the anterior-
posterior and proximo-distal axis of the developing limb. Finally, another major question is 
whether the interaction of GAS1, CDON and BOC with PTCH1 leads to the formation of 
different individual complexes, which could mediate different cellular responses during limb 
development and vertebrate embryogenesis. 
 
3.5 Materials and methods 
Reagents 
General reagents (Table 3.1) and primary antibodies for immunofluorescence (Table 3.2). 
 
Animal Models 
Gas1lacZ (Martinelli and Fan, 2007), CdonlacZ-1 , CdonlacZ-2 (Cole and Krauss, 2003), BocAP 
(Zhang et al., 2011), Cdonfl/fl (Bae et al., 2020), Prx1;Cre (Logan et al., 2002), tdTomato 
(Madisen et al., 2010)  mice have been all described previously. Gas1, Cdon, and Boc mice were 
maintained on a C57BL/6J background. CdonlacZ-1 mice (Cole and Krauss, 2003) were 
maintained on a mixed 129S4/SvJaeJ/C57BL/6 background for expression analysis. 
Prx1Cre;tdTomato and Prx1;Cre;Gas1+/-;Cdonfl/fl;Boc-/- mice were maintained in a mixed 
background FVB/NJ/C57BL/6. For embryonic dissections, noon of the day on which a vaginal 
plug was detected was considered as E0.5. For precise staging, somites were counted during the 
dissection. Embryos with 34-38 somites were considered E10.5 embryos. All animal procedures 
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were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) at 
the University of Michigan.  
 
X-gal staining 
Embryos were dissected in 1X PBS, pH 7.4, and fixed (1% formaldehyde, 0.2% glutaraldehyde, 
2mM MgCl2, 5mM EGTA, 0.02% NP-40) on ice for 10-60 minutes depending on the embryonic 
stage. Subsequently, the embryos were washed 3 x 5 minutes with 1X PBS, pH 7.4 + 0.02% NP-
40 for permeabilization. B-Galactosidase activity was detected with X-Gal staining solution 
(5mM K3Fe(CN)6, 5mM K4Fe(CN)6, 2mM MgCl2, 0.01% Na deoxycholate, 0.02% NP-40, 
1mg/mL X-gal). The signal was developed from 25 minutes to 24 hours at 37° C depending on 
the lacZ allele. After staining, the embryos were washed 3 x 5 minutes with 1X PBS, pH 7.4 at 
4°C, and post-fixed in 4% paraformaldehyde for 20 minutes at room temperature, followed by 3 
x 5 minute washes in 1X PBS, pH 7.4. Finally, embryos were stored and photographed in 1X 
PBS, pH 7.4 + 50% glycerol. X-gal staining of sections (20µm) was performed as described 
above for whole mount embryos. After staining, sections were washed 3 x 5 minutes with 1X 
PBS, pH 7.4, counterstained with nuclear fast red for 5 minutes and dehydrated in an ethanol 
series (70% ethanol, 95% ethanol, 100% ethanol and 100% Xylenes) followed by application of 
coverslips with permount mounting media.  
 
Alkaline Phosphatase Staining 
Embryos were dissected on 1X PBS, pH 7.4, and fixed (1% formaldehyde, 0.2% glutaraldehyde, 
2mM MgCl2, 5mM EGTA, 0.02% NP-40) on ice for 10-60 minutes depending on the embryonic 
stage on ice. Subsequently, the embryos were washed 3 x 5 minutes with 1X PBS, pH 7.4. To 
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deactivate endogenous alkaline phosphatases, embryos were incubated in 1X PBS, pH 7.4 at 
70°C for 30 minutes. Then the embryos were rinsed with 1X PBS, pH 7.4 and washed for 10 
minutes in alkaline phosphatase buffer (100mM NaCl, 100mM Tris-HCl pH9.5, 50mM MgCl2, 
1% Tween-20) at room temperature. Embryos were stained with BM purple from 2 to 3 hours at 
37°C depending on the embryonic stage. After staining, the embryos were washed 3 x 5 minutes 
with 1X PBS, pH 7.4 at 4°C, and post-fixed in 4% paraformaldehyde for 20 minutes at room 
temperature, followed by 3 x 5 minute washes with 1X PBS, pH 7.4. Finally, embryos were 
stored and photographed in 1X PBS, pH 7.4 + 50% glycerol. Alkaline phosphatase staining of 
sections (20µm) was performed as described above for whole mount embryos. After staining, 
sections were washed 3 x 5 minutes with 1X PBS, pH7.4, counterstained with nuclear fast red 
for 5 minutes and dehydrated in an ethanol series (70% ethanol, 95% ethanol, 100% ethanol and 
100% xylenes for five minutes each) followed by application of coverslips with permount 
mounting media.  
 
Whole-Mount Digoxigenin in situ Hybridization  
Whole-mount digoxigenin in situ hybridization was performed as previously described in (Allen 
et al., 2011; Wilkinson, 1992). In brief, embryos were dissected in 1X PBS, pH 7.4 and fixed in 
4% paraformaldehyde overnight on a rocking platform. After fixation, embryos were dehydrated 
in a methanol/PBST (1X PBS, pH 7.4 + 0.1 % Tween) series (25% methanol, 50 %methanol, 
75% methanol) and stored in 100% methanol at -20°C until the experiment was performed for up 
to 6 months. Embryos were digested with 10µg/mL proteinase K at RT for 2 minutes. 
Hybridization was performed with the indicated digoxigenin probe with a concentration of 
1ng/µL for 16-19 hours at 70°C. The embryos were incubated in alkaline phosphatase-
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conjugated anti-DIG antibody at a dilution of 1:4,000. AP-anti-DIG was detected with BM 
purple, and signal was developed for 3.5 hours at room temperature. Embryos were cleared in 
50% glycerol in 1XPBST and were photographed using a Nikon SMZ1500 microscope.  
 
Immunofluorescence  
Section immunofluorescence was performed as in (Allen et al., 2011). Embryos were dissected 
in 1X PBS, pH 7.4 and fixed for 1 hour in 4% paraformaldehyde on ice, followed by 3 x 5 
minutes washes with 1X PBS, pH 7.4 and cryoprotected for 24-48 hours in 1X PBS + 30% 
sucrose. Embryos were embedded in OCT compound and sectioned on a Leica cryostat (12 µm 
thick forebrain and forelimb neural tube sections). Sections were blocked in blocking buffer (3% 
bovine serum albumin, 1% heat-inactivated sheep serum, 0.1% TritonX-100 in 1X PBS, pH 7.4) 
for 1 hour. Primary antibodies were diluted in blocking buffer incubated overnight at 4 °C in a 
humidified chamber. A list of all the primary antibodies used in this study is provided in (Table 
3.2). Secondary antibodies were diluted in blocking solution and incubated for 1 hour at room 
temperature, followed by 3 x 5 minutes washes with 1X PBS, pH 7.4. All Alexa Fluor Dyes 
secondary antibodies were used at a 1:500 dilution. Nuclei were labeled with DAPI for 10 
minutes at room temperature and slides were mounted with coverslips using Immu-mount 




Skeletons were prepared as previously described before in (Allen et al., 2011). E18.5 embryos 
were skinned and eviscerated. Subsequently, embryos were fixed in 100% ethanol, followed by 
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100% acetone for 24 hours respectively at room temperature. Cartilage and bone were stained 
with alcian blue/alizarin red staining solution (5% alcian blue, 5% alizarin red, 5% glacial acetic 
acid and 70% ethanol) for 4 days at room temperature. The remaining tissue was digested with 
several washes of 1% potassium hydroxide. The skeletons were cleared by 24 hour washes of a 
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3.8 Tables  
Table 3.1 General reagents II 
Reagent Vendor Catalog number 
Alcian blue Millipore Sigma A5268 
Alizarin red Millipore Sigma A5533 
Alexa Fluor Dyes Thermo Fisher Scientific A21428, A21131 and A21240 
Anti-Digoxigenin-Ap, Fab 
fragments Roche 11 093 274 910 
BM purple Roche 11442074001 
BSA Millipore Sigma A7906 
DAPI Thermo Fisher Scientific D1306 
EGTA Millipore Sigma E3889 
EDTA Thermo Fisher Scientific S311-500 
Formaldehyde VWR EMD-FX0410-5 
Formamide Millipore Sigma 4650-500ML 
Glacial Acetic Acid Thermo Fisher Scientific BP2401-500 
Glutaraldehyde Millipore Sigma G5882 
Glycerol VWR EMGX0185-5 
Igepal (NP-40) Millipore Sigma I8896 
Immu-mount Thermo Fisher Scientific 9990412 
K3Fe(CN)6 Millipore Sigma PX1455 
K4Fe(CN)6 Millipore Sigma P9387 
MgCl2 VWR 0288-500G 
NaCl Millipore Sigma SX0420-3 
Na deoxycholate VWR SX0480-2 
OCT Thermo Fisher Scientific 23730571 
Paraformaldehyde Thermo Fisher Scientific 50980489 
Permount Thermo Fisher Scientific SP15100 
Potassium hydroxide VWR PX1490-1 
Proteinase K Roche 03115836001 
Sheep serum Bioworld 30611168-1 
Tris VWR JT4109-2 
Triton X-100 VWR 9410 
Tween-20 VWR 9480 
X-gal Goldbio X4281C 






Table 3.2 Primary antibodies used for immunofluorescence II 
Antibody Vendor Catalog number Dilution 
PDGFRa (rabbit IgG) Cell Signaling 3174S 1:100 
E-CADHERIN (mouseIgG2a) BD-biosciences 610181 1:500 





















Figure 3.1 Analysis of HH-coreceptor expression and function in the developing forelimb bud. 
Whole mount X-Gal and Alkaline Phosphatase staining of E10.5 forelimb buds (A-D), wildtype (A), Gas1lacZ/+ (B), CdonlacZ/+ 
(C), and BocAP/+ (D). Panel (A-D), was also shown in Supplemental Figure 2.1) In situ hybridization detection of Gli1 expression 
in E10.5 forelimb buds (E-P). Dorsal views of E10.5 forelimb buds of wildtype (E,I,M), Gas1-/- (F-H), Cdon-/- (J-L), Boc-/- (N-P) 










Figure 3.2 Gas1;Boc and Gas1;Cdon but not Cdon;Boc mutant embryos exhibit significant reduction of Gli1 in the 
developing forelimb bud. 
Analysis of collective co-receptor function in E10.5 forelimb buds. 
In situ hybridization detection of Gli1 expression in E10.5 forelimb buds (A-D). Dorsal views of E10.5 forelimb buds of wildtype 
(A; also showed in Figure 3.1) Gas1-/-;Boc-/- (B), Gas1-/-;Cdon-/- (C), Cdon-/-;Boc-/- (D) embryos are shown. Note that the levels of 
Gli1 in Cdon-/-;Boc-/- embryos is not significantly reduced as in the other double HH co-receptor mutants. Somite number (s) is 





















Figure 3.3 Analysis of limb development in single and double HH co-receptors mutants. 
Forelimbs (A-F) and hindlimbs (G-L) of E18.5 embryos stained with alcian blue and alizarin red. Gas1-/- (A,G), Cdon-/- (B,H), 
Boc-/- (C,I), Gas1-/-;Boc-/- (D,J), Gas1-/-;Cdon-/- (E, K), Cdon-/-;Boc-/- (F, L). Numbers denote specific digits where 1 is the most 
anterior and 5 is the most posterior. Arrow denotes fusion and loss of digits 2 and 3 in Gas1-/- (A, G, inset in A), and Gas1-/-
;Cdon-/- (E,K) forelimbs and hindlimbs. Gas1-/-;Boc-/- (D,J) mutants exhibit the most severe phenotype in the forelimbs and 
hindlimbs, where only digits 1 and 5 identifiable and the third digit is unidentifiable (denoted as ?). Note that Cdon-/-;Boc-/- (F,L) 





Figure 3.4 Conditional Cdon knockout allele. 
Diagram of the Cdonfl/fl allele. The following shapes depict different structures, yellow boxes (exons), orange box (floxed exon 
9), green triangles (flippase recognition target site; FRT), red triangles (loxP sites), blue box (LacZ), dark green box (neomycin 
cassette). Enzyme restriction sites are represented by black vertical lines. Arrows below the alleles denote primers for screening 
and genotyping. The predicted CDON protein is represented by its structure next to each allele. Wiltype Cdon allele (panel A), 
Cdonfl/fl allele (panel B; before Cre mediated recombination), Prx1Cre; Cdonfl/fl allele (panel C; after Cre mediated 














Figure 3.5 Prx1-Cre recombination activity in E10.5 embryos. 
Whole-mount immunofluorescence visualization of Cre activity in E10.5 Prx1-Cre;tdTomato mouse embryos. Left panel, 
brightfield images of E10.5 wildtype (A) and Prx1-Cre;tdTomato (C, E, G, I) embryos. Right panel, tdTomato expression 
labeling Cre recombinase activity in 10.5 wildtype (B) and Prx1-Cre;tdTomato (D, F, H, J) embryos. Note the lack of tdTomato 
(indicating no Cre activity) expression in wildtype embryos (B), while in Prx1-Cre;tdTomato embryos tdTomato is expressed in 
multiple structures (indicating Cre activity) (D). Expression of tdTomato in the forelimb bud (F), hindlimb bud (H), neural tube 






Figure 3.6 Tissue-specific expression of Cre recombinase in the developing forelimb bud and spinal cord of Prx1-
Cre;tdTomato E10.5 embryos. 
Co-expression of Cre activity by visualization of tdTomato and tissue-specific markers including, PDGFRa (mesenchyme), E-
CADHERIN (epithelium), and TUJ-1 (neurons) in E10.5 Prx1-Cre;tdTomato embryos. Antibody detection of PDGFRa (green; 




























Figure 3.7 Digit specification and long bone defects in E18.5 Prx1-Cre;Gas1-/-;Cdonfl/fl;Boc-/-. 
Analysis of forelimb and hindlimb patterning in 18.5 embryos stained with alcian blue and alizarin red. Brightfield images of 
forelimb (A) and hindlimb (B) of E18.5 Prx1-Cre;Gas1-/-;Cdonfl/fl;Boc-/- and forelimb (E) of Prx1-Cre;Gas1+/-;Cdonfl/fl;Boc-/-. 
Skeletal preparations of forelimbs (C) and hindlimbs (D) of Prx1-Cre;Gas1-/-;Cdonfl/fl;Boc-/- and forelimb (F) of Prx1-Cre;Gas1+/-
;Cdonfl/fl;Boc-/-. Note the severe defects in digit specification in the forelimb and hindlimbs of Prx1-Cre;Gas1-/-;Cdonfl/fl;Boc-/-, 
where digit 1 and 5 are specified (inset in C) and the rest of the digits are fused or absent in both limbs (denoted with a ?). In more 
severe Prx1-Cre;Gas1-/-;Cdonfl/fl;Boc-/-  forelimbs only digit 1 and an unidentifiable digit forms (denoted with a ?). Black arrowhead 
denotes severe defects in the radius and ulna of the Prx1-Cre;Gas1-/-;Cdonfl/fl;Boc-/-. Note that Prx1-Cre;Gas1+/-;Cdonfl/fl;Boc-/-  
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4.1 Summary of findings 
The focus of this thesis is the investigation of novel tissue-specific roles for GAS1, 
CDON and BOC during vertebrate embryogenesis. These HH co-receptors bind to HH ligands, 
interact with PTCH1 and display similar expression patterns (Bae et al., 2011; Izzi et al., 2011; 
Lee et al., 2001; Lee and Fan, 2001; Mulieri et al., 2002; Mulieri et al., 2000; Tenzen et al., 
2006). Further, their combined deletion results in a complete loss of HH signaling, leading to a 
model where these proteins play essential, but redundant roles as positive regulators of the HH 
signaling pathway (Allen et al., 2011; Allen et al., 2007; Cole and Krauss, 2003; Seppala et al., 
2007; Seppala et al., 2014; Zhang et al., 2011). However, in certain tissues these proteins can 
function to restrain HH pathway function (Bergeron et al., 2011; Cardozo et al., 2014; Cobourne 
et al., 2004; Ohazama et al., 2009). The ability of these HH co-receptors to alternately promote 
or antagonize HH signaling in a tissue-specific manner has been understudied (Figure 4.1). My 
work provides an extensive characterization of single and compound HH co-receptor mutants 
across multiple tissues; uncovering novel roles. Specifically, my analyses revealed a novel 
antagonistic role for Boc during craniofacial development (Chapter Two) and a novel positive 
role for Cdon in limb development (Chapter Three).  
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A particularly exciting result was the discovery that Boc differentially regulates HH 
signaling during craniofacial development. Previous studies concluded that Boc-/- embryos did 
not display any HPE phenotypes, but its deletion in a Gas1 or Cdon null background enhanced 
the severity of the HPE defects (Seppala et al., 2014; Zhang et al., 2011). However, in mouse 
models the severity of the craniofacial defects depends on the genetic background of the mouse 
model (Hong and Krauss, 2018). Generally, in a mixed (129/Sv/CD-1/C57Bl/6J) background the 
craniofacial defects associated to HPE are mild, while in C57Bl/6J background the phenotypes 
are extremely severe (Hong and Krauss, 2018). The differences in the severity of the craniofacial 
defects is attributed to silent modifier genes in each genetic background (Hong and Krauss, 
2018). Mutations in silent modifier genes do not produce craniofacial defects but can alter the 
phenotype of another mutation that exhibit a phenotype (Hong and Krauss, 2018). One of the 
major caveats of some of the previous studies was their lack of control of the genetic background 
of the HH co-receptor mouse models (Seppala et al., 2014). My research addressed this caveat by 
examining all the HH co-receptor mutants on a congenic C57BL/6J background. In addition, I 
performed an extensive examination of HH transcriptional targets within the craniofacial 
structures and in other HH-responsive tissues to establish tissue-specific differences. 
Surprisingly, loss of Boc in a C57BL/6J resulted in internasal distance widening, increased levels 
of Gli1 in the nasal processes, and increased proliferation in the cranial neural crest-derived 
mesenchyme. Other HH-responsive tissues such as the limbs and the ventral neural tube had 
normal levels of HH transcriptional targets. In contrast, the deletion of Gas1 and Cdon results in 
severe HPE defects and decreased Gli1 transcript. These data suggest that Boc works in 
opposition to Gas1 and Cdon in the craniofacial structures by antagonizing HH signaling. 
Moreover, I also demonstrated that deletion of Boc in a Gas1 null background ameliorates the 
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craniofacial defects observed in Gas1 single mutants. Interestingly, the rescue of the craniofacial 
defects in Gas1;Boc mutants is restricted to certain craniofacial structures, including the nostrils, 
nasal bone and snout, further confirming that Boc functions in a tissue-specific manner. Thus, 
these data demonstrate that Boc functions as a tissue-specific antagonist of HH signaling during 
craniofacial development and opens a series of mechanistic questions about how it interacts with 
SHH ligand to regulate HH signaling.  
My thesis research also revealed a novel role for Cdon during limb development. 
Interestingly, previous studies determined that Gas1 and Boc, but not Cdon had a role in digit 
specification during limb patterning (Cole and Krauss, 2003). This conclusion was based in the 
lack of phenotypes in Cdon mutants and its inability to enhance the severity of the limb defects 
in a Gas1 or Cdon null background. However, in some tissues these co-receptors are functionally 
redundant. To define a role for Cdon during limb development, I wanted to analyze triple HH-
coreceptor mutants. To generate this mutant I utilized a novel Cdon conditional allele in 
combination with a Prx1-Cre driver in a Gas1;Boc null background (Logan et al., 2002). My 
data indicate that Prx1-Cre;Gas1-/-;Cdonfl/fl;Boc-/- mutants exhibit severe digit specification 
defects and patterning defects in the radius, ulna, tibia and fibula. These data indicate that Cdon 
does contribute to proper HH-dependent limb development. Overall the findings of my thesis 
research demonstrate that HH co-receptors are tissue-specific, multi-functional regulators of HH 
signaling during vertebrate embryogenesis.  
 
4.2 Future directions  
The data presented in Chapters Two and Three have generated a series of open questions 
about HH co-receptor function during vertebrate embryogenesis. In this section I highlight 
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several interesting questions based on my data and propose a series of experiments that will 
address these questions. 
 
What is the consequence of Boc deletion on HH signaling across different genetic backgrounds? 
My data demonstrate that on a C57BL/6J background E10.5 Boc-/- embryos display 
internasal distance widening and increased levels of HH signaling. However, in mouse models 
the severity of the craniofacial defects can be influenced by the genetic background (Hong and 
Krauss, 2018; Schachter and Krauss, 2008). To investigate whether these phenotypes persist on a 
different genetic background, I would examine Boc-/- embryos on a congenic 129S4/SVJaeJ 
background. On a 129 background the craniofacial defects are less sensitive to be altered by 
modifier genes (Hong and Krauss, 2018; Schachter and Krauss, 2008). I have been working to 
backcross mice carrying the Boc mutant allele from a C57BL/6J to a 129S4/SVJaeJ background. 
After ten generations of backcrossing, I now have Boc mutant animals maintained on a congenic 
129 S4/SVJaeJ background. In the future, I would examine Boc-/- embryos to quantify the 
internasal distance, determine the levels of Gli1 by qPCR and whole mount in situ hybridization, 
and the levels of GLI1 protein by western blot. With this experiment I would be able determine if 
the gain-of-function phenotype and antagonistic function of Boc is dependent on genetic 
background. If Boc-/- embryos do not display similar phenotypes on a 129S4/SVJaeJ background, 
this would suggest that the function of Boc is influenced by strain-specific silent modifier genes. 
If this is the case, I could use the Boc mouse models maintained on the separate 129S4/SVJaeJ 
and C57BL/6J backgrounds to identify the modifier genes that dictate its function. To analyze 
modifier genes, I could analyze the transcriptome of the heads of E9.5 and E10.5 Boc-/- embryos 
by RNA deep sequencing and subsequently performing gene expression analyses. This 
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experiment could also be performed with Gas1 and Cdon mutants which display variable HPE 
phenotypes in 129S4/SVJaeJ and C57BL/6J backgrounds.  This approach is currently being 
utilized to analyze the variable HPE phenotypes in Lrp2 mutant mice in two different 
backgrounds, where 138 genes were differentially regulated when the C57BL/6N and FVB/N  
strains were compared (Mecklenburga, 2017). Understanding how genetic background 
influences the function of HH co-receptors such as Boc will be critical to understand the 
variability in the craniofacial defects in mice and human HPE patients. 
 
What are the effects of mesenchyme-specific deletion of Boc on craniofacial development? 
The increased levels of Gli1 in the mesenchyme of the nasal processes and the increased 
proliferation in the cranial neural crest-derived mesenchyme of Boc-/- embryos suggests a tissue-
specific antagonistic function for Boc during craniofacial development. To further investigate a 
potential antagonistic function for Boc, I propose to conditionally delete this gene specifically in 
the mesenchyme. To perform this experiment, I would utilize a Boc conditional allele 
(Boctm1a(KOMP)Wtsi) that is available from the Knockout Mouse Project (www.komp.org). This 
allele would be used in combination with either Pdgfr𝛼-CreER or Wnt-1-Cre2 drivers to 
specifically delete Boc in the mesenchyme of the developing craniofacial structures and in neural 
crest cells respectively (Chung et al., 2018; Lewis et al., 2013). Using this approach, I expect to 
compare the effects of the ubiquitous deletion of Boc with mesenchyme- or neural crest cell-
specific deletion. I could expect several different scenarios when comparing these animals: 1) 
mesenchymal deletion of Boc phenocopies the germline mutants, confirming that Boc acts as a 
tissue-specific HH pathway antagonist; 2)  mesenchymal deletion of Boc  results in a more 
severe phenotype, suggesting that upon Boc deletion, the HH signaling pathway compensates 
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this loss by increasing the levels of HH activity; 3) mesenchymal deletion of Boc results in a less 
severe phenotype, suggesting that the increase HH signaling in the craniofacial mesenchyme is 
an indirect or cell-non-autonomous result of Boc deletion in a different craniofacial tissue 
compartment like the surface ectoderm (which was not explored in Chapter 2). In this case, I 
could use the Foxg1-Cre which drives Cre-mediated recombination in the cranial epithelium and 
telencephalon (Hebert and McConnell, 2000). To extend these genetic experiments and 
investigate the mechanism of a putative antagonistic function for Boc in the mesenchyme, I 
could use FACS to isolate recombined mesenchymal cells (based on either PDGFRa expression 
or by tdTomato expression using a reporter allele) and perform bulk RNA-Seq. This would allow 
for the identification of targets genes that are upregulated or downregulated after the 
mesenchymal or neural crest ablation of Boc, providing mechanistic insight into specific genes 
that might act downstream of BOC to antagonize HH signaling. Additionally, I could utilize the 
Boc conditional allele to delete Boc during different stages of craniofacial development, to more 
precisely assess when and where BOC is critical for HH-dependent craniofacial patterning. By 
performing this experiment, I could define if Boc functions as an antagonist throughout 
craniofacial development or just at specific stages. For example, I would be interested to 
investigate Boc function during both early craniofacial development around E7.5 when Boc 
expression initiates, and at later stages at E10.5 when the facial prominences begin to form the 
craniofacial structures.  
 
Is the antagonistic function of Boc partially masked by redundancy with other HH pathway 
antagonists?  
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 Multiple proteins at the cell surface have the ability to antagonize HH pathway activity 
including PTCH1, PTCH2, HHIP, LRP2, GPR161, and a subset of GPCs (Carpenter et al., 1998; 
Christ et al., 2015; Holtz et al., 2015; Holtz et al., 2013; Marigo et al., 1996; Mukhopadhyay et 
al., 2013; Nieuwenhuis et al., 2006; Williams et al., 2010). Previous studies have demonstrated 
that these proteins function redundantly and compensate for the absence of each other (Holtz et 
al., 2013; Jeong and McMahon, 2005). Even though Boc-/- embryos display widening of the 
internasal distance in the craniofacial structures, it is a subtle phenotype that was overlooked by 
previous studies. One possibility is that the antagonistic function of Boc is masked by the 
redundant activity of other HH pathway antagonists. To test this hypothesis, I propose to 
generate different compound mutants lacking HH pathway antagonists. Specifically, I plan to 
examine Boc-/-;Hhip-/-, Boc-/-;Ptch2-/- and Boc-/-;Hhip-/-;Ptch2-/- E10.5 embryos. In these mutants 
I would examine the gross morphology of the embryo and analyze patterning in the craniofacial 
structures, ventral neural tube and the limb bud by examining the expression of different HH 
pathway targets. If I do not observe any apparent phenotypes, I could also perform similar 
experiments by targeting Ptch1. Previous studies from our lab by (Holtz et al., 2013) to address 
possible redundancy between HH pathway antagonists, utilized an MT-Ptch1 transgene which 
produces low levels of HH signaling that largely rescue the gain-of-function HH phenotypes 
observed in Ptch1 mutants (Milenkovic et al., 1999). Taking advantage of this tool (Holtz et al., 
2015) performed the double and the triple deletion of Hhip, Ptch2, MT-Ptch1;Ptch-/-, revealing a 
collective requirement for HH inhibition in the neural tube. Based on this study I could generate 
Boc-/-;MT-Ptch1;Ptch-/- animals and also integrate the deletion of Hhip and Ptch2 to reveal if Boc 
function can be masked by the redundant function of these proteins. 
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Are the structural requirements for the HH co-receptors similar in the spinal cord and in the 
forebrain? 
 Previous studies from our lab have shown that CDON and BOC employ distinct 
structural domains to promote HH signaling in the developing spinal cord (Song et al., 2015). 
This study performed a gain-of-function approach by overexpressing different CDON and BOC 
constructs in the developing spinal cord by chicken in ovo electroporations. However, the 
artificial nature of overexpression studies could affect the interpretations of the results. To 
circumvent this issue, I propose to perform this type of experiment but in mutant mouse embryos 
lacking different HH co-receptors. To perform this experiment, I would take advantage of the 
whole mouse embryo roller bottle culture system (Sakai and Trainor, 2014), which would allow 
me to culture mouse embryos lacking Gas1, Cdon and Boc from E8.5-E11.0. The Allen lab has 
an entire series of GAS1, CDON and BOC constructs that lack specific domains of each protein. 
These constructs would be injected into the lumen of the spinal cord, and in the forebrain 
mesenchyme and subsequently electroporated. If the overexpression of the constructs is 
inefficient, alternatively we can deliver the constructs by viral infection. With this technique I 
would be able to define which domains are required for the promotion of HH signaling in the 
spinal cord and in the developing forebrain in the same embryos. Analysis of HH pathway 
targets in both tissues can be examined by immunofluorescence or RNAscope.  Specifically, I 
would like to test the requirements for membrane attachment, the cytoplasmic domain, and 
extracellular interactions with PTCH1 in these two tissues. Additionally, this system could be 
also used to overexpress constructs with mutations identified in human birth defects associated 
SHH, like HPE, where mutations have been identified in Gas1, Cdon and Boc (Bae et al., 2011; 
Hong et al., 2017; Ribeiro et al., 2010). 
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Does the cytoplasmic domain of Boc contribute to its tissue-specific functions? 
 CDON and BOC are two very similar proteins from the Ig superfamily (Kang et al., 
2002). These co-receptors share significant amino acid identity and structural motifs in their 
extracellular domains (Kang et al., 2002). Interestingly, their cytoplasmic domains are unique 
and do not share any homology with each other or with any other proteins (Kang et al., 2002). 
Recently, studies have identified proteins that bind to the BOC cytoplasmic domain:  the non-
receptor tyrosine kinase ABL and the adaptor protein ELMO1 (Makihara et al., 2018; Vuong et 
al., 2017). These data suggest that the cytoplasmic domain could be essential to mediate tissue-
specific HH-dependent functions, or HH-independent functions that could lead to the activation 
of distinct intracellular signaling cascades. To test a potential role for the BOC cytoplasmic 
domain, I propose to generate a Boc mouse mutant lacking this region. This mouse model could 
be generated by taking advantage of CRISPR/CAS9 technology (Hsu et al., 2014). This region is 
comprised by 238 amino acids, and previous studies have shown that it is dispensable for HH 
signal transduction in the neural tube and during myogenic differentiation (Kang et al., 2002; 
Song et al., 2015). Next, I could define the effects of the deletion by examination of defects in 
multiple HH-responsive tissues such as craniofacial structures, the spinal cord and the limb bud. 
In addition, I could also exchange the cytoplasmic domain of BOC with that of CDON. Distinct 
from BOC, the cytoplasmic domain of CDON is required for myogenic differentiation and 
dispensable for HH signal transduction in the neural tube (Kang et al., 2002; Song et al., 2015). 
The generation of these mouse models would allow for the assessment of the contribution of the 
BOC cytoplasmic domain in HH signal transduction in vivo. Lastly, we could knock in Cdon 
into the Boc locus, and Boc into the Cdon locus to investigate whether the differential 
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contributions of these genes are due to differences in protein function or due to differences in 
expression.  
 
How does BOC interact with HH ligands? 
Previous studies have demonstrated that the HH ligand binds to the third FNIII domain of 
BOC (McLellan et al., 2008; Tenzen et al., 2006). The current paradigm is that SHH ligand also 
binds to PTCH1 through a different interface, forming an active complex of BOC-SHH-PTCH1 
(Qi et al., 2018a; Qi et al., 2018b). However, its unknown if this co-receptor-ligand-receptor 
complex exists in vivo, and if so, where it is localized within a cell, and whether this localization 
may vary from one tissue to the next. Recent studies of commissural axon guidance in vivo 
suggest that SHH induces BOC internalization into early endosomes through an endocytic 
adaptor NUMB (Ferent et al., 2019). This internalization event is required for proper SHH-
mediated axon guidance (Ferent et al., 2019). Another example of a receptor that regulates 
endocytosis and cellular trafficking of the SHH-PTCH1 receptor complex is LRP2, which 
controls SHH ligand concentration (Christ et al., 2012). I propose that understanding the 
localization of SHH-BOC complexes in vivo can help to elucidate the mechanism by which BOC 
regulates HH signaling.  
To address this question, I propose two different approaches. First, I could perform 
proximity ligation assays to detect in situ physical interactions between SHH and BOC in tissue 
sections that express SHH (Fredriksson et al., 2002). I would be particularly interested, but not 
limited, to examine these interactions in tissue sections of craniofacial structures, where SHH is 
expressed in the ventral forebrain and in the medial nasal process. A second approach to 
visualize the interactions in vivo would be to generate alleles of Shh and Boc that contain split 
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GFP domains. Specifically, this technique is called bimolecular fluorescence complementation 
(BiFC) (Foglieni et al., 2017). This technique requires the splitting of a GFP protein into two 
different fragments of different sizes (Foglieni et al., 2017). The first fragment is comprised of 
216 amino acids and has the first ten 𝛽 strands of GFP (GFP1-10), while the second fragment 
contains 16 amino acids and has the eleventh 𝛽 strand of GFP (GFPs11), which is a very small 
protein tag (Foglieni et al., 2017). Ideally, I would utilize CRISPR/CAS9 technology to perform 
a targeted insertion of the GFP fragments in the Boc and Shh loci (Hsu et al., 2014). The GFP1-10 
fragment will be inserted after the signal peptide of the Boc locus and the GFPs11 fragment in the 
Shh locus before the cholesterol attachment site (a new intein cleave-cholesterol site will have to 
be engineered to ensure proper ligand processing). Following the successful generation of these 
alleles and subsequent mouse breeding to generate Boc:GFP1-10; Shh;GFPs11 animals, I would be 
able to use GFP expression to visualize sites of interaction between SHH and BOC. Importantly, 
a related approach has been previously used by (Chamberlain et al., 2008), in which they 
generated mice that produce SHH ligand fused to a GFP protein instead of wildtype SHH. This 
study demonstrated that this modified version of SHH undergoes regular processing but is less 
efficient, and heterozygous mice were normal while homozygous mice displayed reduced levels 
of SHH and were stillborn (Chamberlain et al., 2008). Notably, for these proposed experiments, I 
would not need to generate homozygous animals; Boc:GFP1-10; Shh;GFPs11 compound animals 
should suffice to visualize GFP. Further, it is possible that the use of a smaller GFP fusion (16 
amino acids instead of 238) will allow for normal SHH function such that homozygous animals 
will be viable. Even with these caveats, these will be useful tools to directly observe and localize 
the interaction of SHH and BOC during embryogenesis. Specifically, I will be able to visualize 
the in vivo interactions of SHH and BOC in multiple tissues and define the subcellular 
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localization of these interaction as well as temporal changes in these interactions. If successful, 
this approach could be extended to investigate SHH interactions with other HH co-receptors (i.e., 
GAS1 and CDON) as well as with the canonical receptor, PTCH1. Finally, I could perform 
analogous experiments to generate split GFP alleles of Ihh and Dhh to examine potential 
differences in the localization and dynamics of ligand-receptor interactions between different HH 
ligand and HH receptor pairs. 
 
Could Gas1, Cdon and Boc differentially regulate gene expression during craniofacial 
development? 
 The deletion of the HH co-receptors results in variable craniofacial defects. Specifically, 
Gas1 and Cdon mutants display highly variable HPE defects, while Boc mutants display facial 
widening at E10.5. Interestingly, the severity of the HPE defects and the facial widening in these 
mutants, correlate with the downregulation and upregulation of Gli1 respectively. These data 
suggest that the HH co-receptors differentially regulate Gli1 expression during craniofacial 
development. Also, it raises the possibility that the HH co-receptors could differentially regulate 
the expression of other genes during craniofacial development. To address this question, I 
propose to assess the changes in gene expression in E10.5 heads of Gas1-/-, Cdon-/- and Boc-/- 
embryos by single cell RNA-seq (Kolodziejczyk et al., 2015). This method would allow me to 
examine changes in gene expression at a single cell resolution and throughout the different 
populations that comprise the craniofacial tissues in the same embryo. Specifically, I would like 
to examine, 1) overall changes in gene expression and 2) changes in specific tissue 
compartments (mesenchyme, surface ectoderm and forebrain neuroepithelium) and 3) changes in 
in the distinct facial prominences. Particularly, I would like to examine the expression levels of 
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the Fox genes, which are HH transcriptional targets in the craniofacial structures (Jeong et al., 
2004). Additionally, I would like to determine if there are any gene expression differences that 
correlate with the variable severity in the phenotypes of Gas1 and Cdon mutants and the 
widening of Boc mutant embryos. Finally, I will be able to determine if there are any stochastic 
changes in expression that correlate with the variable phenotypes in the craniofacial structures. 
 
What roles do HH co-receptors play in postnatal development, adult tissue homeostasis, and 
tissue regeneration? 
To date the available knockout alleles for Gas1, Cdon and Boc have provided numerous 
insights about their role in HH signal transduction (Allen et al., 2011; Allen et al., 2007; Cole 
and Krauss, 2003; Martinelli and Fan, 2007; Seppala et al., 2007; Seppala et al., 2014; Tenzen et 
al., 2006; Zhang et al., 2011; Zhang et al., 2006). However, the redundancy of these cell surface 
regulators of HH signaling requires the generation of triple mutant embryos to reveal their full 
contribution (Allen et al., 2011). Unfortunately, these embryos die around E9.5, which precludes 
a complete analysis of co-receptor function during later developmental stages, not to mention 
during postnatal development and in adult tissue function. Therefore, news tools are required to 
understand HH co-receptor function in different tissues at later developmental stages. One 
solution is to generate triple HH co-receptor conditional mice to define their contribution to 
postnatal development, adult tissue homeostasis and tissue regeneration. Conditional alleles for 
Gas1, and Cdon are already available, and in a previous section I described the existence of a 
conditional Boc allele that is available through the Knockout Mouse Project (Bae et al., 2020; Jin 
et al., 2015). Having these alleles available will provide a great opportunity to explore the 
individual and collective roles for the HH co-receptors in different tissues. To explore the 
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function of the HH co-receptors in multiple adult tissues, I would perform the triple conditional 
ablation of the HH co-receptors using the ubiquitous Cre, ROSA26-CreERt2 (Ventura et al., 
2007). With this approach I will be able to examine all adult tissues and screen for potential 
phenotypes. Notably, HH signaling plays key roles in several tissues such as the skin and the 
lingual epithelium in which I could explore HH co-receptor function (Abe and Tanaka, 2017; 
Mistretta and Kumari, 2019).  
Taken together, the data presented in this dissertation demonstrates that the HH co-
receptors are tissue-specific regulators of HH signaling during vertebrate embryogenesis. 
Specifically, I provide evidence that shows that BOC antagonizes HH signaling in the 
craniofacial structures. Also, I uncovered a role for CDON in digit specification and limb 
patterning. These results provide novel insights about the mechanisms by which the HH co-
receptors regulate HH signal transduction during vertebrate embryogenesis. The future directions 
proposed in this section provides a strong foundation for further experiments that will elucidate 
the role of the HH co-receptors in HH pathway function during development, adult tissue 
homeostasis and disease. Expanding the genetic tools available to study the HH co-receptors will 
be essential to broaden our understanding about their mechanistic function in different tissues. 
Furthermore, the careful and detailed simultaneous examination of single and compound HH co-
receptor mutants will provide insights into their collective and distinct functions in HH signal 








Figure 4.1 Summary of the tissue-specific roles of the HH co-receptors 
(Left panel) Schematic of the HH co-receptor structure. (Middle panel) Tissues in which the HH co-receptors positively regulate 
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